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 Development of multicellular organisms requires precise coordination of gene 
expression, regulated by alterations in genomic accessibility and chromatin structure.  
Changes in chromatin architecture also mediate the transition from plasticity to cell fate 
commitment.  This work describes a candidate RNAi screen in C.elegans designed to 
identify factors functioning in transcriptional silencing, based on 
enhancement/suppression of phenotypes associated with mutants in three major 
transcriptional silencing pathways: mes-3/Polycomb, met-2/SET-DB1, and hpl-1; hpl-
2/HP1. 
 Strikingly, all known members of the Mes/Polycomb pathway of transcriptional 
repression, including members of PRC2 (mes-2/mes-3/mes-6), mes-4, and set-2 strongly 
suppress the hpl-1; hpl-2 larval arrest phenotype.  A number of additional factors also 
strongly suppressed hpl-1; hpl-2 arrest, including members of the COMPASS/MLL 
complex (H3K4me), members of the NuA4 HAT complex, members of SWR1 
nucleosome remodeling complex (incorporation of H2A.Z), O-GlcNAc transferase 
(catalyzes a type of posttranslational modification), a novel factor (T19B4.5), and two 
proteins involved in DNA repair.  
Based on the hypothesis that the strong hpl-1; hpl-2 suppression signature 
indicates association with the Mes pathway, these genes were tested in a number of 
secondary analyses related to Mes function, including maternal effect sterility, germline 
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morphology, H3K27 methylation, interaction in the SynMuv pathway of vulval 
specification, suppression of mep-1/NuRD larval lethality, and desilencing of tandem 
arrays in the germline.  Phenotypes associated with these assays suggest that hpl-1; hpl-2 
suppressors can be divided into two classes based on similarity to either MES-4 or PRC2 
phenotypes. 
Data suggest that the activating complex(es) NuA4/SWR1 interact with MES-4, 
and may contribute to repression of X linked gene expression.  Our analyses also indicate 
that the COMPASS complex likely functions in the Mes/PcG pathway in two or more 
forms, one of which is independent of SET-2.  Phenotypes associated with SET-2-
independent COMPASS complex correlate well with mes-4, while SET-2 may interact 
more closely with MES/PRC2.   
 This work also demonstrates a novel phenotype associated with the coiled-coil 
protein T19B4.5.  Loss of this factor induces upregulation of let-858::GFP transgenic 
constructs in the soma, coupled with reduced expression in the germ line.   These data 
suggest that T19B4.5 may modulate both the SynMuv and Mes pathways in a context 
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Gene expression in eukaryotes is regulated in part by alteration of genomic 
accessibility and chromatin structure.  Chromatin is made up of DNA that is wrapped around  a  histone  octamer  core,  organizing  the  DNA  into  less  compact transcriptionally active and more compact quiescent domains.     Each histone has a labile  tail  that  is  subject  to  posttranslational  modifications  which  function  to regulate  chromatin  compaction  and  transcriptional  output.   Histone modifications can also act as binding platforms for chromatin remodeling complexes that  induce further changes in chromatin structure.    The Polycomb Repressive Complex PRC2 mediates trimethylation of histone 3  lysine  27  (H3K27me3),  a  mark  that  is  strongly  correlated  with  transcriptional silencing and chromatin compaction (Campos & Reinburg, 2009; Simon & Kingston, 
2009; Yuzyuk et al., 2006).      However,  the  mechanisms  regulating  transcriptional repression  downstream  of  the  H3K27me3  mark  remain  unclear.      Although controversial, a complex known as PRC1 is thought to bind H3K27me3 and induce PRC2  mediated  transcriptional  silencing  by  ubiquitination  and  nucleosome compaction  (Margueron  and  Reinberg,  2011).        Yet  some  species,  including  C. 
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elegans and plants, appear to  lack a functional PRC1 complex (Wenzel et al., 2011; Simon and Kinston, 2009).   Moreover, PRC1 is not present at all PRC2 silenced loci in flies and mammals (Ku et al., 2008; Schwartz et al., 2006; Boyer et al., 2006; Leeb et 
al 2010, Schoeftner et al., 2006).  These data suggest that additional factors cooperate in PRC2 induced transcriptional repression.   The C.elegans PRC2 complex is comprised of MES‐2/E(z), MES‐6/Esc, and the novel  factor MES‐3 (Bender et al., 2004).     As  in other species,  the C. elegans PRC2 complex mediates H3K27  trimethylation,  and  is  required  for H3K27me3 marks  in much of  the  germ  line  and during  early  embryogenesis  (Bender  et  al.,  2004).      In addition to maternal effect sterility (mes) induced by germ line necrosis and loss of H3K27me3, mes deficiency results in several phenotypes, including derepression of high copy transgenes in the germline, changes in RNAi efficacy, and suppression of the  synthetic multivulva  (SynMuv)  phenotype  (Capowski  et  al.,  1991,  Kelly  et  al., 1998, Wang et  al.,  2005; Kim et al.,  2005, Cui et  al.,  2006).   Previous  studies have suggested that the phenotypes associated with loss of PRC2 complex function result from  derepression  of  X‐linked  genes,  as  H3K27me3  is  enriched  on  the  X chromosome  in  the wildtype C. elegans germ  line  (Bender,  2004).    Further,  in  the absence of PRC2 complex function, activating marks become ectopically localized to the X chromosomes (Fong et al., 2002).  Silencing  of  the  X  chromosomes  in  the  adult  germ  line  also  requires  the conserved methlytransferase MES‐4,  which  catalyzes methylation  of  histone  3  on lysine  36  (H3K367me2/3),  a  mark  generally  associated  with  transcriptional activation  (Bender  et  al.,  2006).      Loss  of  MES‐4  phenocopies  loss  of  PRC2 
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components, and functional PRC2 is required to restrict MES‐4 activity to autosomes (Bender et al., 2006; Fong et al., 2006).   It is currently unclear how MES‐4 and PRC2, which have seemingly opposing functions,  repress X‐linked transcriptional activity and regulate chromatin dynamics in the germ line and early embryo.      In addition, and in contrast to the germ line, loss of Polycomb‐mediated transcriptional silencing has very subtle effects in somatic tissues. This is surprising, given the global role of Polycomb  repressor  complexes  in  other  organisms.  Together,  these  data  suggest that  additional  silencing  factors  might  be  required  to  regulate  transcriptional silencing in C. elegans.    SynMuv  factors  represent  one  interesting  class  of  candidates  that  may function coincident to the MES pathway of transcriptional silencing.  SynMuv factors represent  a  large  group  of  proteins,  many  of  which  are  involved  in  chromatin structure  and  regulation  of  gene  expression.    A  number  of  these  factors  are associated  with  loss  of  function  phenotypes  similar  to  those  of  mes  mutants, including changes in RNAi efficacy and germ line expression of transgenes.   Loss of the  SynMuv  factor  HP1  (heterochromatin  protein  1),  encoded  by  the  partially redundant hpl‐1 and hpl‐2, induces temperature sensitive larval arrest, a phenotype that  is  suppressed  by  loss  of mes‐2, mes‐3, mes‐6,  or mes‐4  (Schott  et  al.,  2006; Simonet et al., 2007).  This genetic interaction suggests that the PRC2/Mes pathway may  function  in  conjunction  with  HP1  to  regulate  patterns  of  gene  expression during development and germ line maturation.   To identify additional candidates functioning in transcriptional silencing in C. 
elegans, we performed a  candidate RNAi  screen and  isolated genetic  enhancers of 
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mes‐3/Polycomb  as well  as  enhancers  and  suppressors  of hpl‐1; hpl‐2/HP1.    Two classes  of  genes  were  predicted  to  function  in  PRC2‐mediated  transcriptional repression: 1)   genes that enhance mes‐3 maternal effect sterility (similar to set‐2) (Xu  and  Strome,  2001);  and  2)  genes  that  suppress  the  hpl‐1;  hpl‐2  temperature sensitive  larval  arrest  phenotype  (similar  to  loss  of  the Polycomb genes).     Of  the 738  RNAi  clones  tested,  loss  of  97  genes  resulted  in  enhancement  of  the mes‐3 phenotype, while only 17 resulted in strong suppression of hpl‐1; hpl‐2.   The hpl‐1; 
hpl‐2  suppressor  class  includes  all  factors  previously  shown  to  function  in  the MES/PRC2 pathway, demonstrating the strength of our approach.  Intriguingly, the 
hpl‐1;  hpl‐2  suppressor  category  also  contains  multiple  components  of  two complexes generally associated with transcriptional activation:  the COMPASS/MLL complex, which functions as a histone 3 lysine 4 (H3K4) methylation and regulatory complex, and the NuA4/SWR1 complex, which mediates the acetylation of histone 4 as well as incorporation of the histone variant H2A.Z. We  further  characterized  the  hpl‐1;  hpl‐2  suppression  cohort  in  order  to define  the  role  of  these  activation  complexes  within  the  context  of  MES/PRC2 mediated  transcriptional  silencing.   These  secondary  analyses  included  testing  for changes in localization and concentration of chromatin marks, germ line expression of a transgenic array, and a number of additional assays for mes‐related phenotypes.   We show that phenotypes associated with loss of COMPASS/MLL and NuA4/SWR1 complex function appear closely correlated to loss of MES‐4. Based on our findings, we hypothesize that the primary role of the PRC2 complex is not simply to inhibit X‐
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linked  gene  expression,  but  also  to  aid  in  targeting  activation machinery  such  as COMPASS/MLL and NuA4/SWR1 to specific loci.   
Chromatin dynamics, transcriptional  
regulation, and cellular plasticity 
 
Chromatin and transcriptional regulation   
 
Gene expression in eukaryotes is regulated in part by alteration of genomic 
accessibility and chromatin structure, which are controlled by a number of mechanisms.   
Chromatin compaction is highly dynamic; euchromatic DNA is accessible to interacting 
factors and associated with active transcription, while heterochromatic domains are 
generally silent.  Eukaryotic chromatin organization is mediated by the formation of 
nucleosomes, 146 base pairs of DNA wrapped around a histone octamer core composed 
of two copies each of H2A, H2B, H3 and H4.  Histone H1 functions as a linker histone, 
and aids the compaction of nucleosomes thought to limit accessibility to transcriptional 
regulation, replication, and repair machinery.   
The reversible posttranslational modification (PTM) of histone tails is thought to 
be one of the driving forces behind changes in genomic structure.  Histone tail 
modifications include phosphorylation, methylation, acetylation, ubiquitination, 
sumoylation, and poly-ADP ribosylation.   These modifications are tightly regulated by a 
number of enzymes including kinases, methyltransferases (HMTs), demethylases, histone 
acetyltransferases (HATs), deacetylases (HDACs), ubiquitin ligases, and others 
(Kouzarides, 2007).  The type of mark, the residue modified, and the level of 
modification (i.e., mono, di, trimethylation) are key determinants of the resulting 
transcriptional readout (Kouzarides, 2007).  In addition to the introduction of direct steric 
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changes, PTMs also serve as docking sites for “reader” proteins and complexes.   
Different modifications can induce or inhibit subsequent PTMs and effector interactions; 
this cross- talk occurs both in cis and in trans (Lee et al., 2010).  The modification of 
histone tails and the association of effector molecules can influence local chromatin 
architecture, as well as promote or inhibit transcriptional activity; however, much of the 
data is strictly correlative.   
In addition to the somewhat controversial “histone code” of post-translation 
modifications, chromatin dynamics are also controlled by nucleosome remodeling 
complexes and the incorporation of histone variants (i.e., H2A.Z, H3.3) which promote 
nucleosome diversity and influence chromatin structure by altering interactions between 
DNA and nucleosomes and/or changing the accessibility of genomic elements to 
regulatory factors.   Nucleosome remodelers are enzyme-containing complexes that 
utilize ATP hydrolysis to facilitate histone octamer sliding, removal, and/or exchange of 
histone variants.  Chromatin remodeling complexes are divided into several subclasses 
based on the structure of the ATPase domain; these include the SWI/SNF, IWSI, CHD, 
and INO80 families (Lu et al., 2009).  In yeast, the INO80 family contains the NuA4 
complex and SWR1, but in mammals and Drosophila, these function as a single complex 
called Tip60-p400, capable of both remodeling and HAT activity (Hargreaves & Crabtree, 
2011).   
 
Types of chromatin 
Active chromatin, or euchromatin, is associated with productive transcription and 
correlates with engaged RNA Polymerase II (PolII) and a specific cohort of histone 
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marks.   Generally, the promoter regions of actively transcribed genes contain H3K4me3, 
a mark catalyzed by Trithorax group proteins.  Elongation of RNA PolII is correlated 
with the deposition of H3K36me2/3 across gene bodies, while H3K4me3 and 
H3K36me2/3 correlate with the initiation and elongation phases of transcription (Schaner 
& Kelly, 2006).   Acetylation of histone tails is also associated with gene activity, and   
has been shown to sterically alter the nucleosome-DNA interaction, resulting in an open 
configuration thought to allow processivity of the RNA PolII complex (Campos & 
Reinburg, 2009).   Together, these marks define transcribed promoters and block off-
target interactions between polymerase and gene bodies.  
As shown in Figure 1, heterochromatin is defined by condensation of nucleosome 
bound DNA and associated proteins, forming a structure that is relatively stable and 
refractory to transcriptional machinery.  Heterochromatin is found in at least two forms.  
The first is constitutive heterochromatin, which is gene-poor, globally silenced 




Figure 1.  Different forms of chromatin.  Nucleosomes in heterochromatin are highly 
compact, and histone tails are modified with repressive marks and associated with co-
factors supporting the condensed state.   Euchromatic DNA is open and associated with 
transcriptional activity.   
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elements, suggesting that this type of domain evolved as a mechanism of genomic 
stability.  Constitutive heterochromatin is capable of silencing nearby genes (i.e., 
position-effect variegation), but appears to function primarily in the organization of 
nuclear sub-domains and chromosomal structures including telomeres and centromeres 
(Grewal & Moazed 2003).  
Facultative heterochromatin includes regions of the genome targeted for silencing 
in a context-specific manner, including individually silenced loci that are repressed in a 
spatial and/or temporal-specific manner.  Genes silenced by facultative heterochromatin 
can be expressed in response to specific cues, and regulation of gene expression by 
heterochromatin may play an important role in cell fate specification and differentiation 
(Jenuwein & Allis, 2001).   
Some histone modification states are shared by both constitutive and facultative 
heterochromatin, including hypoacetylation and H3K9me2/3.   However, H3K9me3 
(trimethyl) is generally associated with constitutive heterochromatin, while H3K9me2 
(dimethyl) correlates with facultative silencing in most organisms (Trojer & Reinberg, 
2007).  Similarly, H4K20me3 and H3K27me1 mark constitutive heterochromatin, but 
H4K20me1 and H3K27me2/3 are associated primarily with facultative repression 
(Campos & Reinburg, 2009).  Heterochromatin protein 1 (HP1) has classically been 
associated with stabilization of constitutive silencing, but the role of HP1 has become 
somewhat less clear as different isoforms have been shown to function in a number of 
processes, including DNA repair and even active transcription (Kwon & Workman, 
2011).  Therefore, while both types of heterochromatin are involved in repression, they 
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are likely associated with different effector molecules and carry out different functions 
within a cell.   
Heterochromatin is an important feature of the genomic landscape, yet the 
mechanisms directing heterochromatin formation are currently unclear, as are the 
mechanisms responsible for heterochromatin remodeling and gene expression.  Current 
hypotheses suggest that directed heterochromatin formation may function during cell fate 
commitment and lineage specification.   
 
Transcriptional silencing: Plasticity to commitment 
One of the central questions facing developmental biologists today concerns the 
mechanisms mediating developmental potential and its loss during the onset of 
differentiation.  Pluripotency refers to the ability of a cell to differentiate into any of the 
three germ layers, and is often associated with the ability to self-renew, as has been 
observed for ES cells derived from a transient population of pluripotent cells in the 
blastocyst and cultured in vitro.   Within the context of an organism, pluripotent cells 
must proliferate, commit to specific cell fates, and become progressively restricted in 
developmental potential in order to generate a fully developed animal.  In addition, a 
subset of pluripotent cells must be compartmentalized (or be regenerated in some 
systems), in order to retain pluripotency and reproductive potential.  As cells become 
developmentally restricted and begin to acquire positional and cell type identity, global 
changes in chromatin structure occur concomitantly with changes in gene expression.  
Loss of pluripotency has been correlated with decreased transcriptional permissivity, 
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increased heterochromatic foci by EM, and the establishment of heritable gene expression 
programs (Mattout & Meshor; Efroni et al., 2008). 
The pathways controlling cell fate specification are well studied, as are the 
transcription factors involed in induction and maintenance of pluripotency.  However, the 
mechanisms coupling loss of pluripotency with cell fate establishment remain largely 
unexplored.  While ES cells represent an important model with which to study 
pluripotency, it is also important to address the mechanisms governing the transition from 
plasticity to cell fate specification in in vivo models such as C.elegans.  This system 
allows for a better understanding of endogenous mechansims, taking into account 
developmental timing, cell to cell interactions, etc., in cells that are not articially induced 
or maintained. 
 
Reorganization of chromatin during cell fate commitment 
One striking difference between pluripotent cells and differentiated cells is the 
makeup of the nuclear architecture.  By electron microscopy, the nucleoplasm of 
pluripotent cells appears diffuse; this open configuration is associated with euchromatin 
(Niwa, 2007; Leung et al., 1999).  The chromatin of embryonic stem (ES) cells is highly 
sensitive to nuclease activity, indicative of weak interactions between DNA, histone 
octamers, and structural proteins (Gaspar-Maia et al., 2011).  Chromatin in ES cells is 
also enriched with histone modifications associated with active transcription (including 
H3K4me3, H3K9ac3, and H4Ac).  For instance, H3K4 trimethylation is detected at 80% 
of annotated promoters in ES cells, while RNA PolII marks more than 50% of promoters, 
including transcriptionally silent loci (Guenther et al., 2007).  Studies indicate that ES 
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cells are transcriptionally permissive in a very general sense, with low level expression of 
lineage restricted genes and normally silent DNA repeats regions.   The short, aborted 
products of this permissive state have been proposed to participate in gene silencing at 
specific loci, with studies implicating RNA based mechanisms in the targeting of histone 
modifying enzymes and chromatin silencing complexes to loci targeted for 
heterochromatic repression (Fisher & Fisher, 2011; Mattout & Meshorer, 2010).    
Compared to pluripotent ES cells, the nuclei of differentiated cells contain 
numerous large areas of electron dense material associated with compact heterochromatin 
(Niwa, 2007; Meshorer & Misteli, 2006).   By ChIP and immuno-fluorescence based 
assays, lineage specification is accompanied by a global decrease in levels of active 
histone marks (such as acetylated histone H3 and H4, H3K4me3) and an increase in 
repressive histone marks (such as histone H3K9me) (Azuara et al., 2006; Meshorer et al., 
2006).  Studies employing DamID and ChIP-chip analyses to compare ES cells and their 
differentiated counterparts demonstrate that differentiated cells relocalize pluripotency 
factors to the nuclear lamina, an area highly correlated with gene silencing, while areas 
associated with H3K9me increase in size and abundance in a cell type specific fashion 
(Peric-Hupkes et al., 2010; Wen et al., 2009).   My work focuses on the identification of 
factors involved in chromatin compaction and transcriptional silencing during the 
transition from a developmentally plastic state to a lineage committed state, using the 






Polycomb and Pluripotency in Drosophila and mammals 
 Among the factors likely to function at the intersection of pluripotency and cell 
fate commitment are the Polycomb group (PcG) transcriptional repressors.  Initially 
identified as playing a role in the regulation of anterior/posterior body patterning via 
repression of Hox genes in Drosophila, Polycomb factors are now widely appreciated to 
function in a range of processes including cell cycle control, genomic imprinting, X-
inactivation, cell fate transitions, tissue homeostasis, and tumorigenesis (Surface et al., 
2010). 
Although many PcG proteins are well conserved in mammals, plants, Drosophila 
and C.elegans, the composition of the PcG complexes is likely to vary among different 
cell types in a context and perhaps organism specific manner.  The PcG transcriptional 
repressors generally associate with either Polycomb Repressive Complex (PRC) 1 or 2.  
While these complexes are functionally distinct, both are thought to regulate chromatin 
structure.   The PRC2 complex catalyzes the di and tri methylation of histone H3K27, 
and is composed of three core protein components in flies and mammals; the histone 
methyltransferase (HMT) Ezh2/E(Z), as well as Eed/Esc (WD40 domain) and Suz12 (Zn 
finger domain) (Schuettengruber et al., 2007; Surface et al., 2010; Simon & Kingston, 
2009).  The core PRC2 proteins interact with an ever expanding list of factors, including 
the generic histone binding proteins RbAp46/48 (also known as Rbbp7/4), an alternative 
HMT (EZH1), histone demethylases, such as Jarid2, AEBP2 (Zn finger), and several 
PCL (Polycomb like) proteins (Margueron & Reinberg, 2011).   The diverse interaction 
partners have been proposed to refine the function of the core complex, regulate 
enzymatic activity, facilitate conversion between di to tri H3K27 methylation, define 
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tissue specificity, and/or direct recruitment to target promoters (Surface et al., 2010; 
Sauvageau and Sauvageau, 2010).   
The core components of PRC1 complex include Pc (Polycomb), Ph 
(Polyhomeotic), Bmi1/Mel18, and the catalytic components Ring1A/B (Levine et al., 
2002).  PRC1 mediates the monoubiquitination of histone H2AK119 though the ubiquitin 
E3 ligase activity of RING1B, and may direct chromatin compaction independent of 
enzymatic activity (Francis et al., 2004; Eskeland et al., 2010).  Additional complexes 
involved in PcG function have been identified in both Drosophila and mammals, 
including the Pho Repressive Complex (PhoRC) and Polycomb Repressive 
Deubiquitinase (PR-DUB) (Levine et al., 2002).  Orthologs of these complexes, as well 
as the potentially regulatory subunits described above, remain to be identified in many 
species.  Based on these data, however, one emerging hypothesis suggests that multiple 
versions of PRC1 and PRC2 exist, with mounting evidence that alternative subunit 
compositions may confer distinct target gene specificity.  
PcG complexes (specifically PRC1 and PRC2) share a number of targets by 
genomewide analysis, including a large number of transcription factors, morphogens, 
receptors, and signaling proteins involved in major developmental pathways (Schwartz & 
Pirrotta, 2007).  However, whether the PRC1 and PRC2 complexes function 
cooperatively to silence target loci is currently unresolved.  PRC1 has been shown to bind 
directly to H3K27me3 via Pc, leading to the hypothesis that PRC1 functions downstream 
of PRC2 (Schwartz & Pirrotta, 2007); this model is schematized in Figure 2.   In support 




Figure 2.  Controversial interaction between Polycomb repressive complexes.  PRC2 
mediates H3K27me3.  PRC1 is thought to bind this methyl mark, induce ubiquitination 
of H2AK119 and initate chromatin compaction.   However, various studies suggest that 




and mammalian cell culture (Wang et al., 2004; Cao et al., 2002; Cao et al., 2005; Boyer 
et al, 2006).  Other studies supporting the idea that PRC1 function tracks with H3K27me 
marks employed H3K27 demethylation mutants and a viral methyltransferase, which 
both perturb the levels of H3K27me3 without affecting the PRC2 complex, yet induced 
changes in PRC1 targeting (Lee et al., 2007; Mujtaba et al., 2008).  Moreover, chromatin 
decompaction is observed in Ring1B (PRC1) deficient cells despite the presence of PRC2 
mediated H3K27me3 marks, suggesting that PRC1 is necessary to compact PRC2 target 
loci, and arguing against independent functions (Eskeland et al., 2010).   
In contrast, genomewide ChIP-seq analyses indicate that PRC1/H2Aub bound 
sites overlap with PRC2/H3K27me3 at only a subset of silenced promoters, and 
demonstrate the binding capacity of PRC1 in the absence of PRC2 methylation (Ku et al., 
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2008; Schwartz et al., 2006; Boyer et al., 2006; Leeb et al 2010, Schoeftner et al., 2006).  
For example, RING1B recruitment is independent of H3K27me2/3 and instead requires 
the presence of Xist at an early stage of X chromosome inactivation (Schoeftner et al., 
2006).  Studies have demonstrated that PRC1 remains bound at some target loci 
following depletion of H3K27me3 in fly and mouse, suggesting that PRC2 may not be 
required for PRC1 function (Nekrasov et al., 2007; Schoeftner et al., 2006; Lee et al., 
2007).   Lastly, the binding affinity between PRC1 and H3K27me3 is less than typical 
regulatory protein–DNA interactions, suggesting that although this binding is possible, it 
may not be probable in vivo (Schwartz & Pirrotta, 2007). 
Data supporting independent functions of PRC2 and PRC1 are not mutually 
exclusive with data supporting cooperative silencing; the H3K27me3 mark is likely to 
configure local chromatin environments and interact with any number of additional 
protein complexes at target loci, at least one of which is PRC1 in flies and mammals.  It 
has also been suggested that interactions between PRC1 and methylated H3K27 facilitate 
DNA looping and/or interactions between promoter elements and distal enhancers 
(Simon & Kingston, 2009).  In plants and worms, where the existence and function of 
PRC1 like complexes are less clear, it has been suggested that a multi functional complex 
capable of H3K27 methylation, chromatin compaction, and potentially coordination of 
H3K4 demethylation and resolution of bivalent domains, might abrogate the need for a 
PRC1 like complex (Whitcomb et al., 2007; Simon & Kingston, 2009).  Data indicating 
that chromatin compaction and gene silencing may not rely on the catalytic activities of 
PcG complexes adds to the mystery regarding how transcriptional silencing is achieved in 
vivo (Simon & Kingston, 2009; Eskeland et al., 2011).  
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Despite numerous recent studies, many unknowns remain to be examined 
regarding PcG proteins.  The H3K27me3 mark is clearly correlated with transcriptional 
repression, yet the specific mechanism(s) by which this repression is accomplished 
remains elusive.  While some histone tail modifications (i.e., H3K79, H4K20, and 
acetylation) have been shown to affect nucleosome-DNA interactions and higher-order 
chromatin structure, there is no evidence for H3K27me3 having these affects, and unlike 
PRC1, the core PRC2 complex does not compact nucleosome arrays in vitro (Simon & 
Kingston, 2009).  In fact, very little is known regarding how the PRC2 complex interacts 
with chromatin, as core components do not contain recognizable DNA binding motifs 
(Simon & Kingston, 2009).  Another unknown involves the localization of PcG 
complexes to specific target loci, although a number of methods of recruitment have been 
proposed, including Polycomb Responsive elements (PRE) in Drosophila, CpG islands in 
mammals, interactions with the PC-Rho complex, insulator sequences and directed DNA 
looping, as well as noncoding RNAs (ncRNAs) (Margueron & Reinburg, 2011).   
 
Polycomb and pluripotency 
Current models suggest that cellular plasticity is terminated when factors required 
for pluripotency are silenced, and/or regulators promoting differentiation are upregulated. 
Although the roles of PcG proteins in ES cells and pluripotency have been debated, 
studies suggest that PcG proteins are important to define cellular gene expression 
programs and ensure proper cell fate specification (Sauvageau and Sauvageau, 2010).  
In pluripotent ES cells, a core network of transcription factors, including Oct4, 
Sox2 and Nanog are required to establish and maintain pluripotent cell potential, as loss 
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of these factors leads to spontaneous differentiation (Surface et al., 2010).  Genome-wide 
ChIP data in ES cells demonstrate that significant overlap in genes repressed by OCT4 
and/or Nanog and genes shown to be targets of PcG, indicating that PcG silencing might 
be recruited by and collaborate with these transcription factors to regulate gene 
expression in these cells (Lee et al., 2006; Bernstein et al., 2006; Boyer et al., 2006).  In 
these cells, genes targeted for PcG repression include many key developmental regulators 
such as Fox, Wnt, Sox, Pou, Pax, GATA, and Tbx family members (Boyer et al., 2006; 
Ku et al., 2006; Lee et al., 2006).   Developmental regulators lose H3K27me3 and 
become activated during ESC differentiation, and by FISH analysis, undergo local 
decompaction, consistent with increased transcriptional activity (Boyer et al., 
2006; Bracken et al., 2006; Lee et al., 2006; Stock et al., 2007; Tolhuis et al., 2006; 
Eskeland et al., 2010).   Conflicting data have contributed to a highly controversial 
hypothesis suggesting that relief of PcG mediated repression may represent a key event in 
the transition from developmentally plastic to differentiated cell types.  
Loss of core PRC2 component activity results in early embryonic lethality in mice, 
whereas inactivation of PRC1 components results in less severe phenotypes occurring 
later in development (Faust et al., 1995; Faust et al., 1998; O’Carroll et al., 2001; Pasini 
et al., 2004; Surface et al., 2010).   Although previous studies suggested that PcG mutant 
ES cell lines could not be established, more recent studies indicate that ESCs lacking 
PRC function can be generated as well as maintained, suggesting that PcG proteins are 
not required for pluripotency (Surface et al., 2010; Margueron & Reinburg, 2011).  For 
instance, Suz12(-/-) mouse ESC lines can be established and expanded in tissue culture, 
and are characterized by loss of H3K27me3 and overexpression of differentiation specific 
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genes (Pasini et al., 2007; Pasini et al., 2010).  In addition, Suz12(-/-) ES cells are unable 
to contribute to endodermal lineages in chimeric implants (Pasini et al., 2007).  
Additional PcG mutant cell lines show similar impairments in differentiation potential 
and/or differentiate spontaneously, due to overexpression of differentiation specific genes 
and/or increased expression of pluripotency factors including OCT4 and Nanog, which 
normally cooccupy the promoters of PcG genes (Boyer et al., 2006; Chamberlain et al., 
2008; Shen et al., 2008; Lee et al., 2006; van der Stoop et al., 2008).   The inability of 
PcG mutant ESCs to maintain expression of lineage specific genes and differentiate into 
specific cell lineages strongly suggests that PcG proteins are essential for cell fate 
transitions. 
It remains unclear what role PcG complex(es) play in the coordination of 
pluripotency and differentiation, as are the mechanisms of target loci derepression 
required to achieve lineagerestriction.  The extent to which PcG factors control these 
processes remains controversial, and are further complicated by potential redundancy 
among the various subunits in some species.  In Drosophila and plants, at least 15 PcG 
factors have been identified, while as many as 37 have been identified in mice and 
humans (Sauvageau and Sauvageau, 2010).  Therefore, interpretation of phenotypic 
severity should be considered in light of possible functional and/or genetic redundancy.   
Interestingly, only three components of PRC2 have been identified in C.elegans, 
providing us with a unique opportunity to investigate how different pathways interact 
with Polycomb mediated silencing during the transition from pluripotency to cell fate 
specificity.  In this system, the Mango Lab has demonstrated a role for PcG factors 
during the transition from cellular plasticity and differentiation.  We’ve shown that PcG 
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proteins function to repress pluripotency factors at the onset of differentiation, rather than 
repress developmental regualtors during pluripotency, as previous models might have 
suggested (Yuzyuk et al., 2006).  As PcG factors may not be required for pluripotency in 
ES cells, this model may represent a general mechanism of Polycomb function.  
C.elegans PcG factors are discussed in detail in later sections.  
 
Bivalent domains and cell fate restriction 
Genomewide mapping data in ESCs have demonstrated that a number of 
developmental and tissue specific target genes are simultaneously marked with 
PcGmediated H3K27me3 (repressive) and Trithorax induced H3K4me3 marks, which 
correlate with active transcription.  Many of these promoters are also bound by RNA 
PolII phosphorylated at Serine 5 of the C terminal domain (CTD), a mark associated with 
transcriptional initiation, and in this case may represent paused polymerase (Bernstein et 
al., 2006; Ku et al., 2008; Stock et al., 2007; Guenther et al., 2007).  Termed “bivalent 
domains,” this duo of PTMs correlates with silent or low level expression in ESCs, and is 
thought to represent genes that are poised for rapid activation following induction of 
differentiation (Stock et al., 2007; Azuara et al., 2006).  
The resolution of the bivalent domains is thought to be related to cell fate 
commitment, although whether it is a driving force remains to be determined (Mikkelsen 
et al., 2007).  Upon differentiation, H3K27me3 marks are erased from the promoters of 
activated genes, while H3K4me3 marks are maintained (Bernstein et al., 
2006).   Conversely, the promoters of genes destined to remain repressed in a given cell 
type retain the H3K27me3 while H3K4me3 is removed (Bernstein et al., 2006).  Removal 
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of these marks have been linked to histone demethylases specific for H3K4me3 (i.e., 
LSD1), and H3K27me3 (i.e., JMJD3 and UTX), consistent with an essential role for 
these demethylases in embryonic development  (Adamo et al., 2011; Lan et al., 2008; Lee 
et al., 2007; Xiang et al., 2007; Agger et al., 2007; Swigut & Wysocka, 2007).  It has also 
been suggested that the PRC2 complex may aid in the targeting of H3K4 demethylase 
activity to specific loci to maintain gene repression during ES cell differentiation (Pasini 
et al., 2008).  These findings are consistent with a model in which developmental 
expression profiles are coordinated by the opposing activities of PcG proteins and 
Trithorax factors.  
Bivalent domains can be subdivided based on the presence of PRC2 or both PRC1 
and PRC2, the latter of which more efficiently maintain H3K27me3 upon differentiation 
(Ku et al., 2008).    In addition, bivalent domains whose promoters show broader 
coverage of H3K27me3 are more likely to be silenced following cell fate commitment 
(Hawkins et al., 2010).   Some developmentally important loci, including the Oct4 
promoter, are further silenced by the addition of H3K9me or DNA methylation following 
differentiation of ESCs; this redundancy may reinforce H3K27me3 silencing and ensure 
unidirectional differentiation (Hawkins et al., 2010).    
One possible mechanism by which PcG repressors might inhibit gene activity at 
bivalent promoters involves inhibition of RNA polymerase elongation. Although the 
mechansims remain obscure, this pausing has been suggested to rely on the short abortive 
transcripts synthesized from these promoters (Guenther et al., 2007; Bernstein et al., 2006, 
Boyer et al., 2006, Lee et al., 2006).  Recent ChIP-Seq and global runon sequencing 
(GRO-Seq) based studies have linked Polycomb with inhibition of RNA PolII 
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recruitment to bivalent promoters by demonstrating that promoter association of Pol II is 
significantly increased in Esc mutants (Chopra et al., 2011; Min et al., 2011).  Similar to 
previous studies, a greater stringency of inhibition is observed when both PRC2 and 
PRC1 bound to a bivalent promoter (Min et al., 2011).   
Bivalent domains are not a unique feature of pluripotent cells but are also present 
in differentiated cell types in culture, as well as in early zebrafish embryos (Azuara et al., 
2006; Mikkelsen et al., 2007; Vasthenow et al., 2010).  During zebrafish embryogenesis, 
bivalent domains are formed at the onset of zygotic transcription; Vasthenow and 
collegues associate this period with embryonic pluripotency similar to what we have 
observed in C.elegans. 
 
Transcriptional silencing, cellular plasticity,  
 
and the MES pathway in C.elegans 
 
Cellular plasticity and cell fate commitment in C.elegans 
 
The nematode C.elegans is increasingly appreciated as a powerful model to study 
developmental plasticity within an intact embryo. In C.elegans, specific cellular 
characteristics can be observed as early are the two cell stage of embryogenesis, a finding 
that was initially interpreted as very early cell acquisition of cell fates (Sulston et al., 
1983; Gonczy & Rose, 2005).  However, multiple lines of evidence indicate that the 
somatic blastomeres are developmentally plastic until the 2E (for 2 endodermal cells) 




The first piece of evidence supporting early developmental plasticity comes from 
analysis of the C.elegans lineage.   Prior to the onset of gastrulation, most blastomeres 
contribute to multiple cell types, whereas after the 8E stage, decendants of a cell typically 
contribute to a single organ or tissue, suggesting that cells commit to a specific lineage 
around 8E (Sulston et al., 1983).  Second, early blastomeres can adopt alternative fates 
when developmental transcription factors are ubiquitously expressed under the control of 
a heatshock promoter (Fukushige and Krause, 2005; Gilleard and McGhee, 2001; Horner 
et al., 1998; Kiefer et al., 2007; Smith and Mango, 2007; Zhu et al., 1998; Yuzyuk et al., 
2009).  Prior to 2E, this “cell fate challenge” will result in dramatic, nearly embryowide 
conversion to the alternate cell fate, but this response is severely reduced after the 8E 
stage, indicating that many cells have become committed.  Third, blastomere exchange 
experiments performed prior to 2E demonstrate that a subset of cells are able to adopt 
different fates when moved to a new position within the embryo, demonstrating 
flexibility in response to intracellular signaling (Wood, 1991; Shelton & Bowerman, 
1996).  While the C.elegans lineage is invariant, this developmental flexibility indicates 
that the worm does not rely on predetermined patterns of development as previously 
thought, but instead responds to reproducible patterns cell signaling.  The fourth piece of 
evidence supporting the plasticity of early blastomeres involves the mutation of early 
functioning regulatory transcription factors.  Loss of transcription factors functioning 
prior to 8E often induce cell fate transformations, while perturbation of post-8E 
functioning transcription factors have more subtle phenotypes (Mango, 2007).   By 
expression analysis, dramatic changes in transcript pools coincide with the observed 
remodeling of nuclear morphology, consistent with global changes in cellular identity 
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(Yuzyuk et al., 2009; Baugh et al., 2003). These global changes in transcription coincide 
with the onset of gastrulation, and may reflect a switch from maternal to bulk zygotic 
transcription (Yuzyuk et al., 2009; Baugh et al., 2003).  Based on these data, the 
transition phase of C.elegans embryonic development may be analogous to the 
midblastula transition (MBT) observed in other animals.  MBT represents a major turning 
point in the life of an embryo, involving a dramatic upregulation of zygotic transcription, 
changes in the cell cycle and cell division dynamics, and increased cell movement 
(Heasman, 2006; Edgar & McGhee, 1988; Sulston et al., 1983; Etkin, 1988).   
Changes in nuclear architecture similar to those observed in mammalian ES cells 
have been observed in the nuclei of C.elegans embryos during the 2E (plastic) to 8E 
(committed) transition (Yuzyuk et al., 2009; David Hall, pers. communication) 
suggesting that the remodeling of nuclear architecture is a key feature in the onset of cell 
fate commitment. In sum, the 2E-8E transition period in characterized by changes in 
blastomere plasticity, nuclear architecture, and transcriptional expression.  
 
Transcriptional silencing in the early C.elegans germ line 
Embryonic cells are born with the ability to become a diverse number of cell 
types, and are thus plastic in nature.  In order to generate a functional organism capable 
of reproduction, these pluripotent cells must proliferate, commit to specific cell fates, and 
undergo differentiation while preserving the pluripotent compartment (i.e., the germ line), 
which gives rise to the next generation (Strome, 2005).  The germ line and somatic 
tissues of multicellular eukaryotes are functionally distinct.  The germ line remains 
pluripotent and maintains reproductive capacity necessary to give rise to subsequent 
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generations, while somatic cells derived from the germ line give rise to all other cell 
types and tissues required to generate a function animal.  The pluripotent germ line must 
be insulated from somatic signals in order to preserve reproductive potential.  
Transcriptional repression is a necessary feature of the germ line in flies and 
C.elegans, as loss of silencing mechanisms induces failure in germ cell formation and 
survival (Strome, 2005).   In the C.elegans embryo, the germ line is generated through a 
series of asymmetric cell divisions to produce the germ line blastomere (P4)(Strome, 
2005).  Transcription is inhibited in P4 by maternally endowed PIE-1, which inhibits 
transcriptional elongation by blocking phosphorylation of the RNAP II C-terminal 
domain (CTD) (Strome, 2005).  P4 divides only once during embryogenesis, producing 
the primordial germ cells (PGCs) Z2 and Z3 at ~100 cell stage (Strome, 2005).  PIE-1 is 
degraded in these cells, and RNA PolII is transiently activated, evidenced by CTD 
phosphorylation (Strome, 2005).   Following this window of transcriptional activation, 
PGCs remain transcriptionally silent until the embryo is hatched and germ line 
proliferation begins.   
This second phase of transcriptional inactivity is PIE-1 independent, and may rely 
on a chromatin based mechanism, as marks associated with gene activity, including 
H3K4me and H4acetylK8 are absent in these cells, while the repressive mark 
H3K27me2/3 is retained and/or enriched (Schaner et al., 2003; Bender et al., 2004).   
PGC DNA has been shown to maintain the decompact architecture associated with 
pluripotent cells (Schaner et al., 2003).  It is currently unclear how repression is 
maintained in the PGCs, although the MES factors (discussed in detail in the following 
sections) likely play a key role. 
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Maternal effect sterile (mes) factors  
 Similar to orthologs in other species, the Polycomb group of transcriptional 
repressors play important roles in C.elegans development, including inactivation of the X 
chromosomes, and silencing of transposons, multicopy transgenic elements, and 
developmental regulators.  PcG/Mes factors also contribute to germ line/soma cell fate 
distinctions and the coordination of pluripotency termination.   The following sections 
describe the MES factors, including the C.elegans PRC2 complex (MES-2, MES-3, 
MES-6), antagonism of PRC2 by MES-4, and the roles of these proteins in the control of 
chromatin dynamics during development.   
The maternal effect sterile (mes) genes were identified in a screen for 
“grandchildless” mutants (Capowski et al., 1991).  These factors are maternally donated 
and function in germ line development.  Four mes genes, mes-2, mes-3, mes-4, and mes-6 
have strikingly similar phenotypes with respect to the germ line.  Loss of these genes 
result in fertile hermaphrodites (M+Z-, for maternal (M) and zygotyic (Z)) whose 
offspring (M-Z-) undergo reduced proliferation of the germ line coupled with necrotic 
degradation of the germ nuclei, resulting in a dramatic reduction in germ cell number and 
strict maternal effect sterility (Capowski et al., 1991; Paulsen et al., 1995; Holderman et 
al., 1998; Korf et al., 1998).  The few germ cells that are visible in mes M-Z- animals, as 
well as in a proportion of M+Z- animals (i.e., ~15% in mes-3), display abnormal 
morphology and appear enlarged or swollen, with germline cytoplasm that is granular or 
coagulated in appearance, and contains large vacuoles and particles in Brownian motion 
(Capowski et al 1991, Paulsen et al., 1995; Garvin et al., 1998).   
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These defects are the result of germ cell degeneration and necrotic cell death, as 
the codepletion of programmed cell death factors (ced-3, ced-4) do not suppress the mes 
(-) germ cell degradation phenotype (Paulsen et al., 1995; Garvin et al., 1998).  Dying 
germ nuclei also lack the characteristic “button” phenotype associated with apoptosis 
(Paulsen et al., 1995; Garvin et al., 1998).   The failure of these mutants to produce 
functional gametes is not attributable to mitotic defects, aneuploidy, or the inability to 
respond to differentiation signals (Paulsen et al., 1995; Garvin et al., 1998). These data 
indicate that MES function is essential for proliferation of the germ line as well as for 
maintenance of viable germ cells competent to undergo gametogenesis.    
Mes mutants are sensitive to changes in X-linked expression, as more severe loss 
of function phenotypes are associated with XXX animals than XX animals (Garvin et al., 
1998).  In contrast, germ cell degeneration is less apparent in XO animals (genetically 
“male”), which undergo gamete differentiation and retain fertility in a sex independent 
manner (Garvin et al., 1998).  These observations led to studies demonstrating that X 
chromosomes are globally repressed in the germ line in a MES dependent matter (Kelly 
et al., 2002; Reinke et al., 2000; Fong et al., 2002; Bender et al., 2006; Bender et al., 
2004; Kolasinska-Zwierz et al., 2009).  Based on these findings, the primary function of 
the MES factors (PRC2 and MES-4) is thought to involve silencing the X chromosome 
the germ line, repression of which are necessary for germ cell viability.    
There are currently two models of MES/PcG function.  In the first, MES factors 
directly contribute to higher order chromatin structure through modification of histones.  
Alternatively, MES factors might inhibit function more locally at individual genes to 
transcription factors or interactions between enhancer elements and promoters.  Animals 
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lacking maternal MES function are able to specify the germ line, but fail to proliferate 
(Capowski et al., 1991; Paulsen et al., 1998).  As maternally donated MES protein is 
sufficient for fertility in M+Z- animals, MES/PcG proteins may function to establish, but 
not maintain chromatin structure inherited by the PGCs (Fong et al., 2002). The observed 
failure to proliferate and the propensity to degenerate have been suggested to result from 
inappropriate levels or patterns of gene expression, specifically with regard to the X 
chromosomes.   
 
Germ line and embryonic expression patterns of MES factors 
 The MES proteins exhibit similar nuclear localization patterns during worm 
development.  As predicted by the germ line phenotypes and maternal effect sterility, 
MES factors localize to adult germ line nuclei, are maternally donated and localized to 
oocyte nucleoplasm, and initially found in all blastomeres of the developing embryo (Xu 
et al., 2001; Holderman et al., 1998; Korf et al., 1998).  At the ~100 cell stage, MES 
proteins begin to fade from the somatic lineage, and by the end of embryogenesis, are 
restricted to the primordial germ cells Z2/Z3 (Xu et al., 2001; Holderman et al., 1998; 
Korf et al., 1998; Fong et al., 2002).  Germ line enrichment of MES factors is evident is 
larval stages through adulthood, where expression is highest in the mitotic and late 
pachytene regions, with marked reduction in the transition to midpachytene zones (Xu et 
al., 2001; Holderman et al., 1998; Korf et al., 1998; Fong et al., 2002).   
Although the mes factors have similar localization patterns and loss of function 
phenotypes, they appear to function in two separate complexes.  MES-2, MES-3, and 
MES-6 form a complex analogous to Polycomb repressor complex (PRC2), and mediate 
  
28 
transcriptional repression by methylation of H3K27 (Xu et al., 2001; Bender et al., 2004).   
MES-4 contains a SET domain (Suppressor of variegation, Enhancer of zeste, Trithorax; 
a domain defining a large family of histone lysine methytransferases) and three PHD 
fingers (Plant Homeo Domain, mediating protein-protein interactions) (Bender et al., 
2006). MES-4 is homologous to mouse NSD1 (Nuclear receptor binding SET Domain 1) 
and is required for H3K36me (Bender et al., 2006).  Current models suggest that MES4 
functions antagonistically to the MES/PRC2 complex, specifically with respect to 
silencing of the X chromosome.   
 
MES-2/MES-3/MES-6 complex:  Orthologous to PRC2 
MES-2 and MES-6, along with the novel factor MES-3, function in a complex in 
the worm orthologous to PRC2  (Xu et al 2001; Korf et al., 1998). MES-2, a SET domain 
protein homologous to Drosophila Enhancer of Zeste E(Z) and human EZH2, is the 
catalytic component of this complex, di and tri methylating H3K27 in vitro and in vivo 
(Bender et al., 2004; Strome, 2005).  MES-6 is a WD repeat containing protein 
homologous to Drosophila Extra Sex Combs (Esc) and human Eed (Strome, 2005).  
MES-2 and MES-6 interact with MES-3, a novel protein containing no known functional 
domains (Paulsen et al., 1998).   
Proper nuclear localization of the PRC2 complex members is interdependent, 
consistent with PcG factors in other organisms (Xu et al., 2001; Rastelli et al., 1993; 
Platero et al., 1996).   MES-2 and MES-6 localization is mutually dependent, while 
proper localization of MES-3 requires both MES-2 and MES-6 during mid-stage 
embryogenesis, but not during early embryogenesis or germ line development (Xu et al., 
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2001).   This suggests that MES-3 may not function with MES-2 and MES-6 in all 
contexts, and may be replaced by an alternative subunit in some scenarios (Xu et al., 
2001).  In addition, mes-3 mutations have somewhat intermediate effects on the 
localization of MES-2 and MES-6 (Holderman et al., 1998; Korf et al., 1998; Xu et al., 
2001).  
The C.elegans PRC2 complex is similar to that observed in other species, with 
respect to the contribution of noncatalytic subunits to overall HMT activity (Ketel et al., 
2005).  In vitro, the complete ESC-E(Z) complex, containing Suz-12 and Nurf55, is 1,000 
fold more active than E(Z) alone (Ketel et al., 2005).   In the absence of MES-3 and 
MES-6, MES-2 in the absence of other components lacks HMT activity in vitro, as do the 
MES-2/MES-3 and MES-2/MES-6 dimers (Ketel et al., 2005).  MES-2 is required for 
complex formation, as MES-3/MES6 do not dimerize in vitro (Ketel et al., 2005).  
Therefore, MES-2 binding to both MES-3 and MES-6 is required to generate robust 
HMT activity, indicating that loss of any of the components will result in loss of PRC2 
activity in vivo, a finding consistent with loss of H3K27me marks in different RNAi 
treatments (Bender et al., 2004; Senchuk et al., unpublished).  A previous study found 
that MES-3 does not directly interact with either MES-6 or MES-2 (Xu et al., 2001), 
which suggests that additional factors may mediate the formation of the complete 
complex, or that both MES-2 and MES-6 are required for optimal binding of MES-3.   
The MES/PRC2 complex has not been extensively purified from worm extracts, 
therefore, it is possible that additional subunits remain to be identified.  In coIP 
experiments, MES-6 pulls down only MES-2 and MES-3 (Bender et al., 2004), indicating 
that these factors may represent the sole members of the complex, or may function as the 
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core complex, with additional/alternative subunits binding more transiently, weakly, or in 
a context dependent manner, as has been observed in other species.   The MES/PRC2 
complex immunoprecipitated from C.elegans embryo extracts is able to methylate 
nucleosomes but not free histones, which are targeted by the cognate complex isolated 
from Drosophila extracts (Bender et al., 2004; Ketel et al., 2005).   This may indicate the 
requirement of additional cofactors, or may indicate that MES/PRC2 function is 
somewhat more specific than PRC2 in other species, perhaps mediated by the novel 
MES-3.   Data from sucrose density gradient and gel filtration analyses are also 
somewhat unclear as to whether MES-2/3/6 are the sole components of this complex, the 
predicted size of which is 230 kDa.  The experimental weight of the complex is 255 kDa 
(Xu et al., 2001); thus the interaction of an additional small protein or posttranslational 
modification cannot be ruled out.   More than 15 PcG components have been identified in 
the fly, and while orthologs of these components have not been identified in C.elegans by 
sequence homology, functional homology has not been fully explored.   
While the MES/PRC2 complex is localized to the nucleus, MES-2, MES-3, and 
MES-6 do not appear to localize specifically to chromatin (Holderman et al., 1998; Korf 
et al., 1998; Xu et al., 2001).  Inferences about the activity and targeting of this complex 
are primarily based on immunofluorescence based analysis of MES/PRC2 dependent 
H3K27me, which have demonstrated enrichment on X chromosomes in the germ line, 
supporting the hypothesis that MES proteins function in direct transcriptional repression 
of the X chromosome (Bender et al., 2004).   
Immunofluorescence assays have also been used to examine the distinct patterns 
of MES/PRC2 mediated di and trimethylation during development.   In the germ line and 
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early embryo, H3K27me2 is localized all chromosomes in all nuclei, with a nonuniform 
or “banded” pattern of chromatin staining (Bender et al., 2004).  Just prior to the division 
of the Z2/Z3 PGCs (~100 cell stage), H3K27me2 is decreased in the P4 germ line 
blastomere, and remains undetectable in the germ lineage through embryogenesis 
(Bender et al., 2004).  In contrast, H3K27me3 is highly enriched on the X chromosomes 
in both germ line and embryonic nuclei (Bender et al., 2004).  As observed for 
H3K27me2, H3K27me3 is present in all embryonic nuclei until the 100 cell stage, but 
when H3K27me2 decreases in the PGCs (Z2/Z3), H3K27me3 becomes enriched in these 
cells, consistent with the global repression of the germ line (Bender et al., 2004; Strome, 
2005).   These findings generally reflect the expression pattern of MES-2/MES-3/MES-6, 
and suggest that H3K27me3, rather than H3K27me2, represents the primary repressive 
mark in the germ line precursor cells. 
Analyses of H3K27me patterns in mes-2(-) animals has demonstrated that MES-
2/PRC2 is responsible for the majority of H3K27me2 and H3K27me3 in most of the 
germ line and early embryogenesis (Bender et al., 2004).  Depletion of mes-2/3/6 leads to 
loss of H3K27me2 and H3K27me3 in the distal germ line, although some accumulation 
in seen in late pachytene and oogenesis (Bender et al., 2004).  These marks might be 
attributed to an as yet unidentified HMT functional in the proximal germ line.  However, 
these methyl marks are absent in early embryos, with the accumulated signal being 
extruded with the meiotic polar body (Bender et al., 2004).    
At least one additional non-MES HMT dimethylates H3K27 during 
embryogenesis, as this mark is observed in mes (-) embryos, allowing for near wildtype 
levels in some embryonic nuclei and relatively normal levels of H3K27me2 throughout 
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the somatic tissues by adulthood (Bender et al., 2004).  In addition, this or yet another 
HMT capable of catalyzing the dimethyl mark becomes active specifically in the PGCs of 
mes(-) mutants at the 100 cell stage (Bender et al., 2004). This mark appears elevated in 
mes-2 mutants compared to wildtype embryos, suggesting a failure in the conversion of 
di to trimethyl (Bender et al., 2004).   As H3K27me3 remains low in all somatic tissues 
as well as the PGCs throughout development in mes-2(-), it is possible that MES/PRC2 
function is unnecessary for H3K27me2 in the PGCs, but is required for H3K27me3.  
Bender and colleagues hypothesized that in PGCs, the MES/PRC2 complex may prevent 
accumulation H3K27me2 by blocking expression or activity of the dimethylase, or by 
rapid conversion of H3K27me2 to H3K27me3.  Similar staining patterns were observed 
in the germ cell nuclei of males, indicating that MES function is not hermaphrodite 
specific (Bender et al., 2004).  
In addition to H3K27 methylation, MES/PRC2 function may also be required for 
the majority of H3K9me3 in the germ line, although this complex appears to be 
dispensable for H3K9me2 (Bessler et al., 2010).  Immunofluorescence data in this study 
differ from findings of similar assays, as well as in vitro data published previously, 
possibly reflecting the use of different antibodies and/or more careful analysis of the 
germ line compared to embryos (Bender et al., 2004; Andersen & Horvitz, 2007).  In 
vitro biochemical studies of PRC2 are also inconclusive with respect to MES-
2/E(Z)/EZH2 methylation of H3K9me3 (Muller et al., 2002; Czermin et al., 2002; 
Kuzmichev et al., 2002).  These conflicting data indicate that H3K9me3 by PRC2 may be 
indirect, mediated by additional proteins, and/or occur in a spatiotemporally restricted 
manner.  Even within the germ line, a subset of H3K9 methyl marks are MES-2 
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independent; H3K9me3 (like H3K27me3) is present on condensed chromosomes in 
diplotene and diakinesis, as well as within the mitotic zone, indicating the presence of at 
least one additional HMT capable of catalyzing H3K9me3 and H3K27me2/3 (Bessler et 
al., 2010).  
An additional factor found to play a significant role in gene silencing in many 
systems is the HMT Su(Var)3-9, required for H3K9me2/3 (Bannister et al., 2001; Jacobs 
et al., 2001; Lachner et al., 2001).  Although C.elegans has no clear Su(Var)3-9 homolog, 
the SETDB1-like HMT MET-2 has been shown to methylate H3K9me2 and is required 
for normal levels of H3K9me2/3 in this species (Bessler et al., 2010;  Andersen & 
Horvitz, 2007).    By western blot, H3K9me3 levels are reduced as much as 80% in met-2 
mutant embryos (Andersen & Horvitz, 2007).  Conversely, an immunofluorescense based 
analysis found that MET-2 is required for H3K9me2 but dispensable for H3K9me3 in 
adult germ cells (Bessler et al., 2010).  While it is possible that the observed decrease in 
H3K9me3 in embryos was the result of decreased H3K9me2, these findings are not 
mutually exclusive, but suggest that the mechanisms of H3K9me3 differ in the germ line 
and somatic tissues.  However, additional possibilities cannot be ruled out.  For instance, 
the inefficiency or modulation of demethylase enzymes may account for residual methyl 
marks following loss of HMT function.  There is also a precedent for a SETDB1 
mediation of different marks in different tissues in Drosophila, lending further 
complication to interpretation of these findings (Bessler et al., 2010).  Alternatively, 
additional HMT(s), including MES-2, may be responsible for the majority of H3K9me3 
during development.  However, H3K9me3 is present in embryonic cells where MES-2 is 
not localized, suggesting the presence of additional HMTs, increased activity of MET-2 
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in mediating H3K9me3 in late embryogenesis, and/or the down regulation of 
demethylase activity in these cells, allowing purdurance of H3K9me3. 
Intriguingly, mes-2; met-2 double loss of function did not demonstrate additive 
phenotypes with respect to H3K9me marks and germ line function, indicating that these 
proteins are unlikely to be functionally redundant (Bessler et al., 2010).  Despite 
mediating the similar marks, some data suggest that mes-2 and met-2 may have opposing 
functions, as opposite phenotypes are observed with respect to suppression/enhancement 
of a strain carrying mutations in each of the partially redundant heterochromatin 1 (HP1) 
factors, hpl-1; hpl-2.  mes-2 suppresses the hpl-1; hpl-2 larval arrest phenotype, while 
met-2 enhances this phenotype, inducing larval arrest and lethality at an earlier stage 
(Simonet et al., 2007; Senchuk et al., unpublished).   Based on these data, MES/PRC2 
dependent repression likely involves H3K27me2/3 and H3K9me3, while the HMT MET-
2 mediates H3K9me2.  It is currently unclear how these factors interact.   
By chromatin immunoprecipitation (ChIP) analysis, H3K27me2/3 marks across 
the C.elegans genome are anticorrelated with levels of gene expression, RNA PolII 
localization, and marks associated with gene activity, consistent with a role in 
transcriptional repression (Liu et al., 2011).  The H3K9me2/3 is correlated with gene 
repression in other systems, and ChIP data in C.elegans indicate that H3K9me2/3 marks 
are enriched on silent genes and repetitive sequences, and are found associated with 
nuclear lamina proteins, suggesting these marks may denote more stably silenced 




One of the primary domains associated with MES/PRC2 repression are the X 
chromosomes.   Immunofluorescence analyses have demonstrated enrichment of MES 
dependent H3K27me3 throughout the proliferative (mitotic) and most of the maturing 
(meiotic) germ line in both hermaphrodites and males (Bender et al., 2004).  In addition 
to enrichment of H3K27me3, X chromosomes lack activating marks including H3K4me2, 
H3K36me2, histone acetylation, and RNA PolII CTD Serine 2 phosphorylation, a mark 
associated with transcriptional elongation (Kelly et al., 2002; Reuben and Lin, 2002).  
These data are consistent with very low expression of X-linked genes in the germ line of 
either sex, consistent with the paucity of germ line genes encoded on the X chromosome 
(Reinke et al., 2000; Bender et al., 2006).  Mutation of mes-2, mes-3, or mes-6 leads to 
inappropriate acquisition of active marks, demonstrating that MES/PRC2 proteins are 
required for the silencing of X chromosomes (Fong et al., 2002; Strome, 2005).  
Silencing of the X chromosomes and transgenic elements also requires MES-4 (Bender et 
al., 2006; Kelly et al., 1998).   
Xu and colleagues (2001) proposed that the MES system functions in the maternal 
germ line and early embryos to epigenetically mark genes and regulate expression in the 
embryonic germ line (Z2/Z3), suggesting that somatic genes, and the X, which contains 
few germline genes, are marked for transcriptional repression by H3K27me3.  Following 
the degradation of PIE-1, germ line genes (i.e., not marked by H3K27me) become 
expressed.    It is suggested that the desilencing of X encoded genes leads to the observed 
defects of germ cell degeneration and sterility in the F1 generation.  This idea is supported 
by the observation that marks of gene activation localize to the X chromosome in the 
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absence of MES-2/MES-3/MES-6 and that X chromosome dosage is an important 
determinant of lethality in mes mutants (Fong et al., 2002; Garvin et al., 1998).   
 
MES-4:  Antagonism of MES/PRC2  
MES-4 is a histone methyltransferase that catalyzes di and trimethylation of 
histone H3 on lysine 36 (H3K36me2/3), marks correlated with gene expression in a 
number of systems including C.elegans (Lui, et al., 2011; Rechsteiner et al., 2010; 
Bender et al., 2006).   MES-4 HMT activity appears to be specific for H3K36; additional 
histone marks, including H3K4me2/3, H3K9me2, H3K27me2/3, H3K79me2, and 
H4K20me2 are unaffected by the loss of mes-4 (Fong et al., 2002; Bender et al., 2006).  
Similar to its homologs NSD1 (mouse) and MMSET (human), MES-4 contains three 
plant homeodomain (PHD) fingers, which mediate protein-protein interactions, and a 
SET domain flanked by cysteine rich regions required for HMT function (Fong et al., 
2002).    
Unlike MES/PRC2, MES-4 physically associates with chromatin via its first PHD 
domain (Fong et al., 2002; Bender et al., 2004).  In contrast with the X localized PRC2 
complex, MES-4 is enriched on autosomes and is excluded from the X chromosome in 
the germ line and early embryos, a finding consistent with ChIP data indicating very few 
MES-4 bound sites on the X chromosome (Fong et al., 2002; Bender et al., 2004; 
Rechsteiner et al., 2010).  Based on immunofluorescence localization and biochemical 
assays, MES-4 does not associate with the MES/PRC2 complex (Fong et al., 2002; 
Bender et al., 2004).  Instead, autosomal localization of MES-4 and H3K36me2/3 is 
dependent on the PRC2 complex and/or H3K27me2/3, as MES-4 spreads to the X 
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chromosome in MES/PRC2 mutants (Fong et al., 2002; Bender et al., 2004).  Despite the 
observed autosomal localization and correlation of H3K36 methylation with gene activity, 
microarray data indicate that the primary effect of loss of MES-4 function is upregulation 
of X-linked genes, demonstrating that MES-4 participates in repressing genes on the X 
chromosome, a function similar to MES/PRC2 (Bender et al., 2006; Rechtsteiner et al., 
2010).  
It has been suggested that MES/PRC2 dependent H3K27me2/3 marks on the X 
chromosomes inhibit MES-4 binding and/or methylation of H3K36 (Bender et al., 2006).  
As depicted in Figure 3, two models have been proposed to account for the role of MES-
4 in X-linked repression.  In the first model, MES-4 might activate the expression of 
autosomal gene that induces repression of X-linked genes, possibly by influencing the 
localization of MES/PRC2.  Alternatively, MES-4/H36me localized to autosomes might 
repel a limited repressor, such that repressive activity is concentrated on the X 
chromosomes.   MES-4 antagonism is likely indirect, as patterns of H3K27me2/3 appear 
unchanged in mes-4 mutants (Fong et al., 2002; Bender et al., 2006).   
MES-4 is associated with, but not required for, expression in the germ line.  This 
is evidenced by the lack of MES-4/H3K36me localization to the X during the transient 
period of X-linked gene expression at the end of pachytene  (Fong et al., 2002; Bender et 
al., 2006; Kelly et al., 2002).   During this time, the X chromosomes in hermaphrodites 
accumulate H3K4me2 and elongating PolII, likely involved in the transcription of 






Figure 3.  Schematic representation of current models of MES antagonism.  The 
Mes/PRC2 complex mediates H3K27 trimethylation on the X chromosome.  This mark 
and/or the localization of a repressor molecule (R), induces transcriptional repression 
and/or exclusion of MES-4.  If such a repressor molecule exists, it is unknown how this 
factor interacts with H3K27me3.  For instance, it may localize to the X chromosome by 
sequence specific binding or be recruited by/bind H3K27me3.  As X enrichment of 
H3K27me3 is MES-4 independent, it is unlikely that the MES-4 associated repressor 
recruits PRC2.   In the first autosome model, a repressor molecule (R) is transcribed from 
the autosomes in a MES-4/H3K36me3 dependent manner. In the second model, MES-
4/H3K36me3 actively repels the repressive function, leading to concentration of 
repressive function on the X chromosome.  These models are not mutually exclusive, but 
the second model predicts that MES-4 is not required for the production of R, and loss of 
MES-4 would result in repression of autosomes if R is not in limited supply.  Adapted 
from Bender et al., 2006. 
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Silencing of the unpaired X chromosome and repetitive arrays  
In C.elegans, extrachromosomal arrays are formed by the concatamerization of 
DNAs injected into the germ line syncytium, resulting in highly repetitive arrays carrying 
several hundred copies of a construct (Stinchcomb et al., 1985).  In spite of the high copy 
number, expression of repetitive arrays is often lower than that observed from the 
endogenous locus, suggesting that these arrays are subject to silencing mechanisms 
(Mello & Fire 1995).  Moreover, these arrays of often complete silenced in the germ line 
(Mello & Fire, 1995; Kelly et al., 1997).   Germ line repression can often be relieved by 
coinjection with complex DNA (i.e., fragmented genomic DNA or exogenous DNA), 
resulting in 10-100 fold dilution of the expression construct (Kelly & Fire, 1998).   
The MES proteins (-2, -3, -4, & -6) are required for the silencing of repetitive arrays in 
the adult germ line, a function consistent with the ascribed role of Polycomb in context 
and repeat dependent silencing in Drosophila (Kelly & Fire, 1998; Kennison, 1995; Pal-
Bhadra et al., 1997).  In mes mutants, germline desilencing occurs prior to cytological 
defects (i.e., necrotic degeneration of germ nuclei), lending support to the hypothesis that 
the primary function of MES factors in the germ line involves repression of target loci, 
including the X chromosomes and repetitive elements (Kelly et al., 1998).  Kelly and 
colleagues also found that germ line degeneration is not indicative of germ line 
depression in most cases, as only 1/17 germ line defective mutants demonstrated 
desilenced transgene expression (Kelly et al., 1998).  In addition to the MES factors, 
germ line silencing of high copy also requires a number of chromatin factors, including 
HPL-2/HP1, HIS-24/H1.1, and a subset of the conserved repressors known as SynMuv 
factors (Couteau et al., 2002; Jedrusik & Schulze, 2001; Kim et al., 2005; Cui et al.,  
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2006).  Based on these findings, it’s likely that silencing of repetitive transgenes in the 
germ line occurs at the level of chromatin.   
A recent study demonstrated that different mechanisms are employed within the 
germ line to silence arrays carrying somatic specific promoters and arrays composed to 
germ line competent promoters.   High copy arrays with somatic promoters are marked 
by H3K9me3, and do not appear enriched for H3K27me3 (Bessler et al., 2010).  This 
result was observed even when the repetitive array was integrated into the genome, 
including sites on the X chromosome (Bessler et al., 2010).  H3K9me3 also correlate 
with DAPI faint chromatin domains, suggesting these arrays may not be fully 
heterochromatinized (Bessler et al., 2010).  Intriguingly, H3K9me3 enrichment on these 
arrays was also observed within the nuclei of somatic cells, suggesting that this mark 
does fully induce gene repression, or may reflect partial silencing, consistent with low 
level expression observed from high copy arrays (Bessler et al., 2010; Mello & Fire, 
1995).  Bessler & colleagues found that H3K9me3 is reduced, but not absent on these 
arrays in mes-2 mutants, suggesting the presence of a MES-2-independent H3K9 
methylation pathway.  Alternatively, H3K9me3 may perdure at these sites in mes-2 
mutants due to inefficient demethylase activity.  In the soma, high copy arrays are also 
marked with H3K27me3 (Towbin et al., 2010; Yuzyuk et al., 2009).  In contrast to 
somatic-specific arrays, arrays bearing germ line competent promoters are enriched for 
H3K9me2, rather than H3K9me3 (Bessler et al., 2010; Kelly et al., 2002).  Curiously, 
while H3K9me2 marks were depleted from germ line competent arrays in the absence of 
functional met-2 HMT, desilencing of the array in the germ line was not observed 
(Bessler et al., 2010).  It is currently unclear how MES/PRC2, which appears not to 
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methylate these arrays, contributes to maintenance of the silenced state within the germ 
line.  However, this study did not examine H3K27me2/3, although previous studies 
suggest that these marks would be present and likely to change in mes loss of function 
(Towbin et al., 2010; Yuzyuk et al., 2009).  Similarly, the role of MES-4 in this process is 
unknown, but it has been observed that MES-4 localizes to complex arrays (similar to 
autosomes), and is excluded from repetitive arrays (Fong et al., 2002), suggesting that 
mechanisms of array silencing are likely similar to X chromosome silencing, or may be 
due to lack of activating marks, rather than enrichment of silencing marks.  These 
findings highlight the complex dynamics of histone modifications in the regulation of 
chromatin activity.     
Similar to somatic specific promoter arrays, the unpaired male X chromosome, as 
well as free autosomal duplications, are enriched for H3K9me2 (Kelly et al., 2002; Bean 
et al., 2004).  The lone X is also highly condensed and lacks marks of transcriptionally 
competent chromatin throughout the adult germ line, including H3K4me2 (Kelly et al., 
2002; Bean et al., 2004).  This meiotic silencing may involve siRNA based mechanisms, 
as the RNA directed RNA polymerase (RdRP, involved in amplifying dsRNA) EGO-1 is 
required for H3K9me2 enrichment (Maine et al., 2005). CSR-1 (an Argonaute protein), 
DRH-3 (a Dicer-related DEAH/D-box helicase), and EKL-1 (a Tudor domain protein) all, 
like EGO-1, promote RNAi and influence meiotic H3K9me2 distribution (She et al., 
2009).  Loss of MET-2 HMT activity, and presumably H3K9me2 marks, leads to ectopic 
deposition of H3K4me activation marks on the unpaired X (Checchi & Engebrecht, 
2011).   mes-2 and met-2 depletion result in similar increases germ line apoptosis 
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phenotypes in XO germ lines, suggesting that MES-2 activity is also required for 
silencing of the unpaired X (Checchi & Engebrecht, 2011). 
 
MES interactions with synthetic multivulva (SynMuv) factors 
While MES-4 activity appears to oppose MES/PRC2, a group of proteins 
collectively known as SynMuv factors likely oppose MES-4 function.  The SynMuv 
genes (for Synthetic Multi-Vulva) were initially identified as redundant negative 
regulators of vulval differentiation, as loss of Class B SynMuv function coupled with loss 
of a Class A or C SynMuv gene function results in ectopic induction of vulval tissues and 
formation of multiple vulval structures (Muv), a phenotype that can be suppressed by 
mutations in the RAS signaling pathway (Cui & Han, 2007).  The SynMuv factors 
promote somatic cell fate decisions in a number of developmental contexts.   
SynMuv factors are highly conserved, chromatin associated proteins increasingly 
implicated in transcriptional repression.  SynMuv factors include members of the 
nucleosome remodeling and histone deacetylase complex (NuRD), composed of MEP-
1/HDA-1/LET-418, the heterochromatin 1 (HP1) homolog HPL-2, the E2F components 
EFL-1 and DPL-1, and the retinoblastoma (Rb) homolog LIN-35 (Cui & Han, 2007).  
Studies have suggested that these factors may mediate chromatin dynamics and 
posttranscriptional modifications, including histone tail deacetylation, methylation, 
acetylation and sumoylation, although for the most part, the associated mechanisms 
remain uncharacterized (Poulin et al., 2005; Fay & Yochem, 2007).   
Studies indicate that SynMuv factors mediate cell fate decisions in a number of 
contexts, in addition specification of vulval cells.  For instance, loss of individual 
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SynMuv genes induces ectopic expression of the distal tip cell reporter lag-2::GFP in gut 
and endodermal cells, indicating non-redundant transcriptional repression outside vulval 
tissues (Poulin et al., 2005; Cui et al., 2006).  SynMuv genes also affect the specification 
of pharyngeal cell fate.  The TRIM/RING SynMuv B protein TAM-1 physically 
associates with the pharynx selector factor PHA-4/FoxA by yeast two hybrid, and tam-1 
and NuRD components function synergistically with the pharyngeal selector gene pha-4, 
leading to a hypothesis suggesting that repression is mediated via direct interactions 
between transcription factors and NuRD components (Li et al., 2004; Kiefer et al., 2007). 
Many SynMuv genes promote development of somatic cells by preventing 
expression of germline genes in the soma; SynMuv mutants (i.e., mep-1) misexpress 
germ line-specific P-granule proteins in somatic cells (Unhavaithaya et al., 2002; Wang 
et al., 2005; Petrella et al., 2011).  However, these cells are not completely converted to 
germline like fates, as somatic genes remain correctly temporally and spatially expressed 
(Unhavaithaya et al., 2002).  In addition, perturbation of several SynMuv B genes results 
in enhancement of RNAi and transgene desilencing, phenotypes often associated with the 
germ line (Lehner et al., 2006; Unhavaithaya et al., 2002; Wang et al., 2005; Petrella et 
al., 2011).   Surprisingly, acquisition of germline characteristics does not appear 
detrimental to somatic development, as most SynMuv mutants grow to adulthood when 
cultured at low temperatures (Andersen et al., 2008).  The ability of SynMuv mutants to 
develop appears to be temperature dependent, as culture at 26oC induces high 
temperature arrest (HTA) and ectopic expression of germ line genes in the soma, while 
other SynMuv mutations (i.e., mep-1 and hpl-2) are temperature sensitive at 25oC 
(Petrella et al., 2011; Unhavaithaya et al., 2002; Schott et al., 2002).  
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Notably, loss of germ line regulators, including mes-2, mes-3, mes-4, mes-6 and 
chromodomain containing mrg-1 are able to suppress SynMuv induced somatic fates.  
Loss of these factors rescues larval arrest phenotypes in both SynMuv mutants and HTA, 
and suppresses the expression of germ line proteins in somatic cells (Unhavaithaya et al., 
2002; Cui et al., 2006; Takasaki et al 2007; Wang et al., 2005; Petrella et al., 2011).  
These data indicate that the SynMuv factors antagonize MES repression of germ line 
genes.   In addition, a number of chromatin factors, including MES-4, MRG-1, GFL-1 
and ZK1127.3 function as SynMuv suppressors in that loss of these factors inhibits the 
formation of multiple vulval structures in SynMuv A/B mutants (Wang et al., 2005; Cui 
et al., 2006).   
The repression of SynMuv factors is also key in the insulation of the germ line 
from somatic cell fate commitment (Shin & Mello, 2003).  In the early germ line 
blastomere (P4), transcriptional repression is maintained by maternally donated PIE-1, 
which inhibits the NuRD complex thru direct repression of deacetylase activity 
(Unhavaithaya et al., 2002).  Models suggest that during this period of germline specific 
transcriptional repression, the surrounding somatic cells are able to respond to 
differentiation factors.  Stage specific patterns of chromatin organization are established 
within each cell lineage thru the concerted action of transcriptional activators and 
repressors, with MES factors promoting the germline like fate, and SynMuv genes 
promoting somatic fates.  PIE-1 inhibition of MEP-1/LET-418/HDA-1 is thought to 
prevent chromatin remodeling and preserve MES dependent germline pluripotency 
during the early embryonic phase of somatic cell fate specification (Unhavaithaya et al., 
2002).  As the major role of MES factors is thought to involve repression of the X 
  
45 
chromosome, it has been proposed by some researchers that desilencing of genes on the 
X chromosome may contribute to the suppression of SynMuv phenotypes.  
 
Silencing by RNA: the role of MES and SynMuvs 
In C.elegans, dsRNA can induce posttranscriptional and transcriptional gene 
silencing (PTGS and TGS, targeting mRNA and nuclear pre-mRNAs respectively).   
These silencing mechanisms may have evolved for protection of the genome against 
viruses and transposable elements, as well as to regulate endogenous gene expression 
and/or the formation of heterochromatin.  In this system, RNA-based mechanisms are 
required for RNAi (silencing of exogenous dsRNAs), germline silencing of transponsons, 
transgenes, and the phenomenon termed cosuppression, in which the endogenous gene 
locus becomes silenced by the presence of a repetitive array carrying the target sequence 
(Ketting et al., 1999; Tabara et al. 1999; Kelly et al. 1997; Dernburg et al. 2000; Ketting 
and Plasterk 2000).  Numerous studies have demonstrated the existence of partially 
overlapping pathways controlling these mechanisms through the activity of rde (RNAi 
deficient), mut (mutator, involved in transposon silencing), and cde (cosuppression 
defective) genes (Ketting & Plasterk, 2000).  The silencing of transposons and repetitive 
elements (including transgenes and transgene induced cosuppression) occur 
predominantly in the germ line, although these processes differ in their requirements for 
specific RNAi associated factors (Ketting and Plasterk, 2000).   Intriguingly, many 
chromatin associated factors are involved in RNA mediated silencing pathways, 
including both RDE-1 dependent and independent silencing mechanisms.   
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Chromatin factors shown to play a positive role in RNAi include MES-4, GFL-1, 
and ZK1127.3; RNAi is less effective in these mutants (Dudley et al., 2002; Kim et al., 
2005; Cui et al., 2006).   MES-3 and MES-6 may also play a role in RNAi, although these 
data are less clear, and conflict with an earlier study (Dudley et al., 2002; Tabara et al., 
1999).  The concentration of dsRNA injected, as well as the degree to which these 
proteins are knocked out (i.e., null mutation vs. RNAi), suggests that the PRC2 complex 
may play some indirect role in RNAi silencing pathways (Dudley et al., 2002; Tabara et 
al., 1999).   Alternatively, perhaps the MES/PRC2 complex plays a role in transcriptional 
gene silencing, and may be triggered in response to high doses of injected dsRNA but not 
low dose or feeding RNAi.  However, mes-2 was not found to effect RNAi mediated 
silencing in these assays, in contrast to mes-3 and mes-6 (Dudley et al., 2002).  A number 
of chromatin associated factors, including MES-4, HPL-2, MRG-1, and subset of RNAi 
associated factors are also required for cosuppression, suggesting that cosuppression is 
also an RNA based silencing mechanism, perhaps similar to those mechanisms targeting 
repetitive elements (Robert et al., 2005).   The same subset of RNAi factors required for 
cosuppression are required for transposon silencing; however, MRG-1 and MES genes do 
not appear to be essential for the silencing of transposons, suggesting that although the 
RNA based silencing mechanisms overlap, they are unlikely identical, perhaps requiring 
different factors depending on the targeted loci (Vastenhouw et al., 2002; Robert et al., 
2005).   While different from each other, cosuppression and transposon silencing 
mechanisms also differ from exogenous RNAi mechanisms, and are thus thought to occur 
at the transcriptional level (Grishok, 2005).   Additional chromatin factors are involved in 
transcriptional gene silencing of transgenic arrays (reduced somatic expression, reduced 
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pre mRNA), including HPL-2, GFL-1, SET-2, and MRG-1 (Grishok et al., 2005); 
however, this screen did not identify the Mes factors.  HP1 and PIWI proteins directly 
associate during repeat induced gene silencing, further supporting a role for RNA based 
chromatin regulation in transcriptional repression (Moazed, 2009).  The fact that a 
number of genes antagonize RNAi silencing (i.e., eri-1, rrf-3), further suggests that 
RNA-based mechanisms of transcriptional silencing likely function during endogenous 
gene regulation.  
SynMuv genes also play a role in RNAi, and like other functions, appear to 
oppose that of MES-4.   RNAi is enhanced in the lin-15B(n744) mutation, suggesting that 
this protein negatively regulates RNAi (Wang et al., 2005).   Other SynMuv factors 
shown to negatively regulate RNAi include LIN-35 (Rb), DPL-1 (DP), LIN-53, LIN-9, 
LIN-13 and HPL-2 (HP1); these genes are epistatic to some RNAi genes (i.e., rde-1/4, 
mut-16, mut-7), but not somatic RdRP rrf-1 (Wang et al., 2005; Lehner et al., 2006).  
These SynMuv B genes also function synergistically with eri-1 and rrf-3, genes involved 
in dsRNA synthesis and turnover (Wang et al., 2005).   However, not all SynMuv genes 
function in the RNAi pathway (i.e., lin-36 and tam-1), nor do all genes that enhance 
RNAi function as SynMuv factors (Lehner et al., 2006; Cui et al., 2007; Wang et al., 
2005).  Moreover, RNAi machinery is not required for the Muv phenotype, indicating 
that changes in RNAi efficacy and/or RNA mediated silencing are unlikely to be the 
underlying cause of vulval defects (Lehner et al., 2006; Cui et al., 2007; Wang et al., 
2005).   It has been postulated that enhanced RNAi in SynMuv mutants may be due to the 
conversion of somatic cells to a more germline like state; however, loss of the germ line 
gene pgl-1 had no effect on RNAi sensitivity of SynMuv mutants, suggesting that 
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enhanced RNAi is not likely attributable to upregulation of germline expressed RNAi 
factors (Cui et al., 2006).  This is also supported by the observation that some SynMuv 
mutations (i.e., lin-35) show enhancement of germ line RNAi, indicating that somatic 
misexpression of germline genes cannot solely account for enhanced RNAi (Lehner et al., 
2007). 
 Inactivation of rrf-3 or eri-1 results in silencing of somatically expressed 
repetitive transgene arrays via an RNA dependent mechanism (Kim et al., 2005).  A 
subset of SynMuv mutations also results in somatic transgene silencing, including lin-35, 
lin-15B, and tam-1 (Hsieh et al., 1999; Lehner et al., 2007).  Interestingly, loss of tam-1 
(Tandem Array expression Modifier) induces transgene silencing in the soma, but does 
not affect RNAi sensitivity, suggesting that these processes can be uncoupled at some 
level (Lehner et al., 2007).  Somatic transgene desilencing in SynMuv B mutants (with 
the exception of tam-1) can be suppressed by depletion of RNAi (dcr-1) functionality, 
suggesting that increased RNAi in these mutants may induce the increased transgene 
silencing (Lehner et al., 2007).  However, a previous study demonstrated that tam-1 
desilencing is Dicer dependent (Cui et al., 2006).   tam-1 dependent silencing of 
transgenes can be suppressed by depletion of mes-4 or mrg-1 (Cui et al., 2006).   While 
mes-4 is required for RNAi, it is currently unclear whether mrg-1 plays a role in RNAi, 
adding an additional level of controversy (Cui et al., 2006).  These data suggest that 
additional pathways function in somatic transgene silencing, perhaps by TGS.  RT-PRC 
analysis demonstrated that tam-1 dependent transgene silencing occurs at the pre mRNA 
stage, supporting this hypothesis (Cui et al., 2006).  Moreover, the observed function of 
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MES-4 in RNAi may reflect a role in TGS, possibly by recruiting transcriptional 
silencing complexes to the targeted locus.  
The mechanism of interaction relating to MES and SynMuv factors, and how 
these interactions mediate different processes including RNA based silencing and germ 
line/soma distinctions is unknown.  These factors may function antagonistically to 
regulate the expression of a common set of target genes, and interact with these targets 
based on where they are expressed (i.e., soma vs. germ line).  Alternatively, these factors 
might directly repress the expression of the other.  A third model posits that MES-4 and 
SynMuv factors might compete for a common set of transcriptional or chromatin 
associated cofactors.   
The enhanced RNAi phenotype associated with SynMuv mutation is postulated to 
be the result of derepression of germ line specific RNAi components in somatic tissue.   
It has been speculated that loss of SynMuv genes leads to inactivation of RNAi based 
heterochromatin formation pathways that would otherwise compete for the RNAi 
machinery.  The release of RNAi machines from heterochromatin would then lead to the 
observed enhanced silencing of exogenous RNAi’s.   
siRNA silencing pathways appear to differ in the somatic and germ line tissues.   
This may be due to differential expression patterns, differences in sensitivity to RNA 
trigger molecules, or tissue specific expression of certain factors, such as the germ line 
specific RdRP EGO-1 (as opposed to the somatic specific RRF-1).  EGO-1 is important 
for normal germ line development and chromosome segregation during meiosis, 
including deposition of H3K9me2 in a Dicer independent manner, suggesting again that 
RNAi pathways and/or machinery are utilized differently in different contexts (Maine et 
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al., 2005).  In addition, some RNA based silencing pathway appear to function only in the 
germ line.  For example, transposons are functional in the somatic tissue but silenced in 
the gonad (Vastenhouw & Plasterk, 2004).  Cosuppression (also known as transgene 
induced phenocopy), is also primarily observed in the germ line and has only been noted 
for a single somatic gene (Dernburg et al., 2000).  High copy transgenes are generally 
well expressed in the soma, but are silenced in the germ line (Kelly et al., 1997).  These 
observations may be due in part to the germ line specific expression of repressive factors, 
including the Mes genes.  An alternative, and nonmutually exclusive mechanism might 
involve somatic expression of adenosine deaminases (ADARs), which modify RNAs 
produced by transgenes and inhibit RNAi degradation (Knight and Bass 2002).  
Accordingly, transgenes are silenced in ADAR mutants in an rde-1 dependent fashion 
(Knight and Bass 2002).  
 
siRNAs and the formation of heterochromatin 
An accumulating body of evidence indicates that small RNA molecules (20-30 
nucleotides) may play a significant role in gene silencing by mediating the formation of 
heterochromatin, and this may reflect the underlying role of chromatin factors in the 
RNA mediated silencing described above.  Noncoding RNAs that function as substrates 
for RNAi have been observed in a number of systems, and high throughput sequencing 
has demonstrated that C.elegans express several classes of endogenous small RNAs, 
including microRNAs, piRNAs, and endo siRNAs (Gent et al., 2010; Maine et al., 2010; 
Pavelec et al., 2009; Ambros et al., 2003; Ruby et al., 2006; Pak and Fire, 2007). 
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 RNAi mediated formation of heterochromatin has been well studied in fission 
yeast, where small ncRNAs direct the formation of heterochromatin at repetitive regions, 
including the centromeres (Grewal, 2010).  In this system, the RITS complex (for RNA 
induced transcriptional silencing) interacts with nascent RNAs, targeting RNA processing 
machinery (including RNA dependent RNA polymerases), and the H3K9 HMT Clr4 to 
target loci, specifically centromeric repeats (Grewal, 2010).  Using the chromodomain of 
the RITS component Chp1, the complex binds methylated histones and induces a self-
reinforcing feedback loop, facilitating the spread of silencing throughout the repeat 
region, an effect which is dependent on the activity of the RNA directed RNA 
polymerase (RdRp) RDP1, AGO1, and Dicer, core components of the RNAi machinery 
(Grewal, 2010).  Loss of any of these components leads to reduced heterochromatic gene 
silencing and loss of H3K9me2/3 at centromeric repeats (Moazed, 2009).  Studies in 
yeast also suggest that the RNAi machinery may directly interact with RNA PolII 
(Moazed, 2009). 
The tethering of RNA processing machinery and the formation of 
heterochromatin appears to be conserved mechanism.  In mammalian cells, introduction 
of siRNAs leads to the acquisition of repressive marks including H3K9 and H3K27 
methylation at targeted promoters, as well as loss of histone acetylation, and recruitment 
of HP1 in an Argonaute dependent manner (Kim et al., 2006; Morris et al., 2004).   ChIP 
experiments indicate that a similar mechanism may be used in C.elegans.  In this system, 
the nuclear RNAi WAGO class Argonaunte protein NRDE-2 (nuclear RNAi defective) 
complexes with exogenous siRNAs, binds genomic target sites, and represses gene 
expression through H3K9me and inhibition of RNA PolII elongation (Guang et al., 2010; 
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Burkhart et al., 2011). siRNAs direct H3K9me to target loci in a NRDE dependent 
manner and induce PolII stalling; ChIP data show decreased H3K9me at siRNA targeted 
genomic regions in NRDE mutants, coincident with increased expression from the target 
locus (Burkhart et al., 2011).   These data demonstrate that endogenous siRNAs are 
necessary and sufficient to induce changes in chromatin and transcriptional status.    
However, the siRNAs in this study targets genes that were highly repetitive, 
poorly conserved, and perhaps nonfunctional (Burkhart et al., 2011).  Therefore, it is 
currently unclear what role the various endogenous small RNAs play in chromatin 
regulation.   These data do, however, demonstrate that endogenous RNAi-mediated 
changes in chromatin and histone modifications can be targeted to genes that are not 
embedded in constitutive heterochromatin as has been observed in yeast, providing us 
with new insight into mechanisms of gene silencing.     
  
MES-4 & H3K36me 
The H3K36me2/3 mark is present in all nuclei during embryogenesis, and is 
catalyzed by the HMTs MES-4 and MET-1 (Bender et al., 2006; Furuhashi et al., 2010; 
Andersen & Horvitz et al., 2007).   Early embryos lacking MES-4 activity (M-Z-) also 
lack H3K36me2/3, indicating that these marks are MES-4 dependent (Bender et al., 
2006).  However, MET-1 becomes active at ~40 cell stage, possibly in conjunction with 
the upregulation of zygotic activity; accordingly, H3K36me2/3 is observed in mes-4(-) 
embryos after the 40 cell stage (Andersen & Horvitz et al., 2007; Bender et al., 2006; 
Reichsteiner et al., 2010).  MET-1 activity appears to be restricted to the somatic tissue 
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until late stage embryogenesis, but does eventually contribute H3K36me to PGC 
chromatin in mes-4 mutants (Furuhashi et al., 2010). 
From late embryogenesis through adulthood, MES-4 mediated H3K36me2/3 is 
restricted to the germ line blastomere and PGCs, consistent with the observed localization 
pattern of MES-4 (Fong et al., 2002; Bender et al., 2006; Reichsteiner et al., 2010).   In 
met-1 (-) embryos, MES-4 mediated H3K36me2/3 is present throughout embryogenesis, 
and although the mark decreases over time in somatic cells, H3K36me2/3 is at wildtype 
levels in the PGCs (Furuhashi et al., 2010, Rechsteiner et al., 2010). H3K36me2/3 is 
absent throughout embryogenesis in met-1; mes-4 double loss of function embryos, 
suggesting that MET-1 and MES-4 are the only embryonic HMTs catalyzing this mark 
(Furuhashi et al., 2010, Rechsteiner et al., 2010).   
Most identified H3K36 HMTs, including MET-1, are recruited to genes through 
association with elongating RNA PolII, and are involved in preventing aberrant 
transcription initiation within the gene body (Lee & Shilatifar, 2007; Furuhashi et al., 
2010; Rechtsteiner et al., 2010).  In yeast, the RNA PolII CTD Serine 2 phosphorylation 
(a mark associated with transcriptional elongation), recruits the MET-1 homolog SET-2, 
which methylates nearby nucleosomes and recruits the Rpd3S complex (Lee & Shilatifar, 
2007).  The Rpd3S complex deacetylates nucleosomes within the coding regions leading 
to suppression of aberrant intragenic transcriptional initiation (Lee & Shilatifar, 2007).  
This mechanism appears to be well conserved in yeast and higher eukaryotes, and may 
also be used to distinguish actively transcribed sequences, inactive genes, and regulatory 
sequences (Lee & Shilatifar, 2007). 
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In contrast to most characterized H3K36me HMTs, MES-4 associates with target 
genes independently of RNA Pol II, as RNAi of the knockdown of the PolII large subunit 
AMA-1 does not result in loss of MES-4 mediated H3K36me2/3, whereas loss of ama-1 
dramatically decreases the level of MET-1 catalyzed H3K36me2/3 (Bender et al., 
2006; Rechtsteiner et al., 2010; Furuhashi et al., 2010).  In mes-4 mutant germ lines 
(M+Z-), H3K36me2 is absent in the mitotic distal region through pachytene.  
Experiments using mes-4 and met-1 mutants, combined with RNAi knockdown of ama-1 
have demonstrated the germ line contains MES-4 dependent, transcription independent 
H3K36me, as well as H3K36me that is dependent MET-1 and ongoing transcription.  
While the majority of MES-4 mediated H3K36me2/3 in embryos and the germ line 
appear to be independent of transcription, a PolII dependent function of MES-4 has not 
been ruled out.  
These observations, coupled with the finding that MES-4 is incapable of de novo 
methylation of H3K36, led to a model proposing that MES-4 functions as a maintenance 
methyltransferase (Furuhashi et al., 2010; Rechtsteiner et al., 2010).  As met-1 mutants 
are homozygous viable and fertile despite loss of ~90% of H3K36me3 in mixed stage 
embryos by western blot, it seems that mes-4 is 1) extremely efficient at maintaining the 
remaining H3K36me, and/or 2) H3K36me is not essential in somatic tissues or 3) a 
different histone mark functions redundantly to mark transcribed genes, and/or 4) MES-4 
functions in some essential capacity in addition to H3K36 maintenance, as suggested by 
the maternal effect sterile phenotype associated with mes-4 but not met-1(Andersen & 
Horvitz 2007; Furuhashi et al., 2010). 
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 Chromatin immunoprecipitation based analyses, including ChIP-chip and ChIP-
Seq performed on embryo lysates provide further insight into MES-4/H3K36me 
localization and function.  First, MES-4 and H3K36me2/3 ChIP signals on all genes are 
highly correlated (Reichsteiner et al., 2010).  Second, MES-4 binding is associated with 
the coding region of genes, consistent with previously studies implicating H3K36me in 
splicing (Rechsteiner et al., 2010; Lee & Shilatifar, 2007).   Third, 1 in 5 genes is bound 
by MES-4, and many of these targets are also bound by RNA PolII (Rechsteiner et al., 
2010).  Fourth, a higher level of MES-4 binding correlates with higher levels of 
transcription, although PolII peaks at the 3’ end of a transcript and MES-4 peaks at the 5’ 
end, lending further support to the notion that MES-4 function is uncoupled from PolII 
and transcriptional activity (Rechsteiner et al., 2010).  
The most striking finding of these embryonic ChIP-based studies is that MES-4 
and MES-4 dependent H3K36me2/3 mark genes that were expressed in the maternal 
germ line, but are not expressed in embryos and are thus not associated with RNA PolII 
(Reichsteiner et al., 2010; Furuhashi et al., 2010).  ChIP-Seq data collected from met-1 
mutant embryos demonstrate that H3K36me3 is primarily associated with this same 
cohort of genes, further implicating dependence on MES-4 (Furuhashi et al., 2010).  
Moreover, H3K36me3 is absent from germ line specific genes in mes-4 mutants, while 
embryo and soma specific genes are still marked by H3K36me in this context, 
presumably due to transcription-dependent MET-1 activity (Rechsteiner et al., 2010).  
The finding that MET-1/transcription dependent H3K36me3 is 3’ enriched, and MES-
4/transcription-independent H3K36me is more 5’ enriched (and in many cases may still 
be associated with MES-4) may provide a method for downstream effector proteins to 
  
56 
differentiate between these marks, allowing for expression in the soma or germ line, 
respectively.  In yeast, H3K36me2 and H3K36me3 marks have different functions, with 
H3K36me3 correlating with transcriptional frequency and H3K36me2 linked to 
transcriptional on/off state (Shilatifard, 2006).   However, it is currently unclear whether 
these marks represent different functions in C.elegans, and whether they are differentially 
regulated by MET-1 and MES-4.    
MES-4 is also required for the PIE-1 independent phase of transcriptional 
repression in the PGCs (Furuhashi et al., 2010). In wildtype animals, RNA PolII becomes 
transiently activated in Z2/Z3 following the division of the P4 cell (Strome, 2005).   This 
activation appears to be regulated in a unique manner, as antibody stains indicate that 
PolII hyper phosphorylation in these cells is independent of cdk-9/P-TEFb (Furuhashi et 
al., 2010).  Intriguingly, PolII activity remains high in the PCGs in mes-4 mutant embryos, 
but is unaffected by loss of mes-2 (Furuhashi et al., 2010).   In mes-4(-) embryos, 
H3K4me2 (a mark of transcriptional activity), is initially erased following the birth of the 
PCGs (as in wildtype embryos), but are significantly increased in late stage embryos 
relative to controls (Furuhashi et al., 2010).  These data demonstrate that MES-4 
functions to repress transcriptional activity in the PGCs.  It is likely that this inhibition 
occurs at the level of PolII activity, as CTD phosphorylation state appears to be the 
primary defect, with H3K4me increasing as an effect of increase PolII activity.  The 
polymerase transcriptional machinery remains excluded from the X chromosome in the 
PGCs, which may be consistent with mes-2 independence (Furuhashi et al., 2010).   
Interestingly, the NuRD complex does not appear to function in the chromatin 
remodeling and germline repression of Z2/Z3 following degradation of PIE-1, suggesting 
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that the role of MES-4 in these cells may be independent of SynMuv function, or 
alternatively, interacts with a SynMuv-like complex other than NuRD (Schaner et al., 
2003).  
As maternal MES-4 and marks associated with gene expression in the germ line 
are initially present in all cells of the early embryo, expression of germline genes is likely 
antagonized in somatic blastomeres.   The SynMuv class of transcriptional repressors 
might be ideal candidates to block or erase marks associated with MES-4 mediated 
activation, as SynMuvs and MES-4 have opposing functions in a number of biological 
contexts.    The marking of germ line expressed genes by MES-4/H3K36me may be 
required for the observed upregulation of germ line expressed genes in the soma of 
SynMuv mutants, where global transcriptional repression mechanisms are defective, with 
H3K36me2/3 inducing default expression when somatic repressors are absent (as in the 
germ line) or defective (in mutants) (Furuhashi et al., 2010).   
The loss of function phenotypes associated with mes-4 are similar to those 
observed in mes-2/3/6 mutants, including maternal effect sterility, germ cell necrosis, 
sensitivity to X chromosome dosage, and silencing of transgenic arrays in the germ line 
(Capowski et al., 1991; Garvin et al., 1998; Kelly et al., 1998).  However, many 
phenotypes associated with mes-4 are stronger than those associated with other mes genes, 
including reduction in germ cell nuclei and suppression of SynMuv defects, including 
suppression of high temperature arrest (Capowski et al., 1991; Cui et al., 2006; Peteralla 
et al., 2011).   Other phenotypes appear to be mes-4 specific.  For instance, mes-4, but not 
mes-2 is not required for the repression of PolII activity in embryonic PCGs, further 
distinguishing the MES/PRC2 complex from MES-4 (Furuhashi et al., 2010).  MES-4, 
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but not the other mes genes, also appears to play a more direct role in RNAi pathways 
(Cui et al., 2006; Wang et al., 2005; Dudley et al., 2002; Kim et al., 2005; Tabara et al., 
1999).  mes-4, but not mes-2/3/6, function in the cosuppression pathway and suppress the 
multi-vulva phenotype associated with SynMuv mutants (Cui et al., 2006; Robert et al., 
2005).  Based on these data, it has also been suggested that the suppression phenotypes 
associated with mes-2/mes-3/mes-6 may reflect the role of MES/PRC2 in localizing 
MES-4 activity.   
To summarize, MES-4 is an autosome enriched HMT essential for repression of 
the X chromosome, marking germ line specific genes with H3K36me, maintenance of 
PolII/MET-1 dependent H3K36me3, and inhibition of PolII activity in the PGCs.  Studies 
have indicated that HMT activity is essential for the maternal function of MES-4; 
however, whether these newly defined functions are linked and/or dependent on HMT 
activity remains to be addressed.   
 
Chromatin compaction 
Previous work in the Mango lab has demonstrated a role for MES-2/PRC2 in the 
regulation of chromatin compaction, specifically during the transition from a plastic to a 
cell fate committed stage, which occurs during the 2E to 8E stages of development.  At 
the 2E stage, when cells of the embryo are plastic and able to adopt a number of cell fates, 
enrichment of the open chromatin configuration is observed using the Nuclear Spot assay 
(Yuzyuk et al., 2009).  During the 4E and 8E stages, when wildtype cells begin to commit 
to specific fates, the proportion of  “open” arrays decreased, with a concomitant increase 
in compact, nuclear envelope associated morphology (Yuzyuk et al., 2009).  These 
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compact arrays are likely heterochromatic, as immunofluorescence analyses have 
demonstrated enrichment of H3K27me3 and depletion of activated RNA PolII when 
compared with the open (floret) counterparts (Yuzyuk et al., 2009).   
In mes-2 mutants, a large proportion of arrays remained in the euchromatic floret 
configuration even in 4E and 8E stages, while a reduced number of heterochromatic 
morphologies were observed (Yuzyuk et al., 2009).  Based on these data, we hypothesize 
that MES-2/PRC2 functions to compact chromatin during the transition from 
pluripotency to differentiation, likely by direct targeting of nucleosomes and histone tails 
modification (Yuzyuk et al., 2009), a finding consistent with studies of PRC2 function in 
other species (Erwin and Lee, 2008; Zaratiegui et al., 2007; Margueron et al., 2008).  
Although indirect means of chromatin compaction regulation have not been ruled out, an 
intriguing hypothesis is that global chromatin reorganization driven by PRC2 contributes 
to the termination of plasticity.   
The timing of pluripotency termination is delayed in the absence of PRC2 activity, 
as blastomeres “challenged” by overexpression of cell fate selector genes are capable of 
undergoing changes in fate at the 8E stage (Yuzyuk et al., 2009).  This finding was 
somewhat unexpected.   Based on the current understanding of PRC2 function, one might 
predict that loss of mes-2 would lead to an early onset of differentiation.   Moreover, loss 
of MES-2/PRC2 activity results in gene expression changes, including failure to 
upregulate a cohort of 8E (differentiation) genes as well as precocious/sustained 
activation of some developmental regulators at the 2E stage.   Embryos eventually 
overcome the sustained expression, and develop normally, indicating the presence of 
redundant pathway(s) leading to cell fate commitment, a hypothesis supported by the 
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finding that target genes of upregulated (derepressed) developmental regulators are 
expressed in normally in late stage embryos.    This analysis also demonstrated that 
developmental regulators (i.e., selector genes) are not key terminators of plasticity, and 
that cell fate restriction can be uncoupled from cell fate specification, a feature which 
distinguishes developing embryos from ESC lines, in which pluripotency is associated 
with arrested development and a static expression landscape (Rossant, 2008). 
Multiple lines of evidence suggest that the role of MES/PRC2 in termination of 
developmental plasticity is carried out in the soma, rather than the germ line.  Although 
the previously ascribed functions of MES/PRC2 deal with silencing of the X 
chromosomes in the adult germ line, the altered expression profiles of mes-2 mutants did 
not show a bias for X linkage, in contrast to expression profiles of mes-4 mutants 
(Yuzyuk et al., 2009; Bender et al., 2006).  The finding that loss of mes-2 activity has 
little effect on early embryonic gene expression (<4E), including activation of zygotic 
genes, also suggests a specific temporal role after the 4E stage (Yuzyuk et al., 2009).  
Instead, loss of mes-2 led to inappropriate activation of zygotic developmental regulators, 
as has been observed in PRC2 in other systems (Yuzyuk et al., 2009; Schuettengruber et 
al., 2007; Niwa, 2007).  Moreover, the altered expression profile in mes-2 mutants was 
not dependent on the germ line, as similar changes in gene expression were observed in 
mutants lacking a germ line (Yuzyuk et al., 2009). Previous analysis identified subtle 
phenotypes in PRC2 mutants during postembryonic development and associated with 
regulation of Hox genes (Ross & Zarkower, 2003; Zhang et al., 2003).  Data from the 
Mango lab, however, clearly demonstrate a role for PRC2 in transcriptional regulation of 
the soma during embryonic development.   
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Loss of MES-2/PRC2 function leads to prolonged plasticity in the early embryo, 
possibly resulting from a failure to compact the permissive chromatin configuration 
and/or downregulate 2E expressed factors.  Despite inappropriate gene expression, 
downstream targets of these developmental regulators are unaffected, and worms are 
viable, suggesting the presence of additional levels of control. 
C.elegans embryos appear to function differently from other species in the degree 
to which transcription factors direct pluripotency programs during development.  Of the 
five classes of TFs know to contribute to pluripotency in mammals (Oct4/Pou/unc-6, unc-
86, ceh-18, Sox2, Nanog/Klf/Kruppel-like/nos-1/nos-2 and c-Myc/mml-1), the known 
C.elegans homologs are not clearly linked to developmental plasticity.  They are either 
not expressed during this early transition period (unc-6, unc-86, ceh-18), have no 
discernable embryonic phenotype (mml-1), or function in some alternative capacity (mep-
1) (Unhavaithaya et al., 2002; Pickett et al., 2007; Baugh et al., 2003; Yuzyuk et al., 
2009).   These data indicate that the transition from pluripotency to cell fate commitment 
in C.elegans may rely on mechanisms distinct from those characterized in other species. 
 
SET-2:  A previously identified PcG interacting factor 
SET-2 is related to yeast Set1 and mammalian SET1/MLL proteins (Xu et al., 
2001). Mixed lineage leukemia (MLL), its Drosophila homolog (Trithorax), and the yeast 
SET1 protein are each found within multisubunit COMPASS (Complex of proteins 
associated with Set1)-like complexes involved in activation of gene expression through 
methylation of H3K4 (Eissenberg & Shilatifard, 2010).  Depletion of SET-2 was found to 
enhance mes-3 and mes-4, leading to enhanced sterility in the F1 (M+Z-) generation, as 
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well as increased desilencing of transgenic arrays (Xu et al., 2001).   The finding that set-
2 enhances mes-3 and mes-4 alleles, but not mes-2 and mes-6, might be attributable to the 
stronger phenotypes associated with loss of mes-3 and mes-4, which the authors 
suggested might relate to perduance of the maternal endowment (Xu et al., 2001).  An 
alternative interpretation suggests that MES-3 may have functions in addition to those of 
MES/PRC; likewise, MES-4 has been linked to a number of functions in addition to X-
chromosome silencing.  SET-2/COMPASS may play a role in mediating these functions. 
Similar to the MES genes, SET-2 is germline enriched and localized to nuclei in 
the germ line and early embryos (Xu et al. 2001).    In the germ line, SET-2 localization 
is highly dynamic, with enrichment in the distal mitotic zone, reduced in the transition 
zone and early pachytene, followed by dramatic upregulation in midpachytene, reduction 
in oocytes, increase in early embryos, and slowing fading in many somatic lineages 
during embryonic development while remaining enriched in the germline progenitor cells 
(Xu et al., 2001).  This localization pattern mimics what has been observed for MES 
factors, lending support to the hypothesis of a common pathway.  Like MES-4, the 
dynamic localization of SET-2 does not require other MES factors, nor do the MES 
proteins require SET-2 for localization or HMT activity (Xu et al., 2001).   Therefore, the 
interaction between SET-2 and the MES factors is currently unclear.  One possibility is 
that SET-2 and MES serve redundant functions in setting up the maternal germline 
chromatin.  Alternatively, SET-2/COMPASS mediated marks may contribute to 
activation of X associated repressors.  
The SET-2 protein, in addition to the methyltransferase domain, contains both a 
proline rich protein-protein interaction domain, and an RRM domain that may bind RNA 
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(Xu et al., 2001).  SET-2 lacks the cysteine-rich region upstream of the SET domain, and 
may not possess HMT activity, but instead may mediate protein-protein interactions via 
the SET domain, similar to the Trithorax (Xu et al., 2001).  However, a recent study 
demonstrated that H34me2 and H3K4me3 are reduced 70-80% in set-2(-) embryos and 
young adults, demonstrating that while functional SET-2 is essential for H3K4me, an 
additional H3K4me HMT is also active during development (Xiao et al., 2011).  By 
western blot, SET-2 is responsible for more than 90% of germline H3K4me2/3, 
suggesting that SET-2 may function primarily in this tissue (Xiao et al., 2011).   With the 
exception of SET-2, no additional proteins have been linked to the Mes/PcG pathway, 
although genetic data, the subtle somatic phenotypes associated with loss of MES 
function, and biochemical evidence suggest that additional factors may function in this 
pathway, if not in the PRC2 complex itself.   
 
Mes factors in the soma and the regulation of Hox genes 
The evolutionarily conserved PcG proteins are best known for their role in 
maintaining the repression of homeotic genes during embryonic development.  
Antagonized by the Trithorax factors, which maintain active gene expression within 
specific domains, PcGs allow for refinement of positional expression along the 
anterior/posterior body axis.   Mes mutant M+Z- animals have a reduced number of 
progeny relative to wildtype controls, suggesting that MES proteins also play a zygotic 
role (Capowski et al., 1991).  However, there is no increased embryonic death, indicating 
that the gene products are not required for embryonic viability (Capowski et al., 1991; 
Paulsen et al., 1995).  Based on these data, MES factors may have some nonessential role 
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in the soma (in addition to chromatin compaction during cell fate specification), which 
would be consistent with Drosophila studies demonstrating a role in Hox gene regulation. 
As homeotic repression is a feature of PcG in Drosophila, C.elegans researchers 
have been interested in the role of MES PRC2 factors in the regulation of Hox genes.  In 
addition to the developing and adult germ line, the PRC2 complex is also present at low 
levels in at least some somatic tissues, where Hox regulation would be expected to take 
place.  Tissue specific expression analysis using various mutants which produce either no 
germ line, and masculinized or feminized germ lines indicate that expression of mes-3 is 
not restricted to the germ line tissues (Paulsen et al., 1995).  In addition, antibody staining 
experiments have demonstrated that the presence of MES-2 and MES-6 in intestinal 
nuclei throughout development (Korf et al., 1998; Holderman et al; 1998).  Intriguingly, 
ectopic induction of germ line markers following high temperature arrest (Petrella et al., 
2011) and loss of mep-1 (Unhavaithaya et al., 2002) are strongest in the intestinal tissue, 
perhaps indicating that the higher levels of MES are required to maintain repression in 
these cells.   
PRC2 components MES-2/3/6 appear to function upstream of the Hox genes mab-
5 and egl-5 during ray V differentiation in the male tail, as loss of mes activity restores 
normal ray development and mating ability in males mutant for Hox activators in a Wnt 
independent manner (Ross & Zarkower, 2003).  As Wnt signaling appears to be one of 
the main regulators of Hox expression, this indicates that MES factors may function in a 
separate pathway.  In addition, reporter assay based analyses demonstrated a small but 
significant change in the patterning of other Hox genes (lin-39, midbody; mab-5, 
neuronal lineage), suggesting that the MES genes are negative regulators of Hox genes 
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during larval development, an effect that is not restricted to males, or development of the 
tail rays (Ross & Zarkower, 2003).  While these effects are fairly subtle, they do support 
MES factors playing some role in somatic development, although whether this effect is 
direct has not been fully established. Whether this repression might be set up in the 
embryo and persisting until larval stages has also not been addressed. 
The finding that loss of H3K27me3 is tolerated during embryonic development is 
surprising, and raises questions about the role of this mark in the somatic tissues.  Loss of 
mes2/3/6 results in low penetrance homeotic transformations (in which the body 
structures are duplicated or lost), including defects in migration of specific neurons, 
expansion of Hox gene expression domains, and mislocalization of sensory rays in the 
male tail, as well as sexual transformations in certain genetic backgrounds  (Korf et al., 
1998; Holdeman et al., 1998; Ross and Zarkower, 2003; Garvin et al., 1998).  
 
The PRC1 complex in C.elegans 
Work in other systems has demonstated the existence of the PRC1 complex, 
which is thought to recognize H3K27me3 and ubiquitinate H2A lysine 119, resulting in 
chromatin compaction and transcriptional silencing.  However, whether this complex 
exists in C.elegans has been a subject of debate.  Two complexes, the sop-2/sor-1/sor-3 
complex, and the mig-32/spat-3a complex have been suggested to function in this 
capacity.   
Loss of SOP-2 complex activity is associated with shifts in male sensory ray 
position, number, and identity, abnormal neuroblast migration and expansion of homeotic 
expression domains, as well as hox dependent precocious differentiation and conversion 
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of alae fated seam cells into male tail specific rays (Zhang et al., 2003; Zhang et al., 
2006; Cai et al., 2008; Yang et al., 2007).  SOP-2 is a SAM-domain RNA binding protein 
that forms distinct nuclear bodies, a feature reminiscent of PRC1 components in other 
organisms (Zhang et al., 2006).  While sop-2 phenotypes resemble the mes/PRC2 
phenotypes with respect to subtle homeotic transformation, the data supporting the SOP-2 
complex functions as PRC1 are weak.  First, mutations of proposed complex members 
have variable phenotypes indicative of at least partially independent functions.  Loss of 
both sop-2 and sor-1 is synergistic, suggesting that these components may not function as 
a complex in vivo, a finding supported by immunofluorescence data demonstrating 
differential localization patterns (Zhang et al., 2006).  These mutants also display 
pleiotropic defects (vulval, neuronal, gonadal) that are not attributable to Hox 
misregulation (Zhang et al., 2009).  Based on these findings, it has been suggested that 
the misregulation of Hox expression is an indirect effect.   
Genetic interactions between sop-2 and the MES complex are also unclear.  
Synergy was not observed between sop-2 and the mes-2/3/6 with respect to the timing 
and extent of ectopic Hox gene expression, but synthetic larval lethality not related to 
Hox misexpression was observed (Zhang et al., 2009).  The authors of this study did not 
examine whether sop-2 and sor-1 might function in one of the other pathways 
contributing to homeotic patterning (i.e., Pry/Wnt).  As the homeotic defects associated 
with loss of MES function as so subtle compared to sop-2 and sor-1, it seems unlikely 
that PRC2 function is a prequisite of Hox gene repression in C.elegans, provided that the 
SOP/SOR complex functions in this capacity (i.e., PRC1 like) at all.  Moreover, it has not 
been shown that sop-2 or sor-1 bind H3K27me2/3, a mark that is recognized by PRC1 in 
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other species.   Whether sop-2 and sor-1 are associated with ubiquitin ligase activity, the 
mechanism by which PRC1 is thought to mediate its repressive effects, has not been 
shown.  Lastly, sop-2 and sor-1 homologs are not found even in C.elegans closest 
relative, C.briggsae (Zhang et al., 2009), indicating that these factors do not represent a 
conserved complex within the nematode phylogeny.   
More recently, the MIG-32 and SPAT-3a have been proposed to represent the 
PRC1 complex in C.elegans (Karakuzu et al., 2009). These genes encode homologs of 
the PRC1 components BMI-1 (Ring domain) and Ring1B respectively.  Consistent with 
these genes functioning in a complex similar to PRC1, loss of either mig-32 or spat-3a 
leads to a marked reduction (spat-3a) or complete loss (mig-2) of H2A ubiquitylation by 
western blot of L1 lysates.  However, localization of mig-2 to nuclei is not mes dependent, 
and whether H2Aub levels decrease in a mes dependent manner has not been examined.   
It was demonstrated by epistasis analysis that mig-32 and mes genes function in a 
common pathway to control patterning of the male tail (Karakuzu et al., 2009).  MIG-32 
and SPAT-3a also play a role in neuronal migration and repression of vulval fates, similar 
to what has been observed in mes mutants (Ross & Zarkower, 2004; Cui et al., 2006; 
Karakuzu et al., 2009).  Reporter analysis also suggest that misexpression of Hox genes 
may be the driving force behind these phenotypes (Karakuzu et al., 2009).  Based on 
these findings, it has been suggested that MIG-32 and SPAT-3a represent the C.elegans 
PRC1 complex, however, both mutants are fertile in spite of broad germline expression, 
in contrast to the mes counterparts, indicating that ubiquitination of H2A by PRC1 is not 
essential for the germ line function of MES/PRC2.  However, possible redundancy of 
H2A ubiquitinases in the germ line has not been fully examined.   
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Whether C.elegans has a complex similar to PRC1 remains unclear.  The 
phenotypes associated with the genes proposed to function in this capacity do not 
resemble predictions based on PRC1 in other organisms, and it is unlikely, based on 
localization patterns, that MIG-32/SPAT-3a and SOR-2/SOP-1 function in a common 
complex, despite a similarity of homeotic phenotypes.   Perhaps, as the homology data 
might suggest, C.elegans has evolved mechanisms of PRC2 repression that do not rely on 
PRC1 function.  Alternatively, these complexes might function in Hox gene regulation 
with the MES/PRC2 complex, and the likely redundancy of additional pathways (i.e., 
Wnt) has made interpretation difficult.  As the majority of cells in these various mutants 
are specified normally, it is unlikely that these factors are essential for the specification of 
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Hypothesis and screen rationale 
 
Loss of key silencing mechanisms induce surprisingly subtle defects with respect 
to somatic tissues and viability, indicating that additional factors may function in gene 
regulation and silencing pathways.   Studies also suggest that additional regulators of 
heterochromatin formation remain to be identified.  One example comes from Drosophila, 
where a recent genomewide ChIP-Seq analysis identified three types of heterochromatin, 
including areas silenced primarily by Polycomb and areas silenced by HP1 and 
interacting proteins (Filion et al., 2010).  The third and most prevelent type of 
heterochromatin (occupying ~50% of the probed genome) is not occupied by marks or 
factors previously recognized as functioning in heterochromatin (Filion et al., 2010).  
These areas are not constitutively silenced, however, as genes expressed in various 
tissues are present, and transposons inserted into these areas undergo active repression 
(Filion et al., 2010).   Analysis of these domains, as well as screens aimed at the 
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discovery of heterochromatin regulating factors, will provide a greater understanding of 
the regulation of gene expression throughout development.  
There are several hints that additional factors may be involved in gene silencing 
and heterochromatin formation in C.elegans.   One might predict that loss of gene 
repression and mechanisms of chromatin compaction might have fatal consequences, as 
loss of these regulators in other organisms result in embryonic lethality or homeotic 
transformation (Kwon & Workman, 2011; Surface et al.,  2011).  However, loss of any of 
the three major mechanisms of transcriptional repression (Polycomb, H3K9me, and HP1, 
depicted in Figure 4) have strikingly mild affects with respect to the soma.  mes-2 
mutants, for instance, are able to produce progeny, and in these animals, differentiation is 
delayed, but not completely blocked, suggesting that additional mechanisms also regulate 
cell fate transitions (Capowski et al., 1991; Yuzyuk et al., 2009).  Animals lacking MET-
2 H3K9me2 HMT activity are viable and fertile for ~20 generations before germ line 
defects become evident (Andersen & Horvitz, 2007).  Animals lacking HP1 activity are 
fertile, although progeny arrest at high temperature (Schott et al., 2006).   
We are particularly interested in the identification of additional factors at work in 
the Polycomb/Mes silencing pathway.  The goal of this screen is to identify chromatin 
associated proteins that interact with MES factors functioning during the transition from a 
state of cellular plasticity to fate committed cell types with fixed lineages.  As the 
C.elegans genomes appears to lack, by sequence homology, a number of Polycomb 
factors, as well most regulatory subunits identified in flies and mammals, a directed 





Figure 4.   Key mechanisms of transcriptional silencing.  In C.elegans, the PRC2 
complex is composed of MES-2, MES-3 and MES-6, and catalyzes the repressive mark 
H3K27me3.  The SET-DB1 ortholog MET-2 mediates H3K9me2/3, a silencing mark that 
in other systems is bound by heterochromatin protein 1 (HP1).  In C.elegans, HP1 is 




research demonstrating the roles of Polycomb mediated silencing throughout 
development.  C.elegans Polycomb factors may be sufficiently divergent from 
Drosophila and mammals, making recognition of PcG orthologs by amino acid sequence 
difficult, yet it is possible that proteins functioning in these complexes are functionally 
conserved. In addition, C.elegans might regulate Polycomb by mechanisms less likely to 
be completely unique than to shed light on the complex interplay of silencing 
mechansims we are only beginning to understand.     
This type of analysis might also allow for identification of factors that may be 
partially redundant and allow for the subtle somatic effects of MES mutation.  A 
precedent for this comes from mouse ES cells, where at least two enzymes are capable of 
catalyzing H3K27 methyl marks (Ezh1, Ezh2), both of which can associate with the core 
 72  
PRC2 complex (Shen et al., 2008).  This type of redundancy might also confer target 
specificity.  A similar redundancy may be observed in C.elegans, where H3K27me2 and 
H3K9me3 are present in cells lacking expression of MES-2, although it is possible that 
this mark is residual and/or due to modulation of histone demethylases (Bender et al., 
2004).   
In addition, biochemical data has not ruled out the presence of additional factors 
in the PRC2 complex, although it seems unlikely.  More probable are factors regulating 
the activity, recruitment to target loci, binding specificity, and/or mediation of 
downstream effects (i.e., chromatin compaction).  One interesting hypothesis suggested 
by the literature is the possibility that PRC2 or MES-4 function in conjunction with 
additional complexes.  These complexes might allow for the removal or addition of 
adjacent histone marks, and/or direct subsequent remodeling activity.  
It is currently unknown whether C.elegans possess a PRC1-like complex, or 
whether an alternative complex exists.   As independent functions of the PRC complexes 
have been observed in multiple species, the field would benefit from the discovery of 
additional proteins capable of reading the H3K27 methyl mark.  It is also unclear how, 
after reading this mark, it is interpreted to generate heterochromatin formation.  Possible 
models might include recruitment of additional factors which block the recruitment of 
transcription machinery, inhibit of PolII elongation, recruit of remodeling machinery to 
compact chromatin, remove machinery which keeping nucleosomes in an open 
configuration, and/or removal of activating histone marks such as acetylation and 
H3K4me2/3. 
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 C.elegans provides an excellent system in which to study histone PTMs and the 
role in heterochromatin formation. As this system lacks DNA methylation at cysteine 
residues, it is likely that a subset of PTMs, histone variants, and effector proteins underlie 
all requisite chromatin regulatory signals, preservation of germ line identity, and 
heterochromatin formation during the transition from cellular plasticity to cell fate 
commitment, all of which are likely necessary for implementation of gene expression 
programs.  It is also possible that the study of these worm genes may shed light of the 
roles of mammalian counterparts in development and disease.   
This work describes an RNAi based candidate screen designed to identify 
mediators of transcriptional silencing in the nematode C.elegans.  Findings of this study 
provide a unique opportunity to more fully characterize the Polycomb pathway in 
C.elegans, and may reveal novel mechanisms of heterochromatin formation functioning 
in the nematode as well as other organisms.   
 
Methods:  Sublibrary and primary screen 
In order to identify additional factors functioning in transcriptional silencing, we 
designed a feeding RNAi based candidate screen to identify genetic enhancers of the 
maternal effect sterile mes-3, a Polycomb component required for the majority of 
H3K27me2/3 and H3K9me3 in the germ line.  Genetic enhancers were also identified for 
met-2, a Su(Var)-93/SETDB1 ortholog required for H3K9me2, which when mutated, is 
superficially homozygous viable.  It was possible to identify of both enhancers and 
suppressors of the partially redundant hpl-1; hpl-2 HP1 mutant, as these alleles induce a 
larval arrest phenotype.   The candidate library was composed of 738 RNAi clones 
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targeting 650 genes localized to the nucleus or involved in RNAi mechanisms by gene 
ontology (GO) terms.  
 
Sublibrary construction 
 The RNAi sublibrary used in this screen was generated using a bioinformatics 
approach, using the GeneOntology database (http://amigo.geneontology.org).  RNAi 
feeding clones were selected based on the GO term “Nuclear,” where chromatin 
regulatory factors are likely to localize.  As individual researchers annotate genes, 
classification terms are widely variable, and gens can be annotated by “molecular 
function” and “biological process” as well as “cellular component.” In order to cull all 
genes of interest, genes associated with a range of GO terms were compiled, including, 
but not limited to:  nucleus (1263), nuclear (323), nuclear part (211), nuclear lamin (2), 
nucleolus (7), nucleosome (27), nuclear envelope (37), transcription (509), transcription 
regulator activity (220), transcription factor binding (39), nucleic acid binding 
transcription factor activity (548), DNA (645), DNA binding (138), nucleic acid binding 
(1301), chromatin (131 genes), chromatin binding (25), chromatin modification (34), 
chromatin organization (140), chromatin assembly/disassembly (108), chromosome (129), 
nuclear chromosome (53), histone (243),  nuclear lumen (153), DNA conformational 
change (102), gene silencing (146).   As RNAi machinery is increasingly implicated in 
gene silencing (see introduction), the GO term RNA interference was also included (126 
genes).  However, as some genes are not annotated by GO terms, a proportion of genes 
were missed, although we also added some genes based on the presence of specific 
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domains (i.e., SET).  The sublibrary gene list was considered saturated when a random 
group of known nuclear factors were listed by GO term analysis.   
The FAS Center for Systems Biology Scriptome was employed to remove 
repeated genes, which was very common as genes are annotated with multiple GO terms.  
The sublibrary gene list was then narrowed by the removal of known transcription factors 
using Scriptome software to compare to the Walout lab transcription factor database 
(Reece-Hoyes et al., 2005).  The sublibrary list was then annotated with “short 
descriptions” using the WormMart database export tool.   Obvious DNA and RNA 
polymerases were removed from the list manually.  By removing these characterized 
transcriptional elements, we hope to simplify the analysis and rule out potential false 
positives, increasingly the likelihood of identifying factors not previously associated 
involved in transcriptional regulation. 
We are interested in genes involved in heterochromatin formation, as well as 
genes required during the transition from pluripotency to cell fate commitment.  This 
transition occurs during the 2E-8E stages of embryonic development, and is accompanied 
by dramatic reorganization of nuclear architecture, changes linked by the function of 
MES/PcG function (Yuzyuk et al., 2009).  Based on these findings, we limited our screen 
to genes that are expressed during the 2E-8E window.  Genes not expressed at any point 
during this period by microarray analysis were excluded.  Using these criteria, we 
identified 816 candidate genes.   
RNAi clone assignment for individual genes was accomplished using the “Get 
locations” Perl script written in collaboration with Amir Karger (Harvard University 
FAS).  This script was run against both commercially available genomewide RNAi 
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library databases (Ahringer and Vidal RNAi libraries), and multiple clones per gene were 
not excluded. As these genomewide libraries have ~90% gene coverage, only 738 clones 
out of 816 were available for screening purposes. 
The sublibrary gene list was also annotated with previously identified RNAi 
phenotypes, specifically noting sterility, lethality and embryonic, larval, or adult arrest.  
Although this represents a large proportion of the candidate genes, these were included in 
the library to serve as internal positive controls and to test hpl-1; hpl-2 suppression.    
Additional controls included empty vector (L4440) and mes-2 RNAi.  mes-2, rather than 
the stronger mes-4, was chosen for a control to ensure that a more subtle suppression 
could be reliable detected.   
 
Picking RNAi clones 
 RNAi targeting clones were organized according to position in the parent plate 
(i.e., the 52 AhRNAi plates arrayed in 384 well format) and cherry picked into 150 ul of 
LB media + antibiotics (12.5 ug/ml tetracycline and 50 ug/ml carbenicillin) using 
autoclaved toothpicks into a 96 well format sublibrary (round bottom plates, Cell Star 
#650180).  All pipetting was performed using autoclaved tips.  All surfaces were 
sterilized with 70% EtOH and bleach.  Gloves were worm at all times.  Parent plates were 
removed from the -80oC freezer two at a time, and kept on dry ice during the cherry 
picking process, before being resealed with aluminum and returned to -80.  These “first 
pass plates” were grown overnight in a humidified shaker at 37oC (rpm <200 to avoid 
spillage/contamination).  In a subset of wells, bacteria failed to grow; these RNAi clones 
were repicked from the Mango Lab libraries and/or the Hunter lab Ahringer collection, 
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grown overnight and used to supplement specific wells.   A sterilized hedgehog was then 
used to replate the first pass plates; these second pass plates were grown 8 hours at 37oC 
to establish bacterial cultures of roughly equivalent concentrations.     These plates were 
then i) spotted unto carb+LB agar plates (Nunc #212811), grown overnight at 37oC and 
stored at 4oC to establish a “hard copy;” ii) replated (2x) into 8% glycerol LB+ antibiotics, 
grown overnight at 37oC, sealed and frozen at -80oC as a stock/backup; or iii) replated 
and grown overnight for use as a starter plates for feeding cultures.    
The resulting nuclear sublibrary containing 738 RNAi clones targeting 650 genes. 
With empty vector controls, the library occupies eight 96 well plates.  The complete list 
of genes targeted by RNAi, RNAi locations, rearray information, microarray expression 
data, and previously described phenotypes are available on the server/supplemental. 
 
Background mutations 
The screen was performed in worm strains carrying mutations in three key 
transcriptional silencing pathways i) Polycomb/H3K27me3, ii) SuVar3(9)/H3K9me2/3, 
and iii) heterochromatin protein 1 (HP1).   The following strains were used:  SS222 (mes-
3 (bn21) I (ts)); MT13293 (met-2(n4256) III); and PFR61 (hpl-1(tm1624) X; hpl-
2(tm1489) unc-49(e407) III (ts)).   
The mes-3 (bn21) allele is temperature sensitive, strict maternal effect sterile at 
25oC (Xu et al., 2001).  The temperature sensitive period has been identified as 
embryogenesis and larval development, and the progeny of homozygous mothers, raised 
at the restrictive temperature, are 100% sterile (Xu et al., 2001).  At 15oC homozygous 
mes-3 (bn21) worms display a severe mortal germ line effect, leading to progressive 
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sterility in five to seven generations (Strome lab, pers. communication, Senchuk et al., 
unpublished). This allele corresponds to single base pair and is not a null mutation, but 
leads to protein destabilization and mislocalization of the MES-3 to the cytoplasm, an 
effect observed at 15oC and much more severe at 25oC (Xu et al., 2001).  By 
immunofluorescence performed in M-Z- embryos at 25oC, H3K27me3 staining is 
severely reduced, consistent with previously published reports of MES/PRC2 function 
(Bender et al., 2004). 
The met-2(n4256) allele represents a 1343 bp deletion of a 5552 bp transcript, and 
removing portions of exon three, all of exon four, and the start of exon five, and is 
presumed to be functionally null (Andersen & Horvitz, 2007).  This strain also has a 
mortal germ line defect, although much less severe than that observed in mes-3 mutants, 
becoming sterile after 18-28 generations (Andersen & Horvitz, 2007).  In agreement with 
most data currently available, met-2 (n4256) embryos in our hands show a dramatic 
decrease in H3K9me2, while H3K9me3 is only marginally affected (Bessler et al., 2010). 
The phenotypes associated with mes-3 and met-2 (H3K9me2/3, mortal germ line) 
allowed for identification of genetic enhancers, where loss of a gene by RNAi mediated 
knockdown results in a more severe phenotype (i.e., sterility, embryonic lethality).  As 
both mes-3 (bn21) and met-2 (n4256) strains will produce F1 progeny, these strains could 
not be used to identify genetic suppressors.   
HPL-1 and HPL-2 encode partially redundant heterochromatin 1 (HP1 proteins).  
The hpl-2(tm1489) (ts) allele mutation starts upstream of the start codon and removes all 
of the first and second exons, which includes the chromodomain (Coustham et al., 2006).  
The hpl-1(tm1624) allele deletes 1700, deleting exons two through and resulting in a 
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premature stop codon.  This allele is likely null, as most of the chromodomain and the 
entire chromoshadow domain are absent (Schott et al., 2006).  Worms carrying both 
mutations (hpl-1; hpl-2) and raised at the restrictive temperature (25oC) give rise to 
progeny that arrest early in larval development (L2), a phenotype allowing for 
identification of both enhancers and suppressors.  Phenotypes associated with this strain 
are temperature dependent; at 24oC hpl-1; hpl-2 worms arrest as L3-adult worms with a 
synthetic multivulva phenotype (Muv). 
 
Plate preparation 
To screen worm populations, the 96 well format was rearrayed to 24 well format 
(Cell Star # 662102).  Standard NGM media was prepared and supplemented with IPTG 
(to a final concentration of 5 mM), carbenicillin (final concentration = 50 ug/mL), and 
tetracycline (final conc. = 12.5ug/ml).  An automatic plate pourer was used to add one 
ml/well.  Plates were dried until solid, and seeded with bacteria within 12-48 hours. 
Bacterial feeding cultures were started one day prior to seeding by growing an 
overnight culture.  This overnight culture was replated into fresh LB + carb (150ul), and 
grown for 8 hours in a humidified shaker (37oC, rpm <200).  From this 8 hour culture, 10 
ul feeding culture was spotted to each well using a multichannel pipette.  Two or more 
replicate plates were made from a single RNAi culture prep.  Plates were stacked and 
covered with worm tupperware to avoid cracking and drying of the agar (outer corners 
most susceptible).   Bacterial culture was allowed to dry/grow for 2 days at 22oC (RT), 
and seeded with worms immediately or stored at 4oC for less than one week before use.   
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Preparation and seeding of worms 
The mutant worms were grown up on multiple (five to fifteen, depending on the 
strain) large NMG plates containing OP50 bacteria at 15oC until the majority of worms 
were gravid hermaphrodites.  Worms were washed off plates with M9 and bleached for 
three to four minutes with constant agitation, washed three times and resulting embryos 
were plated with minimal liquid unto one to two unseeded plates (no food) and allowed 
to hatch at 15oC overnight. Under these conditions, larvae undergo a reversible 
developmental arrest as early larvae. The next day, synchronized L1 larvae were rinsed 
from the unseeded plate.  Concentration was adjusted to one to two worms/ul.   Three ul 
of worms were added to each well, and the presence of three to six worms was verified 
using a dissection microscope.  More worms were added per well for mes-3(bn21) strain 
(eigth to ten) to account for the severe mortal germ line defect and avoid a false positive 
“steriles.”   
 The plates were then shifted to 25oC and incubated for seven to nine days to allow 
for complete development of F1 progeny.   As P0 hpl-1; hpl-2 worms shifted to restrictive 
temperature were found to arrest without producing progeny, screening plates seeded 
with worms were incubated at 15oC (permissive temperature) for 24 hours before shifting 
to 25oC; at this time, hpl-1; hpl-2 worms are still L1 larvae.    
 
Screening and scoring 
Phenotypes of the F1 progeny were scored using a standard dissection scope.  To 
avoid bias, scoring was performed blindly, without knowledge of the RNAi target.  A 






Figure 5.  Schematic representation of the primary screen.   
All mutant strains [mes-3(bn21), met-2(n4256), and (hpl-1(tm1624); hpl-2(tm1489)] were 
screened by seeding the Po generation as synchronized L1s, and shifted to restrictive 
temperature (25oC).   F1 progeny were examined after 7-9 days.  The top panel (A) shows 
the phenotypes associated with mes-3 and met-2 enhancement.  Po were observed to 
arrest as larvae (L1-L4), sterile adults, or dead eggs.  Larval arrest of F1 progeny was not 
observed.  The bottom panel (B) depicts enhancement and suppression phenotypes 
associated with hpl-1; hpl-2.  Similar enhancement phenotypes were observed, as well as 




Enhancement of the three different mutant strains could be divided into three 
classes:  1) larval arrest of P0, defining the strongest category of enhancement; 2) sterility 
of P0; and 3) fertile P0 but dead embryos or developmentally arrested F1 progeny.  
Categories 2 and 3 are classified as enhancement, although category 3 is considered 
appreciably weaker.  As this class of enhancers is quite small, categories 2 and 3 were 
grouped during further analysis. 
Suppression of the hpl-1; hpl-2 double mutant was characterized as growth 
beyond the L2 stage, and was classified as “strong” if more than ~50% of F1 animals 
grew past L3, or more than ~20% grew past L4 and/or developed a protruding vulva, 
indicative of late stage developmental events.  Controls never demonstrated this 
phenotype, and mes-2 positive controls were consistently strong suppressors.  
Phenotypes associated with RNAi in mutant strains were compared to i) the 
replicate test (reproducibility), ii) the published RNAi phenotype(s) annotated in 
Wormbase, and iii) the phenotype observed in replicates tests of the other mutant strains.  
 
Results and Discussion: Primary screen  
 In this work, mutants involved in transcriptional silencing were screened against a 
sublibrary containing 738 RNAi clones targeting 650 genes associated with nuclear 
localization/function or RNAi mechanisms by GO term annotation.  577 RNAi clones 
targeting 511 genes either enhanced or suppressed one or more of the three mutant lines 
at some level in both replicates.  These can be separated into different categories based on 
phenotypes observed in each mutant; genes associated with different categories are 
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plotted in Figures 6 and 7.  Categories were subdivided further based on previously 
annotated RNAi phenotypes (data not shown).  
Of the 577 potential positives, 284 were found to enhance all three mutations; the 
majority of these had previously identified RNAi phenotypes associated with sterility, 
embryonic, larval, or adult lethality, which likely account for the observed phenotype.  18 
genes in this category are not associated with previously annotated RNAi phenotypes, 
and 12 of these 18 genes were tested in an N2 wildtype background.  In N2, 5 of 12 
RNAi treatments resulted in phenotypes similar to those observed in the mutant strains 
during screening, suggesting that at least some genes in this category represent a general, 
but not previously annotated phenotype; these phenotypes are not associated with 
enhancement.  Phenotypes resulting from the remaining RNAi (7/12) may represent 
general enhancers (i.e., sickly or slow and likely to enhance many mutations), although 
this was not tested.  
We identified 293 RNAi clones targeting 268 genes that are potentially interesting 
candidates to function in heterochromatin formation and/or transcriptional repression.    
Many of these genes enhance and/or suppress more than one background mutation, 
suggesting that a great deal of crosstalk exists between these different silencing 
mechanisms.   For example, 102 genes enhanced the met-2 mutation, but less than half of 
that number exclusively affected met-2.  Similar overlap was seen between each of the 
background mutations. 
Next, we queried for specific enrichment of GO terms within each of these 
categories relative to the entire sublibrary using the GOstat online tool developed by Tim 




























Figure 6.  Summary of primary screen results.   The different mutant backgrounds are 
represented by individual columns, and different phenotypes correspond to the different 
colors; red indicates enhancement, black indicates strong suppression, grey indicates 
weak suppression, and white indicates no phenotype.  The number of genes associated 







Figure 7.   Breakdown of primary screen results.  Genes are plotted by phenotypes 
associated with different background mutations.  Red indicates strong suppression and 
pink indicates weak suppression.  Black indicates strong enhancement, and grey indicates 
weak enhancement.  Within the sublibrary, some genes were targeted by multiple RNAi 
clones, and are repeated in this analysis.  Genes that weakly enhanced all mutant 
backgrounds, and genes that showed no phenotype in any background are not shown in 








Figure 7.  Continued. 
 
hpl-1; hpl-2 suppression, mes-3 enhancement, and ii) met-2 enhancement, demonstrate 
enrichment of factors associated with the GO term “DNA repair.”  Other categories failed 
to show significant enrichment, likely due to the number of genes in each category being 
relatively low.  By manual analysis of GO terms, 32 of the 52 DNA repair associated 
factors in the RNAi sublibrary are among the 268 candidate genes, suggesting that DNA 
repair may be linked to heterochromatin formation. 
We next questioned whether components of known complexes would track 
together within any of the categories, indicating a genetic interaction between a complex 
and transcriptional silencing pathway(s).  Complexes examined included those involved 
in chromatin remodeling (SWR1, NURD, etc.), transcriptional activation/repression 
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(DREAM, SAGA, COMPASS, etc.), and complexes involved in DNA damage and repair, 
meiosis, dosage compensation, protein degradation, and RNAi.  This analysis was 
performed manually, against predicted C.elegans homologs.  As subunits of these 
complexes have not been verified in vivo and/or studied in C.elegans, many predicted 
orthologs were not annotated by GO terms, and thus not in the sublibrary used for 
screening – this represents one of the major drawbacks of the bioinformatics based 
approached used.   
Using this comparative method, all known members of the Polycomb Repressive 
Complex 2 (PRC2) (mes-2, mes-3, mes-6) and two interacting factors (mes-4, set-2), are 
found in the “strong hpl-1; hpl-2 suppressor” category, indicating that the combined loss 
of mes gene function and hpl-1; hpl-2 mutation causes a significantly less severe 
phenotype than hpl-1; hpl-2 alone.  In the conditions used for this screen, progeny of hpl-
1; hpl-2 mutants (i.e., F1 animals) arrest as early larvae (L1-L2).  Loss of mes gene 
function in this background strongly suppressed the early arrest, and fit the criteria for 
“strong suppression,” with ~50% of F1 animals grew past L2 or more than ~20% grew 
past L4 and/or developed a protruding vulva, indicative of late stage developmental 
events.  No other complex or pathway shows such a striking pattern of enrichment within 
a single category.  Although we have not ruled out interactions between the Mes pathway 
and HP1, this distinctive signature may allow for the identification of novel factors 
functioning in collaboration with Mes genes in the repression of X-linked expression, 
chromatin dynamics, and the regulation of the transition between cellular plasticity and 




The nuclear/RNAi candidate screen described in the previous sections was carried 
out to identify factors functioning in heterochromatin formation.  To accomplish this, the 
candidate RNAi sublibrary was screened using strains carrying background mutations in 
three conserved pathways mediating transcriptional repression:  mes-3 (Polycomb), met-2 
(H3K9me2) and hpl-1; hpl-2 (HP1).   As loss of these components have subtle 
phenotypes, we hypothesized that additional methods of gene silencing likely exist, and 
that the combined loss of these unidentified components with known mediators of 
transcriptional repression would have additive effects.   
We were most intrigued by the observation that loss of all known MES/PRC2 
components (mes-2, mes-3, mes-6), as well as RNAi’s targeting two genes shown to 
genetically interact with the PRC2 complex (mes-4 and set-2), strongly suppressed the 
hpl-1; hpl-2 larval arrest phenotype, and failed to enhance met-2 and the mes-3 loss of 
function phenotypes.  SET-2 is enriched in the PGCs of L1s and the germ cells of adults, 
similar to the MES factors, and has been shown to enhance the sterility of mes-3 and mes-
4 M+Z- mutants (Xu & Strome, 2001).  Although SET-2 is required for H3K4me2/3, 
these marks are absent in the PGCs (Schaner et, al, 2003), removal of which may be 
dependent on MES-4 and the demethylase SPR-5 (Furuhashi et al., 2010; Katz et al., 
2009).  set-2 also has a mortal germ line, lending further support for SET-2 function with 
MES factors in promoting germ line function (Xiao et al., 2011). 
As SET-2 was initially identified as part of the Mes/PcG pathway as an enhancer 
of mes-3 and mes-4 sterility, we might have predicted that additional components of this 
pathway might also enhance mes-3 sterility.   However, under the conditions used for our 
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screen, set-2 did not enhance mes-3, but rather suppressed hpl-1; hpl-2, suggesting that 
the knockout of mes-3 using the temperature sensitive allele is sets a high threshold, such 
that it cannot be enhanced further by components functioning in a common pathway.   
This is supported by the observation that all F1 animals failed to give rise to an F2 
generation.   In addition, our findings validate a previous result demonstrating that mes-2, 
mes-4 and set-2 suppress the hpl-1; hpl-2 phenotype (Simonet et al., 2007).  However, 
this group did not explore the mechanisms by which this suppression occurred, nor 
address the potential link to the Polycomb pathway.   
Two complexes (SOP-2/SOR-1/SOR-3 and SPAT-3A/MIG-32) have been 
postulated to form PRC1 like complexes in C.elegans.  The defects associated with loss 
of function of these genes are associated with the subtle homeotic transformation 
phenotypes linked to misregulation of Hox genes.  Whether these complexes are PRC1-
like, and whether they interact with mes-2/3/6 is controversial.  As shown Table 1, these 
genes do not suppress hpl-1; hpl-2 larval arrest, suggesting they are unlikely to function 
in the MES pathway of chromatin regulation.  However, interaction between these genes 
(sop-2/sor-1/sor-3 and spat-3A/mig-32) and the MES factors during the regulation of Hox 
genes is not ruled out.  
It is possible that the observed rescue of hpl-1; hpl-2 larval arrest by MES factors 
is due to interaction with the SynMuv related role of hpl-2.  Several studies have shown 
that loss of mes-4 (as well as mes-2/3/6 in the case of lin-15AB(n765)), suppresses the 
Muv phenotype associated with SynMuv mutation (Cui et al., 2006; Lehner et al., 2006; 
Simonet et al., 2007; Petrella et al., 2011), and mes-2/mes-3/mes-6 and mes-4 have been 
shown to suppress some SynMuv associated phenotypes, including the expression of 
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Table 1. Phenotypes associated with predicted components of C.elegans PRC2 and PRC1. 
   Supp.: Enhancement: 




mes-2 E(z)/EZH2, SET (H3K27me) +++ - - - 
mes-3 Novel +++ - - - 
mes-6 ESC/EED +++ - - - 
mes-4 SET (H3K36me), PHD +++ - - - 





) spat-3 Ring1 ZF, H2Aub - - - - mig-32 Ring, H2Aub n.d. n.d. n.d. n.d. 
sor-1 Novel - + + - 
sor-3 Novel, MBT - + - - 
sop-2 SAM domain - - - -  
 
ectopic  P-granules (Unhavaithaya et al., 2002; Petrella et al., 2011).  However, this effect 
is unlikely to be due solely to suppression of SynMuv vulval phenotypes, as a number of 
RNAi clones resulting in strong hpl-1; hpl-2 suppression in this screen (including mes-2, 
mes-3, and mes-6) were characterized by well developed worms in which multiple vulvas 
were apparent.   This observation is explored further in the secondary screens section.   
In addition to members of MES pathway/Polycomb repressive complex, 11 other 
genes were found to strongly suppress hpl-1; hpl-2 with no effect on mes-3 or met-2, 
raising the interesting hypothesis that genes with this signature may represent additional 
genes functioning in the Polycomb pathway.    Table 2 provides a summary of these 
genes, a number of which are associated with different activating complexes, including 
NuA4, SWR1, and COMPASS.  Function of these factors in cooperation with Mes 
mediated repression is somewhat unexpected, as these complexes are generally 
associated with gene activation, mediating histone acetylation, incorporation of the 
histone variant H2A.Z, and H3K4 methylation respectively.     
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Table 2.  Strong hpl-1; hpl-2 suppressors identified in the primary screen. 
 










related protein, cell 
proliferation 
MSL-3, 




ZK1127.3 Uncharacterized conserved protein EAF7, MRGB II CT20 
gfl-1 
Transcription 
initiation factor IIF, 
auxiliary subunit 
Yaf9, Gas41, 
Yeats4, AF9 IV  YEATS 













SET domain, RNA 
recognition motif 
wdr-5 
Histone H3 (Lys4) 
methyltransferase 
complex 
WRD5, SWD3 III WD40/YVTN  
F52B11.1 




CpG binding, Zn 
Finger 



























OGT III Tetratricopeptide repeat 
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NuA4 is a multisubunit complex participating in histone acetylation of H4 and 
H2A at target promoters, and as such, is typically thought to induce transcriptional 
activation.  The SWR1 complex is an ATP dependent chromatin remodeling complex, 
involved in the incorporation of the histone variant H2A.Z, which is important for gene 
regulation and genomic stability.  The incorporation of H2A.Z is thought to change 
nucleosome dynamics, but the effects of these changes on gene expression have been 
controversial (Marques et al., 2009).  In yeast, at least four components are shared 
between these two complexes, and evolutionary evidence suggests that overlap may be 
greater in complex metazoans (Lu et al., 2009).   Four genes predicted to function in the 
SWR1/NuA4 complex were identified as strong hpl-1; hpl-2 suppressors:  mrg-1, gfl-1, 
C08B11.6 and ZK112.73.  The mixed lineage leukemia (MLL) protein and the 
Drosophila homolog, Trithorax, exist in COMPASS (complex of proteins associated with 
Set1)-like complexes and mediate H3K4 methylation.  As shown in Table 2, several 
genes associated with the COMPASS complex were identified as hpl-1; hpl-2 
suppressors, including the H3K4 HMT set-2, a previously identified Mes interactor, as 
well as wrd-5, and F52B11.1. MLL/COMPASS mediated marks form the positive 
component of “bivalent” domains thought to mark gene poised for activation during 
differentiation; this may represent one means of interaction with the Mes pathway.   
In addition to components of the transcription activating complexes noted above, 
two genes potentially involved in DNA repair were identified as hpl-1; hpl-2 suppressors, 
including him-17 and T05A12.4.  HIM-17 is also required for the proper patterning of 
H3K9me2 marks in the meiotic germ line (Reddy & Villeneuve, 2004; Maine et al., 
2005; Bessler et al., 2007).  A gene encoding O-linked N-acetylglucosamine (O-GlcNAc) 
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transferase (OGT-1) was also found to suppress hpl-1; hpl-2, and as this modification 
may be linked to Polycomb function in flies and mammals (Love et al., 2010), we were 
intrigued to discover a link between OGT and the Mes/PcG pathway inthe worm.  The 
last hpl-1; hpl-2 suppressor is T19B4.5, which has been previously linked to the RNAi 
pathway (Wang et al., 2005), but appears to be novel, uncharacterized, and by sequence 
analysis may not be conserved in other species.   
Many of the hpl-1; hpl-2 suppressors identified by this study are generally 
involved in the positive regulation of gene expression.  In the most simplistic model, the 
loss of these factors (and likely complex functionality) may suppress hpl-1; hpl-2 larval 
lethality by “balancing out” the loss of these repressors.  One could imagine that in hpl-1; 
hpl-2 mutants, lethality results from overactive transcription and/or the activation of off-
target genes.  By inhibiting precocious gene activity by removing one mode of gene 
activation, it is possible a favorable equilibrium of gene expression might be 
reestablished, allowing for enhanced developmental potential.   
 There are two main reasons to argue against this hypothesis.  First, the 
MES/PRC2 and associated factors MES-4 and SET-2 represent 5 out of the 16 factors 
whose loss leads to suppression of the hpl-1; hpl-2 phenotype.  As PRC2 is appreciated to 
function primarily in transcriptional repression, the simple model presented above does 
not hold up.  Secondly, in both worms and other organisms, the understanding of HP1 
function is increasingly complex.  For example, recent studies also implicate HP1 in 
processes such as DNA repair and euchromatic gene expression (Kwon & Workman et 
al., 2011).  HP1 has also been associated with both positive and negative regulation of 
PolII elongation (Vakoc et al., 2005; Milne et al., 2005).  Similarly, HP1 has been 
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associated with both heterochromatin and euchromatic regions of Drosophila polytene 
chromosomes (Kwon & Workman, 2011).  As these factors are both transcriptional 
repressors, an alternative model suggests that HP1 function might oppose MES/PcG 
during the transition from cellular plasticity to differentiation (for example, HP1 might 
inhibit differentiation genes while Mes/PcGs inhibit pluripotency). 
In worms, immunostaining has demonstrated that HP1 localized regions lie 
immediately adjacent to condensed chromatin, but were found not to overlap with 
condensed domains (Couteau et al., 2002).   This finding suggests that HP1 in C.elegans 
may function somewhat differently than other organisms.   In addition, numerous studies 
in a range of species has demonstrated that HP1 binds H3K9me2/3, but this link has not 
been established in C.elegans.   In fact, HP1 foci do not appear to overlap with either di 
or tri methylated H3K9, and in differentiated adult nuclei, HPL-2 staining is diffuse 
(Simonet et al., 2007).  However, in hpl-2 mutants, H3K9me3 appears to become more 
concentrated in nuclear foci (Simonet et al., 2007), suggesting that HP1 might function to 
stabilize certain chromatin configurations.  As MES-2 is essential for H3K9me3 in the 
germline, this may provide a link between the MES factors and HP1, despite the lack of 
evidence for direct binding of HP1 to this mark.   Intriguingly, the localization of 
H3K9me3 in hpl-2 mutants is restored to wildtype in hlp-2; set-2 double mutants 
(Simonet et al., 2007).  These data support the findings of our study, which suggest that 
while the activities of MES-2/PRC2 and SET-2 may be in opposition (i.e., repression vs. 
activation), these factors work together to ensure correct expression of germ line gene 
profiles.  It is possible that the role of HP1 is actually to antagonize or erase the germline 
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chromatin state, potentially through removal of MES-4 mediated H3K36me, and in this 
way functions in the SynMuv pathway.   
To begin to define the roles of the hpl-1; hpl-2 suppressors identified by our 
primary screen, specifically with respect to the Mes/PcG pathway, we tested whether loss 
of these factors share similar MES related phenotypes, including maternal effect sterility 
in wildtype worms, loss of H3K27me3 staining during embryogenesis, and rescue of 
mep-1/NuRD associated larval arrest.  We hypothesized the different hpl-1; hp-2 
suppressors identified in our primary screen might function more similarly to either 
MES/PRC2 or MES-4.  Loss of MES-4 has been associated with more severe defects 
than loss of MES-2/MES-3/MES-6, including the germ line degeneration phenotype 
(Capowski et al., 1991, Garvin et al., 1998).   MES/PRC2 complex localization and 
function is distinct from MES-4, although these genes function in a common pathway to 
repress transcription of the X chromosomes in the adult germ line.   While the PRC2 
complex associates with all chromosomes and trimethylates H3K27, MES-4 localizes to 
autosomes and mediates H3K36me2/3 methylation, a mark correlated with transcriptional 
activity, as well as recruitment of histone deacteylase complexes (Fong et al., 2002; 
Bender et al., 2006; Rechtsteiner et al., 2010; Furuhashi et al., 2010; Leib & Clark, 2005).  
Studies have also indicated that these genes may possess some independent functions, 
including repression of RNA PolII elongation in the PCGs, and regulation of chromatin 
compaction and gene expression during the transition from cellular plasticity to cell fate 
commitment (Furuhashi et al., 2010; Yuzyuk et al., 2009).  Identification of additional 
factors primarily affiliated with MES-4, as well as factors functioning predominantly 
with MES/PRC2 will allow for a greater understanding of the Mes as a whole, and 
 97  
perhaps shed light on the mechanisms mediating MES antagonism, targeting, and 
regulation of heterochromatin.  
 
Note on interpretation of results 
It should be noted that the setup and analysis of this screen may contain a certain 
percentage of “false negatives.” As such, we may have overlooked some potentially 
significant factors.   One example is H1.1 (his-24), a linker histone thought to be involved 
in heterochromatin formation (Jedrusik & Schulze, 2001; Jedrusik & Schulze, 2007).  
Loss of his-24 showed no significant phenotypes in hpl-1;hpl-2 or mes-3 mutant strains, 
but “enhanced” met-2.  There are several possibilities that may account for this 
observation.  First, as his-24 RNAi is previously associated embryonic lethal and sterile 
RNAi phenotypes, it is possible that his-24 RNAi in this screen actually suppresses both 
hpl-1; hpl-2 and mes-3 and but has no affect on met-2 other than the previously identified 
phenotype.  An important alternative is that this RNAi clone was only weakly effective, 
resulting in a generally mild phenotype.  It is also possible, based on the inherent 
properties of the RNAi libraries, as well as human error, that some clones may be 
incorrect, and/or contaminated with other RNAi clones.   70/493 clones expected to show 
an embryonic, larval or adult lethality or arrest had no effect in any of the three mutant 
lines; it is likely these are weak or ineffective RNAi’s.  In addition, 54/493 clones with 
previously annotated phenotypes affected only a single mutant line.  However, it must 
also be considered that previously annotated RNAi phenotypes may be overstated, as 
these data are culled from many types of experiments, including different background 
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mutations (including RNAi enhancer strains), and may reflect partial or not fully 
penetrant phenotypes.    
Yet based on previous studies, one might have predicted that his-24 would 
function in the MES/PcG pathway.  Loss of his-24 function is associated with desilencing 
of repetitive transgenes in the germ line, germ line proliferation defects and low level 
sterility, phenotypes commonly associated with loss of MES activity (Jedrusik & Schulze, 
2007).  However, as his-24 loss of function enhanced H3K27me staining in mes-3 (bn35) 
germline nuclei (Jedrusik & Schulze, 2007), we would not predict that his-24 would 
suppress mes-3, as in the alternative interpretation of our results.   Yet, as the ascribed 
role for this protein germ line is dependent on mes-2, mes-3, mes-4, mes-6 and sir-2.1 
(Jedrusik & Schulze, 2007), it’s possible that factors functioning downstream of MES 
activity have different effects on hpl-1; hpl-2 and/or other mutant backgrounds.  
 
Additional data and potential future directions  
 This screen provides a wealth of data not explored in this manuscript.  Each of the 
categories of enhancement/suppression within the different mutant strains may provide 
insight applicable to future studies.  Of specific interest might be the class associated with 
both hpl-1; hpl-2 suppression and mes-3 enhancement, as these factors may function in 
some capacity within the MES/PcG pathway.  As shown in Figure 7, this group contains 
predicted DNA binding proteins (R07E5.8, F21D5.4), histone deacetylases (SIR-2.1, 
SIN-3) and SET domain containing proteins (SET-12, SET-19). These types of factors 
could be hypothesized to function in the MES/PcG pathway of silencing, and may 
represent interesting targets of future study.  
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A second area that may be of interest is the potential connection to DNA repair.  
A total of 90 genes in the C.elegans genome are annotated with the GO term DNA repair. 
Of these, 52 are present in the nuclear sublibrary.   A striking 45/52 DNA repair 
associated genes enhance or suppress one or more mutant strains.  While 12 of these 
enhance all three mutants, and may represent a general enhancers and/or previously 
annotated RNAi phenotypes, the enrichment of DNA repair factors is intriguing, as DNA 
repair machinery is increasingly implicated in transcriptional regulation, and may also 
play a role in the transition from pluripotency to differentiation.  One striking example 
comes from the Tjian lab, where it was recently demonstrated that the stem cell 
coactivator complex (SCC), which interacts directly with Oct4 and Sox2, binds Oct4 and 
Nanog promoters, and is required for both maintenance of ES cell pluripotency and 
differentiation potential is actually the XPC nucleotide excision repair complex (Fong et 
al., 2011).  Although the mechanism is unknown, perhaps a similar complex functions in 
C.elegans embryogenesis. 
In addition, a growing body of work demonstrates that chromatin factors, 
including Polycomb, are recruited to sites of DNA damage and may function to block 
transcription of the damaged elements and/or remodel the surrounding chromatin 
environment to allow access of DNA repair machinery (Bell et al., 2011).  We are only 
beginning to appreciate how the interplay between DNA surveillance and repair are 
coupled with transcription, particularly with respect to the pluripotent cell population.  To 
quote from a recent review:  
“Understanding the contribution of Polycomb group proteins to the DNA damage 
response may lead to novel therapeutic strategies that increase the response of human 
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cancers to therapies that work through DNA damage, while simultaneously sensitizing 
the cancer stem cell population that would otherwise lead to relapse”  (Gieni et al., 2011, 
pg 883). 
 Factors associated with DNA repair were also enriched in the met-2 enhancer 
category.  This may reflect recent findings demonstrating a role for MET-2 in meiotic sex 
chromosome inactivation (MSCI) and shielding the unpaired X chromosome from 
recognition and triggering of checkpoint activation (Checchi & Engebrecht, 2011).  In 
this study, met-2 XO animals undergo increased germ line apoptosis, due to inappropriate 
activation of the recombination checkpoint.  Intriguingly, MES-2 activity also appears to 
be required in this process, supporting the observation that crosstalk likely occurs 




Methods: Secondary screens 
 
hpl-1; hpl-2 suppression assay:  Larval arrest 
The hpl-1; hpl-2 strain used in the previously described screen [PFR61, hpl-
1(tm1624) X; hpl-2(tm1489); unc-49(e407) III (ts)] was used to confirm and quantitate 
the level of suppression in response to RNAi mediated knockdown of the different clones 
identified as hpl-1; hpl-2 suppressors in the primary screen.  RNAi cultures were grown 
using sequenced clones in 5 ml LB + 50 ug/ml carbenicillin for 8 hours at 37oC.  RNAi 
plates were prepared using 5 cm NGM plates, seeded with 1 ml of cultured bacteria 
resuspended in 100 ul of IPTG and carbenicillin to a final plate concentration of 8 mM 
and 60 ug/ml respectively.  Seeded plates were grown for 48 hours at RT/22oC, and 
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stored for up to a week at 4oC. This method of plate preparation was used throughout the 
secondary screening analyses.   
hpl-1; hpl-2 worms were maintained at 15oC, and synchronized as L1s by 
bleaching a population of healthy, gravid adults and seeding embryos on unseeded NGM 
plates.  For each assay, 10 L1s were transferred to individual RNAi plates.  These were 
incubated at 15oC (permissive temperature) for 24 hours to avoid P0 arrest.  Plates were 
then shifted to 25oC (restrictive temperature) for 8-9 days to allow progeny to fully 
develop.  All resulting progeny were counted and scored as L1, L2, L3, L4 or adult based 
on size under dissection microscope.  Staging was verified by examining germline 
development in subsets of worms by Nomarski optics under high power magnification. 
Using RNAi plates prepared using different cultures and different populations of worms, 
three or more replicates were performed per RNAi.  
 
hpl-1; hpl-2 suppression assay: Multivulva formation 
 This assay was performed as above, but plates were shifted to the semirestrictive 
temperature of 24oC instead of 25oC to allow for all worms to reach maturity.  F1 worms 
were scored for the presence of multiple vulvas after 9-10 days.  Three biological 
replicates were analyzed per RNAi.   
 
Maternal effect sterile 
  Gravid N2 wildtype hermaphrodites were bleached and embryos were hatched in 
the absence of food to synchronize L1s.  Ten-twenty L1s were moved to RNAi plates 
(prepared as above) and raised at 25oC.  Late hatched L4 F1 progeny (and thus most 
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strongly affected by RNAi) were moved to fresh RNAi plates and scored after 30-40 
hours of development at 25oC.  Adult worms were mounted on 4% agar pads in 
Levimiasole anesthetic and scored for sterility (i.e., absence of eggs or oocytes and/or 
endomitotic nuclei) at 5x and 20x. Approximatly one hundred worms were scored per 
RNAi treatment.  Worms containing more than five wildtype appearing embryos were 
considered fertile.  
 
Germline morphology 
Germline morphology was assayed in wildtype N2 worms, as well as in worms 
carrying an integrated, germ line expressed H2B::GFP chromatin marker [AZ212 (unc-
119(ed3) ruIs32[unc-119(+) pie-1::GFP::H2B] III)].  Synchronized L1 larvae were 
seeded unto RNAi plates, raised at 25oC until adulthood and either scored as P0 (for 
maternal effect sterile genes) or allowed to lay embryos.  A subset of F1 progeny were 
moved to new RNAi plates and allowed to develop, and examined ~30 hours into 
adulthood.   Fifty to one hundred animals per RNAi were mounted on 4% agar in 
Levimiasole and scored live.  The size, shape, and relative number of germ line nuclei, as 
well as germ line organization in mitotic and meiotic zones were observed in comparison 
to control worms fed empty vector RNAi.  
 
H3K27me3 staining 
Changes in global H3K27me3 and H3K9me2 levels and localization patterns 
were assessed by immunofluorescence staining in fixed embryos following treatment 
with RNAi.  Starved synchronized wildtype (N2) L1 worms were plated to either empty 
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vector or RNAi plates and raised 48-56 hours at 25oC, allowing the majority of animals to 
reach adulthood.  Different incubation times were used as some RNAi treatments 
(including gfl-1 and T19B4.5) result in slow growth in N2.   Gravid adult were dissected 
on polylysine coated slides in M9, and older embryos were picked off the plate.  
Untreated embryos marked by integrated GFP were included to serve as on slide staining 
controls, these included: JR2132 (wIs126 (elt-7::GFP::lacZ)) and AZ212 (unc-119(ed3) 
ruIs32[unc-119(+) pie-1::GFP::H2B] III).  Control stains included mes-2 (RNAi) and 
mes-3(bn21) raised at 25oC.  Coincident with wildtype (N2) experiments, RNAi plates 
from the same preparation were used to establish RNAi efficacy using hpl-1; hpl-2 
worms (i.e., suppression assay).     
Slides were stained using standard protocols.  Briefly, slides were freeze-cracked, 
were fixed for 10 minutes in 4oC methanol, washed 3x10 minutes in TBST, and blocked 
in TNB+NGS.  Primary antibodies were diluted in TNB+NGS and incubated overnight at 
15oC.   The following primary antibodies were used in this analysis:  rabbit anti-
H3K27me3 (Millipore, #07-449, 1:500) and mouse anti-H3K9me2 (ab1220, abcam 
1:500); these antibodies have been verified for specificity by the ModEncode Consortium 
and Egelhofer, et al., 2011.  As a marker of on slide control embryos, chicken anti GFP 
(Milipore/Chemicon; #AB16901) was used at 1:500.  Alexafluor secondaries were used 
at 1:200 (both mouse and chicken primary antibodies were detected using 488) and 
samples were mounted in SlowFade + Dapi (Invitrogen).  Imaging was performed on an 




Suppression of mep-1 larval lethality 
 Suppression of mep-1 larval lethality was performed as in Cui et al., 2006.  When 
raised at 25oC, mep-1(q660) homozygotes arrest as L1-L2 larvae.  RNAi plates were 
seeded with 15-20 synchronized JK2906 [mep-1(q660) IV/nT1(qIs51; GFP)] L1 larvae, 
and plates were shifted from permissive temperature (15oC) to restrictive temperature 
(25oC).   When P0 worms reached L4 (~2 days), they were transferred to new RNAi 
plates and allowed to lay embryos.  Over the course of 4 days, GFP(+) worms (mep-
1(q660) heterozygotes), were removed, and GFP(-) mep-1 homozygotes were allowed to 
develop and scored 3 days later according to body size by dissection microscope.  Larvae 
that did not progress in development during these 3 days were considered arrested.   
 
Assay for germline transgene desilencing 
The assay for germline silencing was performed using the strain PD7271 (pha-
1(e2123) III (ts); ccEx7271) as Cui et al., 2006, using a strain carrying a highly repetitive 
multi-copy array of let-858::GFP, composed of >100 copies of pBK48 (Tabara et al., 
1999; Kelly & Fire 1997).  This array expresses nuclear localized GFP in all somatic cells, 
but no or reduced GFP in germ cells (Kelly & Fire et al., 1997; Kelly & Fire, 1998).  
When maintained at >20oC, pha-1(+) gene on the array selects for maintenance of the 
array.   
 To perform the assay, synchronized L1 PD7271 worms were seeded unto RNAi 
plates and incubated to adulthood at 25oC.  For genes resulting in maternal effect sterility 
(mes-2, mes-3, mes-4, mes-6, mrg-1), germline desilencing was assayed in the P0 
generation.  For the additional RNAi’s, P0 adults were transferred to new RNAi plates, 
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and the F1 adults were examined.  Fifty to one hundred worms were scored per treatment 
per experiment.  Both arms of the adult gonad were observed, and if GFP expression was 
present in one gonad arm, the animal was scored as GFP+.  Levels were not quantified.   
 
Transgene desilencing assay 
 GFP expressing strains were also used to examine additional desilencing 
phenotypes; these strains including both integrated and nonintegrated arrays expressed in 
both somatic and germline tissues.   The properties of these strains are summarized in 
Table 3.   
These assays were carried out similar to the germ line desilencing assay, scoring 
P0 and F1 adults raised at 25oC.  GFP was scored on an Axioscope 63x.  Images were 
collected on the same settings, and differences in germ line vs. soma were quantitated 
when appropriate. 
 Somatic expression of let-858::GFP was quantified using ImageJ.  Pixel intensity 
of 30-100 intestinal nuclei was measured and averaged between different experiments.  
Different let-858::GFP lines showed no difference in ratio intensity between RNAi and 
control.   
 
Assay for RNAi defective 
 The HC57 strain expresses myo-2::GFP in the pharyngeal muscle, myo-3::GFP in 
the body wall muscle, and a GFP targeting dsRNA hairpin construct driven by the 
pharynx specific myo-2 promoter.  This strain was designed to allow for monitoring of 
both localized and systemic RNAi (Winston et al., 2002).  Synchronized L1 worms were  
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plated to RNAi and raised at 20oC.  F1 L1 progeny were transferred to fresh RNAi 
platesand analyzed in early adulthood using a GFP dissecting scope.  When RNAi is 
defective, GFP increased fluorescence in the pharynx (if localized) and body wall muscle 
(if systemic).   
 
Statistical analysis 
 Statistical analysis of hpl-1; hpl-2 suppression and mep-1 suppression were 
performed using logistic regression models, adjusting for variation between experiments.  
Using this model, the odds of surviving past the L1/L2 stage (i.e., control) was calculated 
in comparison to controls. In these assays, the regression coefficient reports the log odds 
of survival.   Logistic regression analysis was also performed to estimate the odds of 
Strain: Transgenic: Repeats: Mode: Promoter:  Expression: 
HC195 nrIs20[sur-5::GFP] Simple Integrated Ub. Soma 










Simple Array Ub. Ub. 
KW1127 ccEx7291[let-858:GFP (pBK481) + pRF4 rol-6] Complex Array Ub. Ub. 
KW1336 
unc-4(e120) let-
858(cc500) II; Ex1336 
[pBK48(let-858::GFP); 
pRF4]   
Complex Array Ub. Ub. 
NL2507 pkIs1582[let-858::GFP + rol-6(su1006)] Complex Integrated Ub. Ub. 
 107  
desilencing for each RNAi treatment compared to controls. The regression coefficient 
reports the log odds of desilencing.  In all analyses, estimates were adjusted for variation 
between different experiments. 
Significance relating to the average number of progeny per worm in the hpl-1; 
hpl-2 assay was calculated using the Student’s T-Test, assuming homoscedastic variance. 
The statistical difference between the fluorescence intensity of somatic expression of let-
858::GFP on empty vector and T19B4.5 RNAi was calculated using the Chi-Square test.   
These findings were reported to be significantly different if associated with p-values 
<0.05.  
Clustering analysis of this data was performed using Mathematica’s 
DendrogramPlot[] function.  The plot was generated by agglomerative clustering with 
complete linkage (i.e., farther neighbor) of the first two principal components (based on 
variance) and represents Euclidean distance of unnormalized data.   Data from each 
experiment were weighted equally for a total of 16 independent variables.   
I gratefully acknowledge Tala Fakhouri (PhD, MPH) and Kareem Carr (PhD) for 
assistance in statistical analysis.  
 
Results:  Secondary screens 
hpl-1; hpl-2 suppression assay:  Larval arrest 
To address whether genes within the HPL strong suppressor category function in 
the Mes/PcG pathway, a series of assays was conducted to examine whether loss of these 
genes would result in classic Mes/Polycomb phenotypes.   Prior to any continued analysis 
of the 11 additional HPL suppressing RNAi clones, each of the clones, including 
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Mes/PcG and mes-4 controls, were sequence verified and the hpl-1; hpl-2 suppression 
assay was repeated, and the number of worms developing to each larval stage was 
quantitated.   Control hlp-1; hpl-2 larval worms, when shifted to restricted temperature, 
produce F1 progeny that arrest at the L1/L2 stage. These worms are smaller as adults than 
wildtype, show defects in somatic gonad development and vulval cell fate specification, 
and are 100 % sterile (Coustham et al., 2003).  
As show in Figure 8, there is a range of suppression resulting from RNAi 
mediated depletion, with mes-4 suppressing the larval arrest defect to the greatest extent, 
with 70% of hpl-1; hpl-2 worms on mes-4 RNAi surviving to adulthood.  mrg-1 RNAi 
resulted in a similarly strong arrest (70% reaching adulthood), while ZK1127.3 RNAi 
yielded progeny of which 50% develop to adulthood.  mes-2, mes-3 and mes-6 RNAi 
resulted in a weaker suppression, with the majority of progeny developing to the L3/L4 
stage, rather than adulthood.  Additional RNAi’s produced a range of phenotypes, with 
him-17 and T05B4.5 having the subtlest suppressive effects, with only 5% and <1% of 
worms reaching L4 in these treatments.  By logistical regression analysis, the odds of 
surviving past L1/L2 in any of the RNAi treatments is significantly different than control 
RNAi.  The regression coefficients and p-values associated with Figure 8 are found in 
Table 4, and are listed in order of strength of significance.  In no case was the sterility of 
F1 progeny rescued by RNAi suppression, and both RNAi treated worms and control 
plates showed significantly less progeny at 25oC than at permissive temperature. 
In this assay, mes-6 does not appear to track with mes-2 and mes-3.  As these 
factors function as a complex, this was somewhat surprising.  However, in this assay,  
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Figure 8.  Suppression of hpl-1; hpl-2 larval arrest.  Strength of suppression is graphed in 
the upper panel.  Strength of suppression is related to percentage of progeny developing 
to late larval stages and adulthood.  Following EV (control), RNAi treatments are sorted 
from strongest to weakest (left to right).   The bottom panel shows examples of RNAi 
treated worm populations at 5x.  The majority of EV controls arrest as L1 larvae, while 
mes-2 treated worms are able to develop to L4/adult.  However, younger larval stages are 





mes-6 RNAi yielded significantly sicker worms compared to mes-2 and mes-3.  This is 
clearly evidenced by the extremely low number of progeny produced by individual worm, 
as shown in Figure 9.  Approximately 40 worms were produced by an hpl-1; hpl-2 worm 
grown on empty vector RNAi, a dramatic reduction from the number of progeny 
produced by wildtype worms, as well as hpl-1; hpl-2 worms grown at permissive 
temperature (~200, data not shown).  mes-2 and mes-3 RNAi treated hpl-1;  
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Figure 9.  Average number of progeny per worm in hpl-1; hpl-2 suppression assay.  mes-
6 and gfl-1 show reduced progeny compared to controls, while C08B11.6 rescues reduced 
fecundity associated with hpl-1; hpl-2.  * = pval < 0.05, ** = pval < 0.02  
RNAi Regression Coefficient Confidence Interval Pval 
mrg-1 8.302 7.578 - 9.025 <0.001 
mes-4 8.183 7.538 - 8.827 <0.001 
ZK1127.3 7.96 7.333 - 8.587 <0.001 
mes-2 7.206 6.576 - 7.837 <0.001 
set-2 6.401 5.794 - 7.008 <0.001 
mes-3 6.319 5.694 - 6.943 <0.001 
T19B4.5 6.305 5.705 - 6.905 <0.001 
C08B11.6 5.662 5.062 - 6.263 <0.001 
wrd-5 5.567 4.961 - 6.172 <0.001 
F52B11.1 5.357 4.741 - 5.972 <0.001 
gfl-1 5.304 4.681 - 5.927 <0.001 
mes-6 5.021 4.326 - 5.717 <0.001 
ogt-1 4.215 3.606 - 4.824 <0.001 
T05A12.4 3.283 2.667 - 3.899 <0.001 
him-17 3.106 2.456 - 3.755 <0.001 
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hpl-2 hermaphrodites produced a similar number of progeny to controls (~30/worm), 
while the average mes-6 RNAi treated worm produced only 4 F1 progeny.  Several 
reasons might account for this, including strength of RNAi or perdurance of different 
proteins following RNAi treatment.  Alternatively, MES-6 may have additional functions 
outside of the MES/PcG complex.  This difference in number of progeny produced 
appears to be specific for hpl-1; hpl-2 mutants, supporting the latter, and further 
suggesting that this additional function may rely on functional HP1. 
gfl-1 RNAi was also found to result in significantly lower numbers of progeny in 
the hpl-1; hpl-2 suppression assay.  However, decreased fecundity was also observed in 
other strains, and is not likely to reflect interaction with HP1 (data not shown).  In 
contrast to the decreased number of progeny produced on mes-6 and gfl-1, some RNAi’s 
appear to rescue the reduced fertility observed in hpl-1; hpl-2 mutants raised at high 
temperature. Loss of the SWR1/NuA4 component C08B11.6 was found to significantly 
increase the number of progeny produced by hpl-1; hpl-2mutants, in addition to 
suppressing the larval arrest of the F1 generation.  Although not significant, the RNAi 
targeting ZK1127.3 (also a SWR1/NuA4 component) appeared to have a similar effect.  
The finding that C08B11.6 and ZK1127.3 supress both larval arrest and reduced fertility 
associated with hpl-1; hpl-2 might suggest that these proteins might interact with HP1 
somewhat differently than other factors.  
 
Suppression of multivulva 
 In quantifying the hpl-1; hpl-2 suppression assay, we observed differences in the 
extent to which the multivulva (Muv) phenotype was suppressed.  Ras signaling in the 
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VPCs is antagonized by two genetically redundant groups of genes, the class A and class 
B SynMuv genes (Ferguson and Horvitz, 1989).  Animals mutant for a gene of either 
class have a normal vulva, but in animals doubly mutant in both a class A and a class B 
gene, VPCs ectopically adopt a vulval fate, leading to the multiple vulval (Muv) 
phenotype.  The Muv phenotype results from the failure to downregulate Ras signaling in 
the vulval precursor cells.  At restrictive temperature, hpl-1;hpl-2 worms also show 
severe defects in the somatic gonad, including the absence of gonad arms, and complete 
sterility (Schott et al., 2006).  Morphogenesis of the vulval occurs during the L4-adult 
molt (Sternberg, 2005).  Thus, it is not possible to consistently score vulval defects in 
worms developed only to the L2 – L4 stage.   To get around this, we took advantage of 
the temperature sensitive nature of the hpl-1; hpl-2 strain.  When raised at the 
semipermissive temperature of 24oC, the majority of F1 progeny will develop to 
adulthood, where vulval defects could be reliably assayed.   
 In this assay, all hpl-1; hpl-2 suppressors were consistently more developed than 
empty vector controls, consistent with the suppression phenotypes noted previously.  
After 8 days, a proportion of empty vector animals remain in larval stages of 
development, although given even time, all will reach adulthood.  At this time point, all 
progeny raised on suppressor RNAi’s had reached adulthood. As shown in Figure 10, a 
number of suppressors, including mes-4, mrg-1, ZK1127.3, C08B11.6, gfl-1, and 
F52B11.1 fully suppress the multivulva phenotype, with nearly 100% of worms having 
no evidence of additional vulval protrusions.  wrd-5 also suppresses the Muv phenotype 
of these worms, albeit to a lesser extent (~50% non Muv).  The data presented here are in 
agreement with previously published data regarding mes-4, gfl-1, and ZK1127.3.  These  
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Figure 10.   A subset of hpl-1; hpl-2 suppressors also suppress Muv and restore fertility.  
The left panel shows images of hpl-1; hpl-2 worms raised on mes-4 and mes-2 RNAi; 
mes-2, but not mes-4, results in suppression of the multi-vulva (Muv) phenotype.  The 
results of this assay are tabulated in the right panel.  RNAi treatments resulting in 
suppression of Muv are marked with (+).  A subset of Muv suppressors also restored 




genes were found to suppress the Muv phenotype associated with a number of different 
SynMuv A/B combinations, including lin-15AB(n765), lin-35A(n754); lin-8B(n2732), 
and lin-36A(n766); lin-8B(n2374) (Wang et al., 2005; Cui et al., 2006).  Notably, these 
genes were found not to suppress the gain of function mutation in let-60/Ras, or the loss 
of function lin-1/ETS, demonstrating that these genes are not Ras pathway genes or 
involved in general suppression of multivulva phenotypes (Cui et al., 2006; Wang et al., 
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2005).   Although we did not perform these additional assays with the hpl-1; hpl-2 
suppressors identified in this study, we expect they would behave similarly to mes-4. 
Strikingly, three suppressors resulting in suppression of the Muv phenotype also recued 
the F1 sterility associated with this strain.  This effect was strongest in C08B11.6 RNAi, 
which also suppressed the reduced fertility.  Nearly 100% of F1 animals observed 
contained embryos.  Not only are embryos produced, but were able to hatch and develop, 
although the extent to which was not assayed.  Similar, but somewhat weaker restoration 
of fertility was observed in gfl-1 and ZK1127.3.   While ZK1127.3 RNAi rescued reduced 
fertility of the P0 generation at 25oC (Figure 9), gfl-1 RNAi treated worms were generally 
sicker; therefore, this result is somewhat suprising, but suggests that these factors might 
function together in some capacity. mes-4 and mrg-1 suppress hpl-1; hpl-2 associated 
growth arrest and Muv phenotypes similarly or even stronger than C08B11.6, ZK1127.3 
and gfl-1, yet do not restore fertility.  Loss of mes-4 and mrg-1 results in maternal effect 
sterility, this may account for the failure of these genes to suppress sterility, and further 
suggests that MRG-1 and MES-4 may be required for additional cellular functions.  wrd-
5 and F52Bll.6 are weaker suppressors in the previous hpl-1; hpl-2 suppression assay, 
and do not result in restoration of fertility, suggesting these factors may function 
differently.  These findings are intriguing, as the homology of these proteins to yeast 
counterparts suggest that MRG-1, ZK1127.3, GFL-1 and C08B11.6 are orthologous to 
members of the SWR1 and NuA4 complexes, which incorporate the histone variant 
H2A.Z and acetylate histones H2A, H2A.Z, and H4 respectively.  In yeast, these function 
as two distinct complexes, while in Drosophila and mammals, homologous factors may 
function in a common complex known as Tip60/p400, or the closely related SRCAP.   
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These complexes have not been studied in great detail in C.elegans, and it is currently 
unknown whether these factors function in one or more complexes and mediate 
chromatin dynamics.   In addition, interaction of these complexes with MES-4 have not 
been previously demonstrated, although based on these initial assays, these factors appear 
more Mes-4-like than MES-2/MES-3/MES-6 like.   
Based on these data, it appears that the SWR1/NuA4 complex(es) antagonize the 
role of hpl-2/SynMuv in control of fertility.  As F52B11.1 and WRD-5, which homology 
predict to function in the H3K4me/COMPASS complex, fail to suppress sterility, it is 
clear that this is not a general reflection of Muv suppression.  MRG-1 is also predicted to 
function in the SWR1/NuA4 complex, but does not result in rescue of sterility.  This may 
be due to maternal effect sterility of mrg-1 (Fujita et al., 2002), and suggests that MRG-1 
may have additional functions outside this complex.    
mes-2, mes-6, mes-6, set-2, T19B4.5, him-17, ogt-1, and T05A12.4 do not 
suppress the Muv defect, suggesting that i) suppression of hpl-1; hpl-2 is not a result of 
interaction with the SynMuv pathway, and ii) this group of suppression is functionally 
distinct from mes-4, mrg-1, C08B11.6, gfl-1, F52B11.1 and wrd-5.  In accordance with 
the findings from our analysis of hpl-1; hpl-2 at semipermissive temperature, previous 
screens performed to identify SynMuv suppressors failed to identify these factors (Cui et 
al., 2006).  mes-2/mes-3/mes-6 have previously been associated with allele specific 
suppression of the Muv phenotype of lin-15AB(n765e); however, this gene is encoded by 
the X chromosome, and suppression in this instance can be explained by the role of 
Mes/PRC2 in X chromosome dosage compensation (Cui et al., 2006; Garvin et al., 1998).  
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Maternal effect sterile and germ line morphology 
The strongest phenotype associated with the MES factors is the maternal effect 
sterility for which they are named.  mes mutant gonads have also been shown to contain a 
reduced number of germ cell nuclei and abnormal cellular morphology, including 
enlargement of the nucleus and “coagulated looking” cytoplasm.   We analyzed the hpl-1; 
hpl-2 suppressor mutants for sterility, maternal effect sterility, and germ line 
morphological defects in both N2 (wildtype) and worms carrying an integrated array 
expressing histone H2B::GFP under the control of the germ line-specific pie-1 promoter 
(Capowski et al., 1991; Paulsen et al., 1995; Garvin et al., 1999). 
With the exception of mrg-1, which has previously been associated with the mes 
phenotype (Fujita et al., 2003), RNAi mediated knockdown of the other 10 identified 
suppressors failed to show sterility defects, maternal or otherwise.  While none of the 
RNAi’s induce complete sterility, some mild germ line defects are observed in a low 
percentage of worms (less than 20% in all cases).  For example, him-17 resulted in germ 
line organization defects, likely associated with its role in meiotic prophase (Reddy & 
Villeneuve, 2004).   gfl-1, F52B11.1, and T19B4.5 also show a small percentage of germ 
lines that appear disorganized, lacking oocytes, or containing endomitotic oocytes, which 
appear to contain multiple nuclei.   This is consistent with gfl-1 having previously been 
associated with embryonic lethality (Dudley et al., 2004).   gfl-1 also produced a low 
number of progeny in the hpl-1; hpl-2 suppression assays, suggesting this RNAi may 
result in a generally sick phenotype.  F52B11.1 and T19B4.5 may also function in germ 
line development.  However, as these phenotypes were relatively low and highly variable, 
these findings were not pursued further.  
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The fact that the hpl-1; hpl-2 suppressors identified by this study do not cause 
strict maternal effect sterility or more global germ line deformation phenotypes is not 
entirely surprising.  Multiple laboratories, including the Ahringer and Vidal labs, have 
conducted genomewide RNAi screens that would have included sterility and/or reduced 
fertility within the screened phenotypes.  Other screens (i.e., Simmer et al., 2003) used 
hypersensitive RNAi strains to perform genomewide screens.  In these assays, T19B4.5 
was identified as a maternal effect sterile (in the rrf-3 background (Simmer et al., 2003)), 
supporting our hypothesis that hpl-1; hpl-2 suppressors function in the Mes pathway, as 
well observation that T19B4.5 RNAi with respect to germ line morphology. 
These data suggest that although the hpl-1; hpl-2 suppressors may interact with 
the Mes/PcG or Mes-4 pathway(s), they are unlikely to required for MES function in the 
germ line.  Instead, these proteins might be required for optimal MES activity, aid in the 
localization or targeting, function with the Mes pathway during early embryonic cell fate 
decisions, or antagonize the activity of the MES/PRC2 complex, similar to MES-4.  
Based on homology, it is unlikely that the hpl-1; hpl-2 suppressors identified by our 
screen function as a direct repressors.  Current models suggest that MES-4 activates the 
expression of an autosomal repressor that participates in X chromosome silencing (Refer 
to Figure 3).  Perhaps the potential activator complexes (i.e., COMPASS/MLL and/or 
NuA4/SWR1) contribute to the expression of this repressor.  This may account for why 
depletion of these molecules appears to result in phenotypes more similar to mes-4 than 
mes-2/mes-3/mes-6.  
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H3K27me3 staining 
 We next examined the concentration and localization patterns of Mes/PRC2 
catalyzed H3K27me3 marks during embryogenesis.  In wildtype animals, H3K27me3 is 
present in all germ line nuclei and enriched on the X chromosome, consistent with this 
chromosome being silenced in the germ line (Bender et al., 2004; Reinke et al., 200).  
H3K27me3 is also present in nuclei of wildtype embryos, and becomes enriched in the 
germ line precursor cells Z2/3 late in embryogenesis (Bender et al., 2004).  In mes-2/3/6 
mutants, however, H3K27me3 is lost from the germ line of the P0 generation and from all 
early embryonic cells of the F1 generation (Bender et al., 2004).    
In wildtype embryos, H3K27me3 is fairly uniform, with areas of enrichment, and 
areas that appear less intensely stained, as shown in Figure 11 (and previously by Bender 
et al., 2004).  H3K9me2 was used as a comarker, and in the early embryos, is more 
punctate, with the strongest stained areas coincident with but not always overlapping with 
domains of H3K27me3.  As shown in Figure 11 (and previously by Bender et al., 2004), 
mes-2, mes-3 and mes-6 RNAi treatment resulted in a dramatic decrease in H3K27me3 
levels.   RNAi targeting the 11 hpl-1; hpl-2 suppressors did not affect levels or 
localization of H3K27me3; an example is shown in Figure 11.  Most RNAi treatments 
had no affect on the H3K9me2 comarker, although him-17 resulted some decrease in 
H3K9me2 staining in very early embryos, which may be consistent with a role for HIM-
17 in mediating H3K9me2 in the germ line (Reddy & Villeneuve, 2004; Maine et al., 
2005).   MES-2 encodes the SET domain responsible for this methyl mark, and MES-
2/3/6 have been shown to form a complex, with interdependent requirements for  
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Figure 11.  H3K27me3 staining in mes-2 and hpl-1; hpl-2 suppressors.  8E stage F1 
embryos dissected from parents raised on RNAi.  Compared to controls, mes-2 embryos 
show greatly reduced H3K27me3 staining.  Surprisingly, embryos lacking these marks 
are able to hatch and grow to adulthood.  The hpl-1; hpl-2 suppressors identified in this 




localization to chromatin; unless this complex itself is disrupted, or MES complex 
targeting is severely abrogated, a dramatic change in H3K27me would be unlikely 
(Holdeman et al., 1998; Xu et al., 2001).   However, it should be noted that the germ line 
was not analyzed in these experiments; it is possible that staining patterns in hpl-1; hpl-2 
suppressors may affect patterning of H3K27me3 in the mitotic/meiotic phases of the 
germ cell.   
Based on these findings, it is unlikely that the hpl-1; hpl-2 suppressors identified 
in this study are required for the MES/PRC2 enzymatic activity.  One caveat to these 
experiments is that antibody staining looks at the embryo from a very global “all or none” 
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point of view, and subtle changes in H3K27me3 concentration at specific loci would be 
very difficult to detect. In addition, while levels of H3K27me3 may not significantly 
change in response to RNAi, it is possible that targeting of MES/PRC2 complex is 
effected, a defect that could only be detected by ChIP analysis (Whetsine & Strome lab, 
pers. communication).  Alternatively, misregulation at the level of gene expression could 
also be tested, perhaps analyzing genes known to be affected in mes-2 mutants (Yuzyuk 
et al., 2009). We have also considered looking at more subtle phenotypes that might be 
associated with proteins required to “read” or “interpret” the H3K27 mark, and may 
function as corepressors, including ectopic enrichment of active marks such as H3K4me 
or phosphorylated Pol II on the X chromosome prior to the 100 cell stage, or increased in 
H3K9me2/3 in the PGC.  However, analysis of the phenotypes may also present 
difficulties.   
 
Suppression of mep-1 larval lethality 
The next assay involved suppression of the mep-1 larval arrest phenotype.  The 
SynMuv factor MEP-1 is a component of the NuRD complex, and is required for 
suppression of germ line factors in somatic cells (Unhavaithaya et al., 2002).  The loss of 
function mep-1(q660) mutant induces L1/L2 arrest when raised at the restrictive 
temperature (25oC).   This arrest is thought to be the result of germ line expression 
programs becoming active in the somatic tissue due to the lack of suppression by 
SynMuv components.  Larval lethality associated with mep-1 is rescued by depletion 
of mes-2, mes-3, mes-4, and mes-6, as is the ectopic expression of the p-granule marker 
PGL-1 (Unhavaithaya et al., 2002).   
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As shown in Figure 12, reduction of the hpl-1; hpl-2 suppressors induces a range 
of mep-1 rescue phenotypes, from strong, with over 75% of worms developing into adults 
(as in mes-4 and mrg-1), to more intermediate phenotypes (>25% develop to adult), to 
weaker but significant suppression, in which the majority of worms develop to L3/L4 
stages, as opposed to the controls, which arrest as L1/L2.    Logistic regression analysis 
of this data demonstrates that all hpl-1; hpl-2 suppressors, with the exception of  
T05A12.4 are statistically different from controls; these data are listed in Table 5.  The 




Figure 12.  Suppression of mep-1 by hpl-1; hpl-2 suppressors.  Following the empty 









Assay for germline transgene desilencing 
 An additional phenotype associated with MES genes is desilencing of repetitive 
transgenes in the germ line.  The strain PD7271 carries a multicopy extrachromosomal 
transgene array of a GFP tagged ubiquitously expressed gene, let-858 (Kelly et al., 1997).  
Expression of let-858::GFP is detectable in all somatic lineages, and is absent in the germ 
line (Kelly et al., 1997).  Although sporadic germline expression is observed at 25oC in 
empty vector controls (Cui et al., 2006), this assay was performed at high temperature to 
allow for i) strongest expression of GFP and ii) strongest RNAi phenotypes.  We had 
hoped that genes previously demonstrated to have a role in germline silencing (i.e., mes-2, 
mes-3, mes-4, mes-6 (Kelly & Fire, 1998), and mrg-1, F52B11.1 (Cui et al., 2006) would 
be verified by our examination and thereby validate findings regarding analysis of our 
other suppressors.  
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Knockdown of genes that result in maternal effect sterility and a necrotic germ 
line are nearly impossible to score for germ line desilencing in the M-Z- generation, 
which lack the majority of germ cell nuclei.  Therefore, we assayed these defects in the 
M+Z- generation (P0, raised from L1 on RNAi, progeny of these worms are 100% sterile).  
As shown in Figure 13, mes-4 and mrg-1 RNAi showed significantly increased 
expression of let-858::GFP in the germ line relative to controls.  Cui and colleagues (who 
our analysis is based on) found that mes-4 and mrg-1 RNAi resulted in 66% and 73%   
germline GFP respectively.  However, these researchers may have scored in the F1 
generation for all treatments, regardless of germ line phenotypes.  If our experiments had 
been quantified in this fashion, similar or even higher levels of expression may have been 
observed, as the majority of the remaining identifiable germline nuclei were GFP(+) 
(Senchuk et al., data not shown).  We were reluctant to score this as such, however, based 
on observations that necrotic C.elegans cells show increased levels of autofluorescence 
(Gerstbrein et al., 2005).  Additional studies have also demonstrated a role for mes-2, 
mes-3 and mes-6 in germ line silencing of transgenic arrays, which by our analyses, was 
not observed (Kelly & Fire, 1998).  This may be due to differences in methods; Kelly & 
Fire (as well as Takasaki et al., 2007), introduced the repetitive let-858::GFP array into 
different null mutants (mes-2, mes-3, mes-6, mes-4 and mrg-1).  mes-2 (M+Z-) mutants 
were absent for let-858::GFP expression the germ line, as in wildtype, while 85% of  
mes-2 (M-Z-) germ lines expressed GFP (Kelly & Fire, 1998).  mes-3 and mes-6 (M+Z-) 
germ lines expressed GFP in 56% and 15% of germ lines (respectively), while the M-Z- 
cohorts were 88% and 100% GFP(+) (Kelly & Fire, 1998).  The PRC2 findings are 
weaker than mes-4, which expressed GFP in 100% of germ lines in both the M+Z- and  
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Figure 13.  Germline desilencing of the let-858::GFP tandem array.  Germline expression 
of let-858::GFP was scored in the Po generation of RNAi treatments resulting in maternal 
effect sterility.  The remaining hpl-1; hpl-2 suppressors were scored in the F1 generation.  
An example of a PD2721 transgenic animal with germline expression of shown.  The 
asterisk marks the germ line.  Expression in these nuclei is lower than the surrounding 




M-Z- generations (Kelly & Fire, 1998).    Similar to mes-4, mrg-1 (M+Z-) mutants 
showed nearly 100% germline desilencing (Takasaki et al., 2007).  Based on these 
findings, it is possible that while RNAi targeting mes-2, mes-3, and mes-6 was strong 
enough to induce loss of H3K27me3 in embryos as well as 100% sterility in the next 
generation, yet not sufficient knockdown to induce desilencing of the repetitive transgene.   
 Several previous studies have used this assay to examine a number of genes, 
including a number of hpl-1; hpl-2 suppressors identified by this study.  This assay has 
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previously been used to analyze the role of additional factors identified by our screen, 
and comparison of these studies suggest that this assay is, for lack of a better word, 
finicky.  For example, C08B11.6 and F52B11.1 RNAi mediated knockdown induced 5% 
germline GFP expression in F1 adults (Cui et al., 2006).  Our assay found the depletion of 
these genes induced stronger phenotypes than previously observed, inducing 40% and 
48% expression of germline GFP, respectively.  Cui and colleagues also examined gfl-1, 
wrd-5, and ZK1127.3, and found that these genes did not appear to induce germ line 
desilencing; these results are in accord with our data.  One additional study, which 
assayed F2 adults found that ZK1127.3 did induce germ line desilencing (Wang et al., 
2005); this finding contrasts with our work and that of Cui et al.  This study also found 
gfl-1 did not result in germ line expression, although this was observed in our assay 
(Wang et al., 2005; Senchuk et al., unpublished).  In accord with our data, Wang and 
colleagues found that T19B4.5 did not induce desilencing.  Somewhat surprisingly, based 
on its role in mediating H3K9me2 in the germline, and the fact that repetitive arrays are 
heavily modified with this mark, the let-858::GFP transgene was found not to be de-
repressed in him-17 mutants, although we found that him-17 RNAi was associated with a 
small, but significant increase in germline expression (Bessler et al., 2007; Senchuk et al., 
unpublished).  A similar low level of GFP expression was observed following RNAi 
depletion of T05A12.4, while depletion of the O-GlcNAc transferase (ogt-1) has no effect 
on germline repression of the transgenic array.      
 Our analysis also demonstrated that SET-2 is required germ line repression of 
transgenic arrays, which has not previously been characterized, but fits well with the 
hypothesized role of SET-2 in the MES/PcG pathway.  Depletion of set-2 leads to 42% of 
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F1 adult germ lines expressing GFP in one or both gonads.  The mechanism responsible 
for this desilencing is unknown.  As other hpl-1; hpl-2 suppressors, as well as HPL-2 
itself, are chromatin associated, it is likely these affects are exerted at the level of 
heterochromatin regulation (Couteau et al., 2002).  As several RNAi components, 
including DCR-1, MUT-16, MUT-7 and DRH-1 also demonstrate this phenotype, it is 
possible that heterochromatin formation in this context may rely on an RNA based 
mechanism (Kim et al., 2005). 
 
Assay for general desilencing 
 As shown in Figure 13, it was noted that RNAi targeting T19B4.5 consistently 
resulted in fewer GFP (+) germ lines when compared to controls.  We found this 
particularly striking as the somatic expression of let-858::GFP was consistently 2.5 (+/- 
0.5) fold brighter in T19B4.5 compared to controls, as shown in Figure 14.  Due to the 
large size, intensity of intestinal nuclei were measured, but changes in intensity were 
observed throughout the somatic tissue, including body wall muscle, pharynx, 
hypodermal, and neuronal cell types (data not shown).  
We initially hypothesized that somatic desilencing might be due to misregulation 
of the repetitive array, and that T19B4.5 might be a soma specific corollary of the MES 
factors.  We tested this hypothesis using a simple tandem array of ubiquitous marker sur-
5::GFP (Acetoacetyl coenzyme A synthetase) (Gu et al., 1998; Yochem et al., 1998).  If 
T19B4.5 is required for silencing of repetitive arrays in the soma, we would also expect 
to see increased expression from the sur-5::GFP array.  To address whether the observed 
desilencing was due to unpaired status of the array in the germline, we tested a similar  
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Figure 14.  Increased somatic expression of let-858::GFP in T19B4.5.  Compared to 
empty vector controls, T19B4.5 RNAi induces a 2.5 fold increase in somatic expression 




sur-5::GFP construct that had been integrated into the genome by irradiation.  However, 
neither of these strains showed increased GFP expression on T19B4.5 RNAi.    
We next compared transgenic strains carrying different forms of the let-858::GFP 
array, including KW1127 and KW1336, which contain complex extrachromosomal 
transgenic arrays composed of the same let-858::GFP reporter interspersed with a large 
number of random C.elegans genomic fragments, as well as NL2507, in which a similar 
array was integrated into the genome (Kelly et al., 1997).   GFP expression in these 
strains is comparable to the PD7271 strain (simple array), although these strains show 
expression of let-858::GFP in germ cell nuclei (Tabara et al., 1999, Senchuk et al., data 
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not shown).   It did not appear that these changes in let-858 reporter expression had any 
significant phenotypic consequence, as might be expected from such dramatic 
overexpression.   
Surprisingly, RNAi mediated knockdown of T19B4.5 in each of these strains still 
increased somatic fluorescence, despite the complex, and in the case of NL2507, 
integrated nature of these arrays.  Increased somatic expression did not occur in the P0 
generation, suggesting that passage of the array through the germ line may be essential 
(Senchuk et al., data not shown).  In addition, increased expression was not observed 
until the L3 stage of F1 development.  A similar pattern was observed in the F2 
generation:  expression in embryo-L2 was equivalent to controls, with increased 
expression starting at the L3 stage and growing more pronounced in L4 and adults (data 
not shown).   This stage specificity suggests that this may be a regulated process rather 
than a general desilencing.  
Even more striking was the observations that in each of the let-858::GFP lines, in 
which the complex nature of the transgenic element allow for germ line expression, the 
germ line appears to be more strongly suppressed following depletion of T19B4.5.   This 
observation is depicted in Figure 15.  The data shown in Figures 14 and 15 suggest that 
T19B4.5 is involved in the positive regulation of germ line gene expression in addition to 
the suppression of somatic expression.  However, changes in GFP expression were not 
observed in the germline specific pie-1::GFP::H2B (AZ212), the HC57 RNAi sensor 






Figure 15.  Germline repression of complex, integrated let-858::GFP construct by 
T19B4.5.  F1 worms raised on T19B4.5 RNAi show a dramatic reduction in germline 
expression of let-858::GFP in this and other strains tested. Asterisks mark the germ line 




One interesting hypothesis that may account for these observations suggests that 
T19B4.5 is involved in regulation of germline competent expression rather than germline 
specific expression.  Previous studies have demonstrated that high copy arrays are 
differentially modified in the germline, with somatic specific arrays are marked with 
H3K9me3, while germ line competent arrays are marked with H3K9me2 (Bessler et al., 
2010).  Perhaps in the absence of T19B4.5, marks associated with germ line expression 
are misread, and interpreted as somatic expression, leading to the observed absence of 
germline expression but increased somatic expression.   
Based on this hypothesis, sur-5::GFP may not have been an ideal candidate to 
determine whether the changes in transgenic expression are due to array composition (i.e., 
repetitive or complex), array localization (extrachromosomal vs. integrated), and/or 
promoter competence, as it seems that sur-5::GFP expression may be a soma-specific 
(Gu et al., 1998; Yochem et al., 1998).  Whether this is due to the gene itself, or the 
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composition of various SUR-5 transgenic constructs is unclear.  In addition, SUR-5 
appears to play some role in vulval development and Ras signaling (Gu et al., 1998).  As 
Mes/PcG pathways interact so closely with the SynMuv pathways, the findings regarding 
this strain might have proved difficult to interpret. 
 An alternative hypothesis is the T19B4.5 may more directly regulate a subset of 
genes, including let-858.   This may represent an interesting finding, as let-858, which 
encodes the highly conserved nucampholin, shares some similarity to eukaryotic 
initiation factor eIF-4 gamma, is nuclear localized throughout development and is at least 
partially associated with chromatin (Kelly & Fire, 1998).   T19B4.5 is required for germ 
line proliferation, early embryogenesis and tissue differentiation (Kelly & Fire, 1998).   
Based on these phenotypes, it’s possible that LET-858 might play a role in MES/PcG 
mediated gene silencing, heterochromatin formation, and/or cell fate commitment during 
development.  However, we were unable to identify a role for let-858 in our screen due to 
a severe RNAi phenotype in all mutant backgrounds tested.   
One mechanism by which T19B4.5 may mediate specific repressive events might 
through interaction with SET-18 (based on the Vidal lab interactome database).  SET-18 
is an uncharacterized protein containing a SMYD domain (SET and MYND (Zinc 
finger), often involved in transcriptional repression, ubiquitin ligase and/or histone 
methyltransferase activity (Gottlieb et al., 2002; Matthews et al., 2009).  
 
Assay for RNAi defective 
This assay was performed using a strain expressing myo-2::GFP in the pharyngeal 
muscle, myo-3::GFP in the body wall muscle, and a dsRNA hairpin targeting GFP driven 
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by the myo-2 promoter.   The use of this strain to examine systemic and localized RNAi 
effects was previously described (Winston et al., 2002).  Based on the ascribed role of the 
Mes/PcG genes in RNAi, and the growing appreciation for the RNA based silencing 
mechanisms in gene silencing and heterochromatin formation, we assayed whether any of 
the 11 hpl-1; hpl-2 suppressors identified in this research function in the classical RNAi 
pathway.  mes-4 clearly displayed the strongest phenotype in this assay (see Figure 16).  
P0 worms on mes-4 RNAi showed a dramatic upregulation of GFP in both the body wall 
muscle and the pharynx, indicative of defects in both systemic and localized RNAi.    
This finding is consistent with previous reports demonstrating the role of MES-4 in 
regulation of RNAi (Lehner et al., 2006; Dudley et al., 2002; Kim et al., 2005).  RNAi 
targeting mes-2, mes-3, and mes-6 also lead to changes in GFP expression in the RNAi 
sensor strain.  These RNAi’s induce an interesting phenotype, in which pharyngeal GFP 
appears decreased relative to controls, suggesting that depletion of mes-2, mes-3, and 
mes-6, leads in increased efficacy of localized RNAi.  In these same worms, GFP 
expression in the body wall muscle was increased, indicating that systemic RNAi 
requires the Mes/PRC2 pathway.  Previous studies have suggested a role for Mes/PcG 
genes and MES-4 in RNAi, by coinjection and suppression of a lethal dsRNA (mom-2) 
(Dudley et al., 2002).   
This analysis demonstrated a stronger phenotype in mes-4, but could not address 
the possibility that PRC2 and MES-4 might function differently in RNA dependent 
silencing, perhaps by regulating different steps in the pathway, or PTGS vs. TGS.   MES-
4 is required for RNAi, while MES-2/MES-3/MES-6 appear to negatively regulate 
localized RNAi, but be required for systemic RNAi.  We know from previous studies that 
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the role of MES/PRC2 in RNAi is dependent on levels of dsRNA (Tabara et al., 1999).  
Perhaps this complex plays some role in regulation of dsRNA concentrations and/or 
processing by RdRPs during endogenous gene silencing.  It is possible that local and 
systemic RNAi respond differently to RNA triggers, and in this way resemble PTGS and 
TGS, respectively.  If RNAi machinery normally dedicated to induction of systemic 
RNAi is not activated, as in the absence of mes-2/mes-3/mes-6, this may account for 
enhancement of local RNAi, as RNAi machinery is focused on the task at hand.  For 
instance, MES-2/MES-3/MES-6 might be involved in directing a pool of dsRNA to 
RdRPs that are required to induce cell nonautonomous production.  Alternatively, loss of 
these factors may have some affect on transgene stability.   
 Depletion of the additional suppressors demonstrated that a subset of these factors 
also appear to function in the RNAi pathway(s).  These include MRG-1, F52B11.1, 
WRD-5, GFL-1, HIM-17, TI9B4.5, SET-2 and T05A12.4.  Knockdown of these genes 
leads to an intermediate phenotype, with increased expression of GFP in body wall 
muscle and a weak increase in pharyngeal expression, as shown in Figure 16.  Some of 
these data are in agreement with previous analyses; for instance, GFL-1 has been shown 
to play a positive role in RNAi (Dudley et al., 2002; Kim et al., 2005; Cui et al., 2006).  
However, our analysis found that MRG-1 functions in the positive regulation of RNAi, 
although Cui and colleagues (2006) found that MRG-1 not to be required.   MRG-1 was 
also identified in a screen for factors required for the persistence of RNAi over multiple 
generations (Vasthenow et al., 2006), which supports our findings.   Our data also support 
a role for F52B11.1, which contradicts a previous analysis (Cui et al., 2006).   Cui and 










Figure 16.  Phenotypes associated with RNAi sensor strain.  The RNAi sensor strain 
contains myo-2::GFP (pharynx), myo-3::GFP (bodywall muscle), and a dsRNA hairpin 
targeting GFP driven by the myo-2 promoter.  In this assay, MES factors show strikingly 
different phenotypes.  mes-4 induces desilencing of GFP in the body wall muscle and the 
pharynx, as expected of a factor required for RNAi-mediated knockdown.  mes-2, mes-3, 
and mes-6 (shown) result in increased GFP in the body wall muscle, with decreased GFP 
expression in the pharynx.  RNAi targeting many of the hpl-1; hpl-2 suppressors resulted 





with our findings, as well as an additional study (Simonet et al., 2007).   Other studies 
demonstrated RNAi functionality for T19B4.5 (Kim et al., 2005), ZK1127.3 (Kim et al., 
2005; Cui et al., 2006), C08B11.6 (Cui et al., 2006), and SET-2 (Simonet et al., 2007), in 
accordance with our data.  Together, these data suggest that many of the hpl-1; hpl-2 
suppressors identified by our study may function in the RNAi silencing pathway.   
There are a number of reasons data from different studies might conflict.   First, a 
number of different assays were used in these different studies, including injection and 
feeding, and previous studies have shown there are fundamental differences in the 
specific RNAi response depending on the concentration of trigger RNAi and on the way 
the dsRNA is administered.  For example, ZK1127.3, one of the suppressors identified in 
our study, was also found to suppress phenotypes associated with feeding RNAi, but not 
injection (Kim et al., 2005).  Concentration of dsRNA is also a factor; mes genes have 
been shown to respond differently based on the concentration of trigger RNAi, and 
appear to be bypassed completely when injection concentrations are low, leading to 
induction of the targeted RNAi phenotype (Tabara et al., 1999).  RNAi efficacy is also 
scored in differently in the various analyses, including lethality, visible phenotypes (i.e.,  
Dpy), and RNAi sensor strains.  As we know that these factors can also influence 
transgenic expression, our data (collected using an RNAi sensor strain), as well as others 
(Cui et al., 2006; Kim et al., 2005), must be interpreted carefully.   
 
Discussion:  Two classes of MES interacting factors 
Of the 738 RNAi clones tested, 236 showed enhancement/suppression of one or 
more heterochromatin mutants and do not appear associated with general enhancement 
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(i.e., enhance all background mutations).  Strikingly, all known members of the 
Polycomb/Mes pathway were found to strongly suppress the hpl-1; hpl-2 early larval 
arrest phenotype.  11 additional genes showed a similar phenotype – strong suppression 
of hpl-1; hpl-2, but failure to effect met-2 or mes-3.  We hypothesized that this signature 
might be indicative of factors functioning in the Mes/PcG repressive pathway.     
To determine whether other hpl-1;hpl-2 suppressors represent factors functioning 
in the Polycomb pathway, a number of secondary screens were performed, including tests 
of maternal effect sterility (mes) and germ line morphology, histone methylation status, 
rescue of mep-1 larval arrest, germ line transgene desilencing, and a role in RNAi; all 
phenotypes associated with mes loss of function.   
Although RNAi knockdown of mes-2/mes-3/mes-6 and mes-4 suppress hpl-1; hpl-
2 larval lethality, Figure 8 shows that mes-4 RNAi allows a greater percentage of animals 
to survive past L4 (57% of progeny survive to adulthood in mes-4, compared to 9% adult 
development in mes-2).  As shown in Figure 10, mes-4 also suppressed the Muv 
phenotype of hpl-1; hpl-2 adults raised at semipermissive temperature, completely 
restoring normal vulval development, which mes-2, mes-3, and mes-6 did not.   In our 
assays, mes-4 also more strongly suppressed the larval arrest phenotype of mep-1 
homozygous mutants, with 87% of mep-1 mutants raised on mes-4 RNAi able to reach 
adulthood, compared to 16% in mes-2 (Figure 12).    
It has previously been shown that mes-4 phenotypes are distinct from those 
associated with mes-2/mes-3/mes-6 loss of function.   For instance, mes-4 null mutant 
hermaphrodites gonads contain fewer germ nuclei compared to other mes mutants 
(Capowski et al., 1991, Garvin et al., 1998).   MES-4 also appears to play a more 
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pronounced role in RNAi (Wang et al., 2005; Cui et al., 2006) and functions in the 
repression of PolII in the PGCs, a role which appears to be independent of MES-2 
function (Furuhashi et al., 2010).  In addition, MES-2/PRC2 is essential in the regulation 
of gene expression during the transition from plasticity to cell fate commitment, with loss 
of mes-2 inducing prolonged pluripotency and expression of 2E and 4E genes, as well as 
a failure to upregulate 8E/differentiation genes (Yuzyuk et al., 2009).   Based on the 
Nuclear Spot assay, changes in gene expression may result from failure to compact 
chromatin in mes-2 mutants (Yuzyuk et al., 2009).  It is currently unknown whether 
MES-4 plays a role during this transition.   Based on the previously observed differences 
in function and phenotypes, we reasoned that it is unlikely that the different effects 
observed between mes-4 and mes-2/mes-3/mes-6 is our assays is likely attributable to 
differences in RNAi efficacy.    
We noted that a number of hpl-1; hpl-2 suppressors identified in this work 
phenocopy mes-4 in these assays:  Strong suppression of hpl-1; hpl-2 larval lethality, 
restoration of normal vulval development, and rescue of mep-1 larval arrest.  We 
hypothesize that these genes interact more closely with MES-4 than with MES-2/PRC2.  
This cohort of genes might i) function with MES-4 to repress X-linked gene expression, 
or ii) function in other MES-4 dependent pathways; these models are not mutually 
exclusive.  We also predict that hpl-1; hpl-2 suppressors with secondary assay 
phenotypes more similar to mes-2/mes-3/mes-6 are likely to interact more directly with 
PRC2 than MES-4, and may play a role X-chromosome silencing and/or the transition 
from plastic to committed.   
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Genes with “mes-4-like” phenotypes include MRG-1 and ZK1127.3, proteins 
previously shown to interact by yeast two hybrid (Li et al., 2004).   MRG-1 is 
homologous to fly MSL3, yeast Eaf3 and human MRG15, proteins found associated with 
a number of HAT containing complexes, including NuA4/Tip60, as well as the 
counteractive HDACs and histone demethylase complexes (Carrozza et al., 2005; Joshi & 
Struhl, 2005; Keogh et al., 2005; Morillon et al., 2005; Martin et al., 2006; Taverna et al., 
2006; Hayakawa et al., 2007; Larschan et al., 2007; Moshkin et al., 2009).  By homology, 
ZK1127.3 is related to yeast Eaf7 and fly MrgBP, chromatin associated proteins also 
thought to function in the NuA4 complex.  Additional proteins that may share a mes-4-
like hpl-1; hpl-2 suppression phenotype include gfl-1 (GAS41) and C08B11.6 (Arp6); 
homologs of these proteins also function in chromatin modifying complexes including 
NuA4 and SWR1 (Lu et al., 2009).  In addition, members of the COMPASS complex, 
including F52B11.1 and wrd-5 appear mes-4-like in some, but not all assays.   In contrast, 
the phenotypes associated mes-2 and mes-3 correlate well with the phenotypes observed 
following loss of SET-2 and T19B4.5.  The phenotypes of him-17, ogt-1, and T05A12.4 
are often weaker than mes-2 and mes-3, indicating that the interactions between these 
factors are perhaps more indirect.  Data from all assays were combined, weighted 
identically, and subjected to agglomerative cluster analysis, shown in Figure 17.  This 
plot nicely summarizes our findings and strikingly resembles the interactions predicted 
by homology.   
The remaining sections focus on the hpl-1; hpl-2 suppressors identified in our 
primary screen and how these factors might function in the MES/PcG pathway.  Proposed 
models and future experiments designed to address these models are discussed.  
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Figure 17.  Cluster analysis of hpl-1; hpl-2 suppressors.  Agglomerative clustering of all 
phenotypes associated with secondary analyses described in this chapter.  T05A12.4 and 
OGT-1 are more similar to control than other hpl-1; hpl-2 suppressors, suggesting that 
these factors may not function in the Mes/PcG pathway.  HIM-17 and T19B4.5, along 
with the previously identified PcG interacting factor SET-2 cluster with MES-2, MES-3, 
and MES-6.  MES-4 is somewhat of an outlier, but still localized in this cluster, 
consistent with previously identified roles in antagonism of MES/PRC2 function.  MES-4 
is also closely related with the third cluster, containing components of the NuA4/SWR1 





As shown in Figure 3, there are currently two models of MES/PRC2 complex 
antagonism by MES-4.  The first model predicts that MES-4/H3K36me activates the 
expression of an autosomally encoded repressor that localizes to the X chromosome and 
inhibits transcription.  This repressor may or may not interact with H3K27me3, but as 
this mark is MES-4 independent, it is unlikely that the MES-4 associated repressor 
recruits H3K27me3.  An alternative model suggests that MES-4/H3K36me3 repels a 
repressor, focusing the repressive function on the X chromosome.  As the main function 
associated with Mes-4-like hpl-1; hpl-2 suppressors is transcriptional activation, the 
simplest model to account for function of these complexes in the Mes pathway suggests 
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that these complexes are involved in activating the expression of the X-localized 
repressor molecule, rather than the repressor molecule itself.  Previous ChIP studies in 
M+Z- mes-4 germ lines only identified only four upregulated autosomal genes (Bender et 
al., 2006), and as such, the repressor targeted for activation by MES-4 is this model is 
unknown, therefore, testing this hypothesis is currently out of reach.  
 
COMPASS/MLL 
The mixed lineage leukemia (MLL) protein and its Drosophila homolog, 
Trithorax, exist in COMPASS (complex of proteins associated with Set1) like complexes 
and mediate H3K4 methylation and gene activation (Tenney & Shilatifard, 2005).  The 
enzymatic activity of SET1/MLL family members is thought to be regulated though 
interaction with a number of additional proteins, including Swd3/WDR5, Swd1/RbBP5, 
Bre2/Ash2, Spp1/CFP1, and Sdc1/hDPY30 (Tenney & Shilatifard, 2005).  Components 
of the COMPASS complex are highly conserved from yeast to humans, although 
different sets of the subunits are distributed among different H3K4 HMT complexes in 
multicellular organisms (Patel et al., 2009; Patel et al., 2011; Steward et al., 2006; Dehe 
et al., 2006).  In many species, COMPASS related gene activation antagonizes PcG 
repression, preventing inappropriate gene silencing (Tenney & Shilatifard, 2005).  This 
work demonstrates that multiple COMPASS like complexes are likely to function in 
C.elegans, supporting recent findings by the Kelly, Palladino, and Strome labs (Xiao et 
al., 2011; Li and Kelly, 2011).  At least one of COMPASS like complex containing SET-
2 functions in the MES pathway, and another complex, composed of a number of shared 
subunits (WRD-5 and F52B11.1), but lacking SET-2 likely functions more closely with 
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MES-4 and/or during vulval differentiation.  As wrd-5 and F52B11.1 have subtle, albeit 
significant, effects on mep-1 suppression, this second complex may have a less 
substantial contribution to promotion of germ line cell fates. 
SET-2 was identified as an enhancer of the MES sterility in a screen for 
performed in germ line compromised mes M+Z- mutants (Xu & Strome, 2001).  We and 
others have shown that only a subset of COMPASS components, including set-2, wrd-5 
and F52B11.1 enhance hpl-1; hpl-2 larval lethality (Simonet et al., 2007; Senchuk et al., 
unpublished).  Like set-2, wrd-5 has a mortal germ line phenotype, supporting that these 
factors function in germ line development, perhaps by interacting with MES pathway 
(Xiao et al., 2011, Li & Kelly, 2011).  Conversely, RNAi of Y17G7B.2/Ash2, set-16/MLL 
and F21H12.1/CFP1 failed to suppress and/or enhanced hpl-1; hpl-2 larval lethality 
(Simonet et al., 2007; Senchuk et al., unpublished).  Several recent findings support the 
hypothesis that these components form at least partially independent complexes.  First, 
set-2; ash-2 double mutants show additive defects in fertility (Xiao et al., 2011).  These 
components may also primarily contribute to different H3K4me marks; SET-2 is required 
for both H3K4me2 and H3K4me3, but Y17G7B.2/ASH-2 is only required for the 
H3K4me2, and is not required for H3K4me3 (Xiao et al., 2011).  These marks also 
display different patterns of chromatin localization, with H3K4me3 enriched around the 
transcription start sites of actively transcribed genes, whereas H3K4me2 displays a 
broader distribution (Xiao et a, 2011).   
 SET-2 mediates the majority of H3K4me3 in most developmental stages and the 
germ line, while ASH-2 contributes to H3K4me3 in embryos, but functions 
independently of SET-2 to mediate H3K4me2 (Xiao et al., 2011).  In fact, 
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immunostaining of ash-2 mutants demonstrated that H3K4me2 is higher in the PGCs 
compared to wildtype embryos, suggesting that ASH-2 might antagonize SET-2 in these 
cells (Xiao et al., 2011).  While this may reflect a defect in the conversion of H3K4me2 
to H3K4me3, this interpretation seems unlikely as H3K4me3 is also low in wild-type 
PGCs (Schaner et al., 2003).  Alternatively, antagonism of SET-2 might be accomplished 
by association of the ASH-2 complex with a histone demethylase, as has been observed 
in yeast and Drosophila (Secombe et al., 2007; Roguev et al., 2003).  Interestingly, the 
spr-5/LSD1 demethylase, specific for H3K4me, enhances the hpl-1; hpl-2 phenotype, 
lending support to this hypothesis, as does the finding that defects associated with spr-5 
defects include germline mortality (Senchuk et al., unpublished; Katz et al,2009).   
WRD-5 and F52B11.1, but not SET-2, suppress the Muv phenotypes associated 
with lin-15AB and hpl-1; hpl-2 (Simonet et al., 2007; Senchuk et al., unpublished).  It is 
possible that WRD-5 and F52B11.1 function as part of a SET-2 independent complex 
(that may or may not possess HMT activity) that functions in vulval development.  
Studies have shown that maintenance of H3K4me2/3 is dependent on WRD-5, but 
independent of AMA-1/PolII (Li & Kelly, 2011).  Perhaps this maintenance function is 
involved in vulval development.   An alternative hypothesis suggests that H3K4me2 
might play a role in vulval development.  While all COMPASS components contribute to 
H3K4me3 (of which SET-2 mediates the vast majority), western blot and 
immunofluorescence analyses demonstrated that WRD-5 and F52B11.1 are also required 
for H3K4me2, which does not appear to require SET-2 (Simonet et al., 2007; Li & Kelly, 
2011; Xiao et al., 2011).   It’s possible that H3K4me2 mediated by these factors 
contributes to SynMuv interactions, as wrd-5 and F52B11.1, but not SET-2, suppress the 
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Muv phenotype. As the other COMPASS components did not suppress hpl-1; hpl-2 
larval lethality, a role for these subunits can not be ruled out. Intriguingly, components of 
a COMPASS/MLL-like complex including SET-16, WRD-5, ASH-2 was pulled out of 
genomewide screen based on the ability to attenuate Ras signaling, the pathway 
controlled by SynMuv factors (Fisher et al., 2010). Components of the NuA4 complex 
also demonstrated this functionality (Fisher et al., 2010).  How MES-4 functions in the 
SynMuv pathway of vulval development is unknown. 
Based on these data, the regulation of H3K4 methylation in C.elegans, as in 
mammals, may involve distinct HMT complexes to yield a variety of different outcomes 
in different tissues and developmental stages.  At least one COMPASS like complex is 
likely involved in the MES pathway, and another, possibly sharing a number of subunits, 
is involved in vulval cell differentiation.  This hypotheses is consistent with the findings 
demonstrating the functionality of COMPASS/MLL like complexes which lack subunits 
previously thought the be essential for function and/or stability, including the HMT SET1 
(Patel et al., 2009; Patel et al., 2011; Steward et al., 2006; Dehe et al., 2006) 
How might the COMPASS like complex interact in the MES pathway?  One 
intriguing hypothesis suggests that similar to its Trithorax counterparts, the SET-2/WRD-
5 complex might mark specific targets, including differentiation specific genes, with 
H3K4me3.  If these targets are cooccupied by H3K27me3, the formation of “bivalent 
domains” might be required to ensure the correct temporal gene expression profiles 
during development.  One might use ChIP analysis to examine whether H3K4me3 marks 
coincide with H3K27me3 at target promoters developmentally regulated by MES-
2/PRC2 (as identified by Yuzyuk et al., 2009).  It would also be of interest to use ChIP-
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based methods to identify additional protein factors bound to these regions, aiding in the 
identification of factors required to target COMPASS and/or PRC2, or to identify factors 
that read one or both of these marks.  It is also possible that a switch in COMPASS 
subunit composition might drive the transition from poised to activated, as has been 
observed for SWI/SNF like BAF transition from proliferating neural stem/progenitors to 
postmitotic differentiated neurons (Lessard et al., 2007).  Recently, it has also been 
suggested that histone demethylases might function within the COMPASS/MLL complex 
(Fisher et al., 2010).  While levels of H3K4me and H3K27me appear to be independently 
regulated at the level of western blot, the demethylase UTX-1 was shown to phenocopy 
SET-16 COMPASS/MLL components in the vulval tissues, and utx-1 depletion induced 
elevated levels of H3K27me3.  Unfortunately, utx-1 RNAi was not in the original screen, 
but tracking of a demethylase might represent a means of PRC2 regulation.  For example, 
PRC2 might methylate all available H3K27 moieties, and the COMPASS complex 
“prunes” repressive marks from loci requiring activation.  Perhaps this would explain the 
lack of specific PRC2 specific DNA targeting in C.elegans and other species.  
Several alternative hypotheses might also account for interactions between MES 
and COMPASS.  First, components of MLL/COMPASS are found associated with the 
DCC complex involved in repression of the X chromosomes during embryonic 
development (Pferdehirt et al., 2011).  As a major function of the MES pathway involves 
silencing the X chromosome, this heterochromatin domain would represent a clear 
candidate where the MES and COMPASS like complexes might interact.  However, as 
dpy-30 (DCC and COMPASS), as well as other DCC factors (i.e., sdc-1) were not 
identified as strong suppressors of hpl-1; hpl-2 larval arrest in the Nuclear/RNAi 
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sublibrary screen (Primary screen, this manuscript) or a Meiosis/Repair sublibrary screen 
(Senchuk et al., data not shown), this hypothesis seems unlikely, although this interaction 
has not been definitively ruled out.  
An interesting third alternative suggests that MES and COMPASS interactions 
may involve epigenetic regulation.  Epigenetics refers to nongenetic, loci fixed chromatin 
components capable of influencing transcriptional programs that are inherited and 
propagated through cell division and development (Campos & Reinburg, 2009).  In many 
eukaryotes, the most common and well-studied epigenetic mark involves methylation of 
DNA at CpG islands; however, C.elegans lack DNA methylation, allowing for a closer 
examination of other forms of epigenetic marking.  Specific histone tail posttranslational 
modifications may also represent epigenetic marks; however, it is unclear how these 
marks are maintained, and what differentiates a nonepigenetic histone mark (i.e., those 
directly regulating transcriptional programs cell autonomously) from a mark that needs to 
be maintained to guide transcription in subsequent generations.   
MES-4 is thought to function as a maintenance HMT, and in the embryo, MES-4 
mediated H3K36me marks genes expressed in the maternal germ line (Furuhashi et al., 
2011).  Recent studies also suggest that H3K4 methylation may play an epigenetic role, 
evidenced by WRD-5 dependent, but transcription independent marks in early embryos, 
and by an uncharacterized mechanism, transgenerational extension of life span (Li & 
Kelly, 2010; Greer et al., 2011).  H3K4me marks are also found in the absence of active 
transcription in zebrafish embryos, suggesting these epigenetic phenomena are likely to 
be conserved in other species as well (Vasthenow et al., 2010).  In the early embryo, it is 
possible that early transcriptional profiles are established by H3K36me, H3K4me, and 
 146  
possibly H3K27me.   Additional studies by our lab and others will likely address these 
hypotheses.   
 
SWR1/NuA4/TIP60, H2A.Z 
The NuA4 complex is an evolutionarily conserved multisubunit HAT complex, 
which is recruited to target promoters and participates in acetylation of H4, H2A, and 
H2A.Z, and is typically thought to induce transcriptional activation.  The SWR1 complex 
is an ATP dependent chromatin remodeling complex, involved in the incorporation of the 
histone variant H2A.Z, which is important for gene regulation and genomic stability.  The 
incorporation of H2A.Z is thought to change nucleosome dynamics, but the effects on 
gene expression remain controversial (Marques et al., 2009).  In yeast, at least four 
components are shared between these two complexes.  Moreover, recruitment of SWR1 
requires NuA4, and evolutionary evidence suggests that overlap may be greater in 
complex metazoans (Lu et al., 2009).  In fact, in mammals and Drosophila, the associated 
factors, including Tip60-p400 and SRCAP, function as a single complex, using different 
subunit compositions to fine tune complex functionality (Lu et al., 2009; Marques et al., 
2009).   
Tip60 possesses both histone acetyltransferase and chromatin remodeling 
activities and can act either as a positive or negative regulator of transcription (Ikura et al., 
2000, Cai et al., 2003; Xiao et al., 2003).   Tip60-p400 transcriptional regulation seems to 
be mediated, at least in part, by the incorporation of the histone variant H2A.Z into 
nucleosomes and by the catalysis of histone acetylation at target genes (Sapountzi et al., 
2006, Squatrito et al., 2006).  Similar to its potentially dual roles in transcriptional 
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regulation, Tip60 plays seemingly opposing roles with respect to DNA double strand 
breaks (DSB).  This complex participates in the activation of DSB formation, and has 
also been shown to be recruited DSB sites where it contributes to DSB repair (Squatrito 
et al., 2006). 
Intriguingly, the Tip60 complex was identified in a large scale RNAi screen for 
chromatin remodeling proteins involved in ES cell function, and was shown to repress 
developmental genes in this cell population (Fazzio et al., 2008).  Loss of TIP60 function 
led to defects in self renewal and differentiation capacity, although the expression of 
pluripotency associated transcription factors (i.e., Oct4) was unaffected (Fazzio et al., 
2008).  ChIP analyses in mESCs indicate that Tip60 colocalizes with Nanog and 
H3K4me; these marks are required for Tip60 recruitment.  The authors also show that 
Tip60 induces H4 acetylation at both activated and repressed target genes (Fazzio et al., 
2008). Given the role of Polycomb and MES factors in pluripotency, this link is 
particularly interesting, and suggests that Tip60 components might play a role in the 
transition from pluripotency to cell fate commitment in C.elegans.  Based on the 
observed recruitment to H3K4me, COMPASS/MLL may also be linked to this function. 
By homology to the yeast SWR1 and NuA4, a number of components are likely 
to function in the C.elegans NuA4/SWR1 or Tip60 like complex(es).  Of these, four were 
found to suppress hpl-1; hpl-2, including gfl-1 (AF9-like), mrg-1 (EAF3-like), ZK1127.3 
(EAF7-like), and C08B11.6 (Arp6 like).  Although it did not come up as a positive in the 
primary screen, the histone variant H2A.Z has been shown by our group and other to 
suppress hpl-1; hpl-2 as well as the SynMuv factor lin-15AB, suggesting that loss of 
H2A.Z is also mes-4-like (Senchuk et al., unpublished; Cui et al., 2006).   Additional 
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factors, including C17E4.6, CD4.7, SSL-1, and MYS-4 were not among the genes 
targeted by RNAi in the initial sublibrary.  Although not screened, we would hypothesize 
that these factors might also strongly suppress hpl-1; hpl-2.   Alternatively, they might 
behave similarly to ekl-4, trr-1, mys-1, epc-1, which were found to enhance all mutant 
background phenotypes (hpl-1; hpl-2; met-2 and mes-3).  This enhancement phenotype is 
likely related to previously annotated RNAi phenotypes, but also suggests that these 
factors play additional roles during development. 
Based on these findings, it is likely that a NuA4/SWR1/Tip60 like complex(es) in 
C.elegans interact with MES-4.  Alternatively, some components (including MRG-1, 
ZK1127.3, GFL-1, and C08B11.6) may form one or more subcomplexes that mediate 
specific, MES-4 related functions.    Data from previous studies support the latter 
hypothesis, as trr-1, mys-1, and epc-1 are SynMuv C genes that repress ectopic 
expression of lag-2 in the intestine (Poulin et al., 2005; Ceol & Horvitz, 2004).  
Conversely, our study and others identified mrg-1, ZK1127.3, gfl-1 and C08B11.6 as 
SynMuv suppressors (Senchuk et al., unpublished, Cui et al., 2006).   Cui and colleagues 
also found that these factors are required for the ectopic expression of lag-2 observed in 
SynMuv mutant backgrounds (Cui et al., 2006; Senchuk et al., unpublished).   Based on 
these data, different NuA4/SWR1 like complexes may have opposing functions, with the 
GFL-1, C08B11.6, MRG-1 and ZK1127.3 complex functioning to promoting gene 
expression (based on the lag-2::phenotype).   
Several interesting hypotheses might account for the interaction of NuA4/Tip60 
and the Mes/PcG pathway, specifically focusing on the HAT activity (SWR1/Tip60 
function, and the incorporation of HTZ-1/H2A.Z is discussed in the following section). 
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As suggested in the first section, one attractive model suggests that the NuA4/Tip60 
complex functions in conjunction with MES-4 to activate an autosomal repressor of the 
PRC2 complex, thereby preventing association of the PRC2 complex with autosomes and 
concentrating the repressive activity on the X chromosome.  It is also possible that 
NuA4/Tip60, independently of MES-4, activates an X localized factor that recruits PRC2, 
which in turn repels MES-4.  Alternatively, this complex might activate the expression of 
a molecule required for targeting of MES-4 to the autosomes, or that autosomal or 
histone acetylation (or incorporation of H2A.Z) directly recruits MES-4 and/or repels 
PRC2.  
Studies have shown that loss of PRC2 activity results in a global increase in 
H3K27 acetylation, a mark thought to be antagonistic to PcG mediated silencing (Tie et 
al., 2009; Pasini et al., 2010).  Although NuA4 has not been previously associated with 
this mark, Mes/PRC2 might be localized to the X chromosome by autosomal H3K27ac, 
added directly by NuA4 or indirectly mediated by this complex.  Alternatively, PRC2 
mediated H3K27me3 marks may repel H3K27ac, which would then be restricted to 
autosomes and might contribute to the localization of MES-4.  In addition, previous 
studies have demonstrated that PRC2 complexes associate with HDACs (Kuzmichev et 
al., 2002; Pasini et al., 2010; Tie et al., 2003; van der Vlaag & Otte, 1999), it is also 
possible that targeting a MES/PRC2-HDAC complex to the X chromosome might 
remove marks of activation in this domain and/or allow methylation of H3K27me3, while 
MES-4 may be recruited to acetylation marks remaining on autosomes.  While, based on 
the findings of this study, the HAT complex NuA4 would be an excellent candidate to 
perform this function, we were unable to identify an HDAC like complex that might be 
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involved with the MES/PcG pathway in this capacity, although MRG-1/Rdp3S has not 
been ruled out.   In the initial screen, however, we identified the histone deacetylase SIR-
2.1, which has previously been associated with heterochromatin, as strong hpl-1; hpl-2 
suppressor, and was not analyzed in this work as loss of sir-2.1 also enhanced mes-3 
sterility.  
In S.cerevisiae and Drosophila, H3K36 methylation has been reported to recruit 
an HDAC containing Rpd3S complex, resulting in deacetylation of the 3' end of actively 
transcribed genes (Carrozza et al., 2005; Joshi and Struhl, 2005; Keogh et al., 2005, Bell 
et al., 2007).  In contrast to Set2/dHypb, the loss of which resulted in reduction of 
H3K36me2/3 and increased histone acetylation, knockdown of dMes-4 had the opposite 
effect, with reduced H3K9me as well as global reduction in acetylation of histone H4K16 
(Bell et al., 2007).  Therefore, while Set2/dHypb (and by correlation C.elegans MET-1), 
may actively recruit HDACs and/or interfere with the acetylation of H4K16, MES-4 
might have the inverse effect and recruit HAT activity.   Although this model is untested 
in C.elegans, one candidate for this might be the NuA4/SWR1 complex. 
 
H2A.Z 
SWR1 and the orthologous complexes Tip60/p400 and SRCAP remodel 
nucleosomes and incorporate the histone variant H2A.Z/htz-1, which occupies specific 
chromatin domains.  H2A.Z is a highly conserved and accounts for ~5-10% of all H2A in 
a nucleus (Marques et al., 2010).   Although not required for yeast viability, loss of 
H2A.Z in other organisms, including Drosophila, worms, and mice, results in embryonic 
lethality (Marques et al., 2010).  In S.pombe, loss of H2A.Z leads to defects in 
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transcriptional activation and alterations in transcriptional silencing.  In this and other 
species, the function of H2A.Z remains unclear. 
Studies have shown that H2A.Z is found at promoters and regulatory regions of 
active genes, including insulators and enhancers, as well as areas of facultative and 
constitutive heterochromatin, but is rarely found within the gene bodies of actively 
transcribed genes (Hardy & Robert, 2010).  H2A.Z is often incorporated into 
nucleosomes flanking the nucleosome free regions associated with transcriptional start 
sites, and is thought to promote nucleosome instability (Marques et al., 2010).  However, 
it has also been hypothesized that the increased mobility of H2A.Z containing 
nucleosomes might also negatively impact transcription by blocking key regulatory 
sequences.  In human, Drosophila and C.elegans, genomewide studies have shown that 
H2A.Z is often associated with RNA PolII, and may play some role in PolII pausing 
and/or recruitment (Hardy & Robert, 2010; Marques et al., 2010; Whittle et al., 2008). In 
addition to the promoters of actively transcribed genes, H2A.Z also occupies large 
domains occupying several hundred kilobases, and can also regulate the localization of 
chromatin to the nuclear periphery, a domain generally associated with transcriptional 
inactivity (Marques et al., 2010; Brickner et al., 2007).  In C.elegans, HTZ-1 is found at 
significantly lower levels on X chromosomes relative to autosomes (Whittle et al., 2008).    
Genomewide analysis of ES cells has demonstrated that the occupancy of 
H2A.Z and PcG protein of promoters are highly correlated and interdependent 
(Creyghton et al., 2008).  By RNAi, the authors show that incorporation of H2A.Z during 
mouse ESC differentiation is essential for proper lineage commitment (Creyghton et al., 
2008).  Moreover, following differentiation, H2A.Z occupies a different subset of genes, 
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suggesting that this relocalization may contribute to the dynamic changes in gene 
expression during the transition from pluripotency to cell fate committed (Creyghton et 
al., 2008), a role that would be highly similar to the Mes/PRC2 complex in C.elegans 
(Yuzyuk et al., 2009).   
 Another potential link between the Mes/PcG pathway and SWR1 function comes 
from studies in flies, where it has been shown that the PRC2 and the PhoRC associated 
protein Pho/YY1 (which is the only sequence specific DNA binding protein identified as 
part of the Polycomb family), physically interacts with the INO80/SWI-SNF remodeling 
complex (Klymenko et al., 2006).  As the SWR1 complex is also an INO80 family 
remodeler, one intriguing model of Polycomb targeting might involve interaction with 
SWR1/NuA4 complexes.   
 As studies in yeast have shown that histone acetylation by NuA4 is a prerequisite 
to incorporation of H2A.Z by the SWR1 complex.  Therefore, it is possible that these 
factors interact in the Mes/PcG pathway based on their requirement for H2A.Z 
incorporation into the genome.  As H2A.Z may function may exert either positive or 
negative effects on gene expression, many models are possible, including those discussed 
above. H2A.Z/HTZ-1 might be integrated into autosomes where it might i) directly 
attract MES-4 and/or repel MES/PRC2, or ii) activate an autosomal encoded repressor of 
the PRC2 function.   
 
MRG-1 
Of all the hpl-1; hpl-2 suppressors identified by this study, the most well studied 
in connection with Mes/PcG pathway is MRG-1, an hpl-1; hpl-2 suppressor with a 
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striking mes-4-like phenotype in all secondary screens analyzed in this study.  MRG-1 is 
a chromodomain binding protein related to human mortality factor related gene 15 
(MRG15), and based on knockout mouse phenotypes, is required for cell proliferation 
and embryo survival (Tominaga et al., 2005).  MRG-1 was identified in C.elegans based 
on a maternal effect sterile phenotype resulting from necrotic degradation of germ cells 
(Fujita et al., 2002).  Like MES proteins, MRG-1 is maternally provided, expressed 
ubiquitously, becomes enriched in germline precursor cells, and is required for silencing 
of X-linked genes known to be targeted by MES-4 (Fujita et al., 2002; Takasaki et al., 
2007).     
MRG-1 is similar to MES-4 in its autosomal localization, but MRG-1 is not 
required for MES-4 localization, and MRG-1 localization is unaffected in mes-2 and mes-
4 loss of function mutants (Takasaki et al., 2007).  It is possible that MRG-1 may be 
recruited and bind by H3K36me2 via its chromodomain, as has been observed in yeast 
EAF3 (Carrozza et al., 2005; Keogh et al., 2005).   Takasaki and colleagues found that 
MRG-1 localization was unaffected by loss of MES-4 mediated H3K36me; however, the 
authors did not address H3K36 methylation induced by MET-1.  In yeast, there is only 
one H3K36 HMT (SET2).  It’s possible that in C.elegans, MRG-1 may interact with both 
transcription independent (MES-4) and transcription dependent (MET-1) mediated 
H3K36me, although it may preferentially interact with one form.  This might explain 
why MRG-1 localization was not affected in mes-4 mutants.   A preference for seemingly 
identical marks might be mediated by 3’ vs. 5’ enrichment, additional cofactors, and/or 
di- vs. tri-methylation.  MRG-1 binding H3K36me may account for it’s autosomal 
enrichment.  Based in the similar phenotypes of mes-4 and mrg-1, we might predict that 
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MRG-1 might bind and stabilize H3K36me mediated by MES-4.  If MRG-1 is able to 
bind both MET-1 and MES-4 mediated H3K36me, MRG-1 could be involved in the 
repression of MES/PRC2; MRG-1 binding to MET-1 mediated H3K36me3 in a mes-4 
mutant might be sufficient to maintain exclusion of PRC2, and account for the 
observation that H3K27me3 patterns are unchanged in the mes-4 mutant.   However, 
MRG-1 remains associated with autosomes in very early mes-4 (-) embryos which have 
been shown to lack H3K36me3, suggesting that MRG-1 in C.elegans is not localized by 
binding H3K36me3 (Takasaki et al., 2007; Rechsteiner et al., 2010). By antibody staining 
of later stages of embryogenesis, MRG-1 is not required for PGCs to acquire 
transcriptional competence of the PCGs, and as activated PolII is not preciously detected 
in P4 precursor cell, it is unlikely that MRG-1 interacts with MES-4 in this capacity 
(Takasaki et al., 2007).   
 In addition to functioning in the NuA4/SWR1 complex(es), MRG-1/EAF3 also 
functions in the Rpd3S HDAC complex, which is recruited to H3K36me2/3 to suppress 
spurious transcription within actively transcribed genes (Lee & Shilatifard, 2007).  Loss 
of EAF3 function induces global changes in acetylation of the yeast genome, with 
increased acetylation in coding regions, and reduced acetylation at promoters, consistent 
with reduced gene expression (Reid et al., 2004).   Other components of the Rdp3S 
complex are homologous to the C.elegans proteins HDA-1, HDA-2, HDA-3; none of 
which were found to strongly suppress hpl-1; hpl-2, suggesting that the NuA4/HAT 




MES-2/PRC2 like genes 
T19B4.5 
 One of the most striking findings of this analysis was the characterization of the 
novel gene T19B4.5.  By sequence homology, T19B4.5 may be nematode specific, 
although functional homology is not ruled out.  By motif searches, T19B4.5 contains 3 
coiled-coil domains, which may be important for interaction with nucleic acids or other 
proteins.  In our analyses, T19B4.5 was found to suppress hpl-1; hpl-2 larval arrest and 
rescue mep-1 larval lethality better than mes-2 (30% adults in T19B4.5 vs. 16% adults in 
mes-2).  The most interesting phenotype was loss of let-858::GFP expression in the germ 
line, inducing this repression even in when the arrays were complex in nature and 
integrated into the genome resulting in consistent expression in the germline.   This 
finding suggests that T19B4.5 may promote germ line expression.  As shown in Figure 
14, RNAi targeting T19B4.5 also induced dramatic upregulation of let-858::GFP in the 
soma, irrespective of the type of transgene analyzed.  These data suggest that T19B4.5 
may function to inhibit repression in the somatic tissue. 
What mechanisms might contribute to increased somatic expression in T19B4.5?   
Although our data demonstrate that let-858::GFP is the only transgene demonstrating 
dramatic changes in expression, a previous study showed that loss of T19B4.5 also 
induces desilencing of transgenic arrays in the seam cells and nonneuronal cells (Kim et 
al., 2005).  One of these transgenes was also tested in our study:  sur-5::GFP.  One 
important difference between these two analyses is that the Kim study tested desilencing 
of transgenes in an RNAi-enhanced background (i.e., eri-1 and/or rrf-3).  However, the 
interpretation of this result is complicated by the fact that T19B4.5 plays a positive role in 
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RNAi (Kim et al., 2005; Senchuk et al., unpublished), and RNA-based mechanisms are 
known to be involved in the regulation of transgenes and repetitive elements.  ERI-1 and 
RRF-3 prevent silencing of repetitive transgenes in the soma, likely by repressing RNAi 
based mechanisms of silencing (Simmer et al., 2002).  One might predict that loss of 
genes promoting RNAi would enhance transgene expression in an eri-1/rrf-3 mutant 
background, and this appears to be the case for a number of RNAi genes, including mes-4 
and gfl-1 (Kim et al., 2005).  However, these genes do not induce increased somatic 
expression in an eri-1/rrf-3 (+) background, as T19B4.5 appears to, suggesting that 
T19B4.5 functions differently than known RNAi genes.   
Although less well studied, somatic silencing of transgenes appears to occur at the 
transcriptional level through RNA dependent mechanisms and histone deacetylases 
(Grishok et al., 2001; Grishok et al., 2005).  The somatic desilencing phenotype of 
T19B4.5 is opposite that of the SynMuv factor tam-1 (tandem array modifier), as well as 
additional SynMuv genes, including lin-35, which are involved in context dependent 
gene silencing in an RNAi dependent manner.  In the soma, loss of tam-1 induces a 
dramatic reduction in expression of tandem repetitive arrays (Hsieh et al., 1999), and it is 
thought that transgene silencing in the tam-1 mutant occurs at the pre-mRNA stage 
(Grishok et al., 2005).  Based on these data, one might predict that T19B4.5 negatively 
regulates TAM-1, or alternatively, these factors function in parallel to regulate transgenic 
expression.  These different hypotheses could be addressed by assessing transgenic 
expression in tam-1; T19B4.5 double knockout.  However, tam-1 does not induce 
silencing of complex arrays (Hsieh et al., 1999), which T19B4.5 clearly does in the case 
of different let-858::GFP constructs.  Therefore, perhaps T19B4.5 also negatively 
 157  
regulates factor(s) responsible for expression of complex arrays and/or endogenous loci.  
An alternative model suggests that T19B4.5 activates a repressor, which might function 
upstream of TAM-1/SynMuv genes as well as factors responsible for the regulation of 
complex array expression.  We have not yet tested whether T19B4.5 leads to increased 
expression of endogenous let-858 and/or other endogenous loci.   
 The effect of T19B4.5 observed in the germ line is opposite of that observed 
somatic tissues, with reduced transgenic expression in the germ cell nuclei, a phenotype 
that has not been previously identified.  A number of models might account for this 
phenotype.  In the simplest model, T19B4.5 might directly activate transgenic expression.  
Very little is known about T19B4.5, although motif prediction software suggests that this 
protein contains a coiled-coil domain that may interact with DNA.  Secondly, T19B4.5 
might activate some other factor required for array expression (i.e., indirect activation).  
A third model predicts that T19B4.5 might repress a factor that activates a downstream 
repressor of array expression.  
It is also possible that T19B4.5 does not affect the array, but instead directly 
regulates a subset of genes, including let-858, which encodes the highly conserved 
nucampholin, shares some similarity to eukaryotic initiation factor eIF-4 gamma, is 
nuclear localized throughout development and is at least partially associated with 
chromatin, and is required for germ line proliferation, early embryogenesis and tissue 
differentiation (Kelly & Fire, 1998).   It is possible that the role of T19B4.5 in the MES 
pathway is mediated through LET-858 or other factors activated or repressed in response 
to T19B4.5.  As noted in the results section, T19B4.5 might interact with arrays and/or 
endogenous genes through it’s proposed binding factor SET-18/SMYD. 
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Overall, the finding that T19B4.5 appears to oppose Mes function in the germ line 
(as a repressor) as well as SynMuv factors in the soma (as an activator), suggests that 
T19B4.5 may represent an important target of future study.  We are currently 
characterizing phenotypes associated with a null mutation of T19B4.5, as well as building 
expression constructs using the endogenous promoter and UTR to examine the 
localization patterns of T19B4.5 throughout development.  Future studies will also 
address the affects of loss of T19B4.5 function on germline competent vs. germline 
specific promoter arrays, as discussed in the results section.  We also hope to address the 
potential role of this factor in transcriptional gene silencing pathways. 
 
O-GlcNAc transferase 
N-acetylglucosamine (O-GlcNAc) transferase (OGT-1) catalyzes the addition of 
O-GlcNAc moieties to nuclear and cytoplasmic proteins at serine and threonine residues.   
There are several hints from the literature that this modification might interact with the 
Mes pathway.  In mice and Drosophila, loss of OGT function is embryonically lethal 
(Myers et al., 2011; Gambetta et al., 2009).  In flies, lethality results from homeotic 
transformations, with homeotic genes expressed outside their native domains (Gambetta 
et al., 2009).  In Drosophila, OGT is encoded by the Polycomb group gene Super Sex 
Combs (sxc), and genomewide profiling has demonstrated enrichment of GlcNAc 
modifications at Polycomb response elements (PREs) (Gambetta et al., 2009; Sinclair et 
al., 2009).  These GlcNAc bound sites overlap with PhoRC; however, binding of Pho at 
PREs is unaffected in sxc mutants, as are H3K27me levels (Gambetta et al., 2009).  
These data suggest that OGT enzymatic activity may function downstream of Polycomb 
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function, perhaps recruited by H3K27me3.  OGT also glycosylates RNA PolII, 
Polyhomeotic, core histones, and various transcription factors, suggesting GlcNAc 
modification may directly involved in transcriptional regulation (Sinclair et al., 2009; 
Gambetta et al., 2009).  OGT is also an enzymatic component of the human dosage 
compensation complex (DCC), suggesting that GlcNAc might be involved in higher 
order chromatin structure of the X chromosome (Love et al., 2010).  A recent proteomics 
based analysis in mESCs demonstrated that GlcNAc modifies a number of proteins 
involved in maintenance of cell identity, including SOX2 and the Nanog interacting 
protein ZFP281 (Myers et al., 2011).  In these cells, PRC2 is necessary to maintain 
normal levels of OGT and for the correct cellular distribution of O-GlcNAc (Myers et al., 
2011).     
Preliminary analysis has shown that localization and levels of OGT and GlcNAc 
appear unaffected in mes-2(-) C.elegans embryos (Senchuk et al., unpublished).  
However, as GlcNAc modification has been associated with a wide array of cellular 
processes, including signaling, protein turnover, nutrient sensing and gene expression, it 
is perhaps not surprising that global levels of this modification were unchanged.  One 
interesting future experiment might involve testing this model using ChIP analysis, to 
address, for example, whether O-GlcNAc modifications are lost on promoters targeted by 
PRC2 in a mes-2 mutant.   It might also be worth investigating whether this molecule 






HIM-17 is a germ line expressed, chromatin localized protein involved in meiotic 
processes, including double strand break formation (DSB), chiasmata, crossovers, and 
recombination (Reddy & Villeneuve, 2004).  HIM-17, as well as the RdRP EGO-1, are 
required for correct patterning of H3K9me2 in the meiotic germ line (Reddy & 
Villeneuve, 2004; Maine et al., 2005).  HIM-17 also functions to regulate the balance 
between germ cell proliferation and meiotic development, inhibiting proliferation and/or 
promoting meiotic entry (Bessler et al., 2007).  However, loss of him-17 function does 
not induce desilencing of transgenes in the germ line (Bessler et al., 2007; Senchuk et al., 
unpublished).  HIM-17 has also been shown to genetically interact with the SynMuv 
protein LIN-35/Rb; codepletion of these factors is synergistic with respect to DSB 
formation frequency (Reddy & Villeneuve, 2004). 
There are two potential models by which HIM-17 might interact with the 
MES/PcG pathway.  First, the stabilization of the H3K9me2 by HIM-17 might recruit 
MES-2/PRC2 to target loci, or vice versa.  This is somewhat unlikely as 
immunofluorescence assays demonstrate the H3K27me3 and H3K9me2 marks are 
unaffected in him-17 embryos.  However, this model is not ruled out in the germ line.   
An alternative model suggests that HIM-17-associated H3K9me2 serves as a template for 
conversion to H3K9me2 by PRC2.  However, Bessler and colleagues suggest that the 
MES-2 and MET-2 H3K9me marks are acquired independently (Bessler et al., 2010).  
MET-2 also associates with HIM-17 by MudPIT mass spectrometry analysis (Bessler et 
al., 2010).  However, loss of met-2 has the opposite effect of mes-2/PRC2 and him-17, 
and enhances rather than suppresses hpl-1; hpl-2 larval arrest (Simonet et al., 2007; 
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Senchuk et al., unpublished).  met-2 may also weakly enhance mes-3 sterility (Senchuk et 
al., unpublished).  While these different pathways concerning H3K9me, HP1, and PRC2 
clearly interact, the mechanisms of antagonism and/or cooperation remain unclear.    
 
Summary 
This dissertation describes a primary screen of >700 nuclear and RNAi associated 
factors.  We identified enhancers and suppressors associated with the three major 
heterochromatin and transcriptional silencing pathways:  mes-3/Polycomb, met-
2/H3K9me2/3, and hpl-1;hpl-2/HP1.  More than 200 factors were found to suppressor or 
enhance one of more of these background mutations, but are unlikely to represent general 
enhancers.  We were struck by the observation that all identified members of the 
Mes/Polycomb pathway strongly suppressed the hpl-1; hpl-2 larval arrest phenotype, and 
did not affect mes-3 or met-2.  Factors that have been associated with the PRC1 complex 
did not have this phenotype, suggesting that these genes do not function in a common 
pathway with MES-2/MES-3/MES-6 (PRC2) and the interacting factors MES-4 
(H3K36me) and SET-2 (H3K4me). 
A number of additional factors showed the distinctive signature of strong hpl-1; 
hpl-2 suppression.  These include members of the COMPASS/MLL complex (H3K4me), 
members of the NuA4 HAT complex, members of SWR1 nucleosome remodeling 
complex (incorporation of H2A.Z), O-GlcNAc transferase, an enzyme catalyzing the 
addition of a common and fairly uncharacterized PTM, a novel factor (T19B4.5), and two 
proteins involved in DNA repair. 
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To further characterize the potential role of these factors in the Mes/PcG pathway, 
a number of secondary assays were performed, including suppression of the SynMuv 
ectopic vulva phenotype, suppression of mep-1/NuRD induced larval lethality, germ line 
desilencing of a repetitive array, and function in the RNAi pathway.  Two major findings 
are associated with these studies.  First, factors associated with activating complexes 
(COMPASS, NuA4/SWR1) demonstrate phenotypes very similar to loss of mes-4, 
suggesting that these complexes may function in cooperation with MES-4, and may 
contribute to indirect transcriptional repression of the X chromosome.  As loss of 
F52Bl1.1 and WRD-5, but not SET-2, phenocopy mes-4, it is likely that the COMPASS 
complex can function in at least two forms, one of which is SET-2 independent and 
interacts with the Ras pathway to control vulval formation.   
The second finding involves the novel, uncharacterized, and potentially 
nonconserved T19B4.5.  T19B4.5 is associated with a unique phenotype, characterized 
by overexpression of the let-858::GFP transgene in the soma, coupled with strong 
repression of expression in the germ line.  This phenotype is not dependent on the type of 
array used, suggesting that changes in expression are not related to repetitive elements 
often associated with transgenic arrays.  As this phenotype appears to oppose SynMuv 











DEVELOPMENT OF A CONTROLLABLE 
 




Use of transgenic animals has become a common practice in most C.elegans labs.  
Transgenes are commonly used as convenient comarkers for genetic studies, to study 
overexpression or ectopic gene expression phenotypes, to study protein localization by 
expressing fluorescent tagged genes, to assess the role of regulatory elements in 
expression patterns, to rescue mutant phenotypes, and to perform structure/function 
analyses.  
Several methods have been developed to introduce transgenes into the soma and 
germline (Merrit & Seydoux, 2010).  However, few methods are available to specifically 
modulate expression of the endogenous gene relative to the transgene, nor to study 
differential expression from an endogenous locus or a transgenic gene.  
Here we describe the use of transgenes from the closely related nematode 
C.briggsae.  These transgenes can be introduced into the C.elegans genome by standard 
methods, and can be detected with species specific PCR and modulated by RNAi.  We 
show that C.briggsae transgenes are expressed and localize similarly to C.elegans 
counterparts, and can rescue C.elegans loss of function and RNAI mediated knockdown 
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of endogenous gene expression.  We also show, by qPCR and western blot, that both 
mRNA and protein levels are specifically targeted by species specific knockdown.   
C.elegans and C.briggsae are closely related members of the nematode genus 
Caenorhabditis, and diverged from a common ancestor 30-110 million years ago (Cutter, 
2008; Stein et al., 2003).  Though morphologically indistinguishable and found in the 
same ecological niche, these species are more evolutionarily divergent than humans and 
mice (Stein et al., 2003).  We hypothesized that the genetic differences between 
C.elegans and C.briggsae might allow researchers to use the C.briggsae genome as a tool 
to engineer transgenes in C.elegans lab strains that are can be modulated using 
speciesspecific RNAi.   
Despite the divergence, the gene makeup, gene structure (i.e. exon length and 
intron placement), and genome assembly of C.elegans and C.briggsae are highly similar, 
with substantial synteny despite the observed intrachromosomal arrangements (Stein et 
al., 2003).  Sixty five percent of C.elegans genes have a clear C.briggsae ortholog, with a 
mean percent identity of 80% (Stein et al., 2003), similar to the identity observed when 
human and mouse genomes are compared (Waterston et al., 2002).  At the genome level, 
52.3% of C.elegans sequence aligns to C.briggsae (Stein et al., 2003).  In addition, 
almost all noncoding RNAs and operons are conserved between species (Stein et al., 
2003).  Of the ~20,000 protein coding genes identified in the C.briggsae genome 
sequence, only 800 genes are unique.  Moreover, the strongest alignments occur in 
coding sequence and in the ~1kb upstream of the start site, indicating that promoters are 
also highly conserved (Stein et al., 2003).    It’s estimated that 30% of the C.elegans 
genome (~5,700 genes) are essential, meaning the loss of these genes result in zygotic 
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lethality, maternal effect lethality, and/or sterility (Herman, 1978; Johnsen & Baillie, 
1997).  These genes likely show above average levels of conservation.   
We introduced the C.briggsae promoter and coding sequence for two essential 
C.elegans genes by two different methods into the C.elegans genome.  hmr-1, a classical 
cadherin, is nearly 60 Kb, and was recombineered into a citirine (a modified GFP) 
expression vector, injected into the germline and maintained as a complex array under 
temperature sensitive cha-1 selection.  C.briggsae sequence corresponding to the 
RhoGAP cyk-4 (2.7 Kb) was used to construct cyk-4C.br::mCherry and introduced in 
single copy into the ttTi5605 locus by mosSCI (Frøkjaer-Jensen et al., 2008).  Similar to 
other ortholog pairs, these gene pairs have very similar intron and exon structures, as 
shown in Figure 18.  The unspliced versions of these genes are 51% and 67% identical to 
their C.elegans counterparts, and coding segments share 74-75% identity by global 
alignment.  The cyk-4 promoter  (1.75 Kb) is 54.7% identical to the C.briggsae 5’ 
sequence; because of lack of sequencing in the promoter region of C.briggsae hmr-1, the 
promoter regions could not be compared.  At the amino acid level, C.elegans CYK-4 and 
HMR-1 share 80-86% identity with the C.briggsae equivalents. 
We first tested whether the exogenous C.briggsae transgenes could rescue when 
the endogenous gene was reduced by RNAi using constructs available thru Gene Service 
(Ahringer library clones), which are each one to two kilobases in length.   Previous 
studies demonstrated that duplexes as short as 26 nucleotides can trigger an RNAi 
response (Parrish et al., 2000).  Lack of confirmed C.briggsae sequence prohibits full 




Figure 18.  Gene structure of cyk-4 (Rho GAP) and hmr-1 (cadherin) in C.elegans and 




C.elegans cyk-4 RNAi sequence that would be capable of targeting the C.briggsae 
transgene.  Feeding wildtype worms C.elegans hrm-1 or cyk-4 RNAi consistently 
resulted in progeny with near 100% lethality (5/5 experiments), while worms carrying the 
C.briggsae transgenes were 80-95% resistant, indicating that the C.briggsae genes are 
functional and capable of rescuing maternal and zygotic defects.  These data are 
summarized in Figure 19.    
 We verified the ability of the C.briggsae transgene to rescue C.elegans cyk-4 loss 
of function by crossing the cyk-4C.br::mCherry line into a functionally null cyk-4 deletion 
PCR, and homozygous deletion mutants carrying the transgenic copy were fully viable,  
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Figure 19.  C.elegans RNAi targeting cyk-4 and hmr-1 induces lethality.  Viability is 
restored if a C.briggsae transgene is present in single copy (cyk-4), or on an array (hmr-1). 
 
 
mutant (ok1034).  Genotypes were confirmed using poison primer PCR while 
homozygous deletion mutants without the transgene were never obtained, suggesting 
lethality.  As expected, western blot analysis probing with a CYK-4 antibody shows that 
the endogenous protein is absent in cyk-4C.br::mCherry; cyk-4C.el (ok1034) homozygous 
mutants, instead showing an upshifted band corresponding to the tagged transgene, as 
shown in Figure 20.  
Immunofluorescence analysis demonstrated that the pattern of transgenic 
localization in cyk-4C.br::mCherry; cyk-4C.el(ok1034) homozygous mutants mimics the 
endogenous pattern, with protein observed at the spindle midzone and division remnants 
(20/20 embryos).  An example of this stain is shown in Figure 21.  Levels of transgenic 
protein appear similar when comparing endogenous CYK-4 stains in wildtype worms to 
mCherry stains in transgenic embryos, suggesting that expression levels are similar.  
However, in both western blots and immunofluorescence stains, a CYK-4 antibody  
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Figure 20.   Genotyping and western blot of various cyk-4 transgenic lines.  Left:  Poison 
primer genotyping (schematized below the gel) demonstrates the ability of C.briggase 
transgene in a C.elegans cyk-4 null background.  Right:  Western blot using a CYK-4 
antibody designed against the C.elegans protein.  The rescueing C.briggsae transgene in 
C.elegans cyk-4(ok1034) background is upshifted ~50 kDa, reflecting the added weight 
of the mCherry fluorphore.  Endogenous CYK-4 is absent in this strain.   The faintness of 
the C.briggsae transgenic band may reflect reduced affinity of the C.elegans antibody for 
the transgenic C.briggsae protein. 
 
 
generated against a C.elegans peptide shows a somewhat reduced affinity for the 
C.briggsae CYK-4 protein (data not shown). 
To set up a system of controllable gene expression, we designed an RNAi 
construct to specifically target the C.briggsae cyk-4 transgene as well as the mCherry 
flurophore.  As previous studies demonstrated that duplexes as short as 26 nucleotides 
can trigger an RNAi response (Parrish et al., 2000), we looked for regions of dissimilarity 
and limited long stretches of base pair identity.   Species specific RNAi was tested by 
comparing viability of C.briggsae transgenic lines (cyk-4 C.br::mCherry; cyk-4C.el (+) and  
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Figure 21.  Immunofluorescence assays demonstrate that endogenous CYK-4 (detected 
with α CYK-4 antibody) and transgenic CYK-4 (detected with α mCherry antibody) 
localize similarly in the early embryo.  Asterisks mark the spindle midzone, and 
arrowheads mark the division remnant.  The wildtype embryo is slightly older, and the 
posterior cell is in metaphase, and in this cell, CYK-4 shows a slightly different staining 




cyk-4C.br::mCherry; cyk-4 C.el (ok1034)) and wildtype worms (no transgene, cyk-4C.el (+)) 
when grown on C.briggsae specific feeding RNAi relative to viability on C.elegans 
specific RNAi and control RNAi.  mCherry RNAi targeting construct was also tested for 
efficacy of RNAi mediated knockdown.  Species specific RNAi was scored by 
quantitation of  F1 lethality, and mRNA levels by quantified by qPCR.  C.elegans specific 
RNAi was found to specifically target endogenous C.elegans cyk-4, as both strains 
carrying the C.briggsae transgene were fully viable (Figure 22, right columns).  This 
finding suggests that this construct is specific, and does not cross react with C.briggsae 
cyk-4 constructs.  In contrast, treatment with C.briggsae specific or mCherry RNAi had 














Figure 22.  Species-specific RNAi constructs induce lethality in specific lines.  
C.elegans-specific cyk-4 RNAi induces lethality in the cyk-4C.el (+), while this strain is 
fully viable when raised on C.briggsae specific RNAi.  Conversely, C.briggsae cyk-4-
specific and mCherry-specific RNAi induce 100% lethality in the cyk-4C.br::mCherry; 
cyk-4C.el (ok1034) line.    cyk-4C.br::mCherry; cyk-4C.el (+) worms are viable on all RNAi’s, 
presumably due to rescue by the un-targeted gene copy.   
 
 
line (cyk-4C.br::mCherry; cyk-4C.el (ok1034)) were 100% inviable in both treatments.  
Neither species specific or mCherry RNAi showed significant lethality in worms with 
both the endogenous copy and transgenic copy, suggesting that there is minimal cross 
reactivity between these constructs. 
 To quantify changes in mRNA levels following RNAi treatment, embryos were 
collected by bleaching adult mothers after 24 and 45 hours on RNAi.  RNA was extracted 
from samples and 1 ug of RNA was used to prepare cDNA, a proportion of which (0.1 ul) 
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was used per qPCR reaction.  Primers were designed against low conservation areas to 
specifically amplify either the C.elegans or C.briggsae gene copies; these primers 
behaved as anticipated using genomic extracts (data not shown).  As shown in Figure 23, 
Columns 1-2, 17-18 primers are specific, and surprisingly, the transgene is expressed at a 
very similar level relative to the endogenous gene.  After 24 hours on RNAi, treatment 
with C.elegans RNAi results in a significant decrease in the level of C.elegans specific 
transcript in wildtype (Figure 6, Column 5, pval = <0.005) and cyk-4C.br::mCherry; cyk-
4C.el (+), which carries both the transgenic and endogenous copy (column 13, p val = 
<0.005).  When targeted with C.elegans RNAi,  a significant decrease in C.briggsae 
transcript is observed in cyk-4C.br::mCherry; cyk-4C.el (ok1034), in which CYK-4 is 
expressed from the rescuing C.briggsae transgene (Column 22).   However, these worms 
are viable, suggesting that the remaining level of transgene is sufficient.  Similarly, 
treatment with C.briggsae RNAi reduces levels of C.elegans specific transcript after 45 
hours (Column 7), but viable progeny are still produced.  In contrast, C.briggsae specific 
and mCherry targeting RNAi constructs result in a dramatic decrease in expression of the 
transgene, and also result in loss of viability (Columns 24 and 20, also previous figure).   
Changes in transcript levels reflect a loss of protein in western blots (data not shown).   
 
Conclusion 
 This work demonstrates the feasibility of a gene expression system where 
fluorescent labeled transgenes from the closely related nematode C.briggsae are 
introduced into the C.elegans genome, allowing for controlled gene expression by species 










Figure 23.  Quantitation of mRNA levels following species-specific RNAi.  C.elegans 
(E) and C.briggsae (B) specific primers were used to assess expression levels following 
control, mCherry, C.elegans-specific, and C.briggsae-specific RNAi treatments in F1 
embryos at 24 and 48 hours after Po generation reached adulthood.  Treatments are 


























































species specific RNAi efficiently depletes the endogenous or transgenic gene copy (Sarov 
et al., 2006).   Here we demonstrate that viability is fully rescued by orthologous 
transgenes.  mRNA levels are measured by qPCR following species specific RNAi and 
demonstrate the ability to targeting a specific gene copy, with minimal affects on 
expression of the closely related gene.  This easy and effective method of controlling 



















MULTIPLE PATHWAYS REGULATE ANTERIOR/ 
 
POSTERIOR AXIS FORMATION  
 




PAR proteins and actomyosin dynamics 
 
Polarity is a fundamental cellular trait required for diverse processes including 
asymmetric cell division, cell fate determination, directed cell migration, organization of 
epithelia, and dendrite axon specification.  The C. elegans one cell embryo provides a well 
characterized system with which to study cell polarity.  A group of highly conserved 
regulators known as PAR proteins (PARtioning defective) regulate polarization of multiple 
cell types in C.elegans and other organisms.  In the C.elegans zygote, the anterior/posterior 
(A/P) axis is specified at the one cell stage in response to fertilization.  Embryos become 
polarized along the long axis of the cell in response to sperm donated cue(s), including the 
centrosome.  Polarization is characterized by the formation of separate PAR protein domains 
at the anterior and posterior poles.  Proper localization of PAR proteins into disparate 
domains is essential for further cellular asymmetry, including the mediation of cell fate 
determinant localization and positioning of the mitotic spindle.  Actin dynamics, specifically 
the asymmetric contraction of the cortical actomyosin network, is critical to establish 
asymmetric PAR protein localization.  The molecular mechanisms by which the sperm cues 
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regulate actomyosin dynamics and the establishment of anterior/posterior domains remain to 
be fully elucidated.   
PAR (PARtioning defective) proteins are key regulators of cell polarity in multiple 
cell types.  The core PAR network includes the PDZ domain containing scaffolding proteins 
PAR-3 and PAR-6, the serine/threonine kinases PAR-1, PAR-4 and aPKC, the 14-3-3 protein 
PAR-5, and the zinc/RING finger domain containing PAR-2 (Boyd et al., 1996; Etemad-
Moghadam et al., 1995; Guo & Kemphues, 1995; Hung & Kemphues, 1999; Levitan et al., 
1994; Morton et al., 2002; Morton et al., 1992; Tabuse et al., 1998; Watts et al., 2000; Watts 
et al., 1996; Cowan & Hyman, 2004; Schneider & Bowerman, 2003).  With the exception of 
PAR-2, these core regulators are extremely well conserved throughout metazoa (Cowan & 
Hyman, 2004; Schneider & Bowerman, 2003). 
In unfertilized embryos, PAR proteins are evenly distributed throughout the cell 
cortex (Rose & Kemphues, 1998; Cowan & Hyman, 2004; Cuenca et al., 2003).  In response 
to fertilization, and following the completion of maternal meiosis, embryos become polarized 
by the formation of distinct domains at the cell cortex.  PAR-3, PAR-6 and aPKC localize to 
the anterior domain (Rose & Kemphues, 1998; Cowan & Hyman, 2004).  PAR-1 and PAR-2 
occupy the posterior cortex (Rose & Kemphues, 1998).  PAR-4 and PAR-5 remain localized 
throughout the cortex and cytoplasm (Rose & Kemphues, 1998; Cowan & Hyman, 2004).  
Proper localization of PAR proteins is essential for subsequent cellular asymmetries.  
Prior to fertilization, oocytes are arrested in meiotic prophase I, and display no 
asymmetry with respect to PAR proteins, cell fate determinants, or cortical actomyosin 
(Guo & Kemphues, 1996a; Rose & Kemphues, 1998; Goldstein & Hird, 1996; Cowan & 
Hyman, 2004).  Fertilization triggers the completion of maternal meiosis and dramatic 
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rearrangement of the cortex and cytoplasm (Strome & Wood, 1983; Strome & Hill, 1988; 
Hird & White, 1993; Goldstein & Hird, 1996).  Just prior to the completion of meiosis II, 
the meshwork of actomyosin associated with the cell cortex (observed with non-muscle 
myosin II heavy chain fused to GFP (NMY-2::GFP, Munroe et al., 2003) becomes highly 
dynamic, forming contractile foci that rapidly assemble, move short distances and 
dissociate or merge with other foci (Munro et al., 2003).  Formation of these contractile 
foci coincides with transient membrane invaginations (“ruffling”) in the cell cortex.  
These local contractions suggest that the cortical actomyosin network stably exists under 
uniform dynamic tension (Munro et al., 2004).  
Polarization initiates following the completion of maternal meiosis II.  The first 
cellular asymmetries are observed when the paternal pronuclear associated centrosomes 
physically contact the posterior cell cortex.  At this point, NMY-2::GFP foci cease to 
form in the cortical region nearest the pronucleus/centrosome (Munro et al., 2004).  As a 
whole, the actomyosin network and existing foci move collectively toward the anterior 
(Munro et al., 2004).  This data is supported by previous reports of an “anterior cap” of 
endogenous concentrated actomyosin (Strome, 1988; Kirby et al., 1990).  The 
relocalization the cortical actomyosin is suggestive of localized relaxation in the posterior, 
leading to contraction of the actomyosin network toward to anterior.  A smooth cortical 
domain forms in the posterior, which ultimately spreads to occupy approximately 50% 
egg length (Munro et al., 2004).  To summarize the current model, initiation of polarity 
induces a local change in actomyosin dynamics in the posterior, which results in a 
gradient of actomyosin contractility and the wave of actomyosin that moves toward to 
anterior.   
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The anterior PAR proteins relocalize to the anterior during the period of cortical 
flow that establishes the anterior actomyosin cap (Munro et al., 2004; Etemad-Moghadam 
et al., 1995).  The cortical localization and asymmetrical domain formation of anterior 
PAR proteins requires actomyosin dynamics (Munro et al., 2004; Etemad-Moghadam et 
al., 1995; Cuenca et al., 2003).   Movement of anterior PARs tracks very tightly with the 
anterior relocalization of NMY-2 (Munro et al., 2004).  In wildtype embryos, physical 
contact between the centrosome and posterior cortex is followed by cessation of 
contractile actomyosin foci formation.  Coincident with clearing of contractile machinery, 
the PAR-3/PAR-6/aPKC complex begins to delocalize from the posterior cortex 
(O’Connell et al., 2000; Cuenca, et al., 2004; Cowan & Hyman, 2004; Munro et al., 
2004; Wallenfang & Seydoux, 2000).  PAR-3 and PAR-6 translocate with contractile foci 
as the actomyosin network sweeps toward the anterior (Etemad-Moghadam et al., 1995; 
Cheeks et al., 2004; Munro et al., 2004; Cuenca et al., 2003; Jenkins et al., 2006).  The 
anterior PAR domain is fully established approximately ten minutes following the onset 
of posterior smoothing (Cowan & Hyman, 2006; Cuenca et al., 2004; Munro et al 2004).  
During maternal meiosis, and prior to the onset of polarity, PAR-2 localizes 
transiently to the cortical region overlying the meiotic spindle (generally in the 
presumptive anterior)(Cuenca et al., 2003; Boyd et al., 1996).  Lagging slightly behind 
the relocalization of PAR-3/PAR-6 to the anterior, but within two minutes of the paternal 
pronuclear associated centrosomes contacting the posterior cortex, PAR-2 begins to 
accumulate in the smooth posterior domain (Guo & Kemphues, 1995; Boyd et al., 1996; 
Cuenca et al., 2003; Cowan & Hyman, 2004).  The smooth, PAR-2 associated posterior 
domains expands during the ten minute period which precedes pseudocleavage (Guo & 
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Kemphues, 1995; Boyd et al., 1996; Cuenca et al., 2003; Cowan & Hyman, 2004).  PAR-
1 colocalizes with PAR-2 at the posterior cortex, a localization pattern that is PAR-2-
dependent (Boyd et al., 1996).   
Embryos treated with Latrunculin A or Cytochalasin D show severe polarity 
defects with respect to both contractile asymmetry and cortical PAR domain formation 
(Severson & Bowerman, 2003; Hill & Strome, 1988, Hill & Strome, 1990; Severson et 
al., 2002).  Loss of polarity is also associated with the RNAi mediated depletion of 
actomyosin cytoskeletal components, including NMY-2 (non-muscle myosin II heavy 
chain), the myosin regulatory light chain MLC-4, and profilin (PFN-1), an actin binding 
protein required for the cortical accumulation of microfilaments (Severson et al., 2002).  
In nmy-2, mlc-4 or pfn-1 RNAi treated embryos, PAR-3 is mislocalized throughout the 
cortex and PAR-2 cortical localization lost entirely (Guo & Kemphues, 1996; Shelton et 
al., 1999; Severson & Bowerman, 2003; Cuenca et al., 2003), indicating that a functional 
actomyosin network is required for the anterior pullback of PAR-3, and may also be 
responsible for the cortical localization of PAR-2.    
The Rho family of guanosine triphosphatases (GTPases) includes RhoA, Rac, and 
Ccd42.  Rho family members act as molecular switches, cycling between the GTP-bound 
(active) and GDP- bound (inactive) states to control a variety of biological processes 
involving actin dynamics. Rho regulates the assembly of contractile actomyosin filaments 
that provide the mechanical force required to drive cell migration, cortical ruffling, and 
cytokinesis (Etienne-Manneville & Hall, 2002).  Rac and Cdc42 regulate the 
polymerization of actin to form lamellipodia and filopodia, respectively (Etienne-
Manneville & Hall, 2002).   
 180  
RhoA-GTPase is essential for early polarity establishment in C. elegans.  In rho-
1/RhoA RNAi depleted embryos, the actomyosin network fails to form normally, 
contractile polarity is abolished, anterior PAR proteins are mislocalized throughtout the 
cell cortex (Schonegg & Hyman, 2006; Motegi & Sugimoto, 2006; Jenkins et al., 2006).  
The downstream effector MLC-4 is also required for A/P polarization in the one cell 
embryo, as genetic knockdown induces mislocalization of PAR-3 throughout the cortex 
(Shelton et al., 1999).  MLC-4 is also required for the polarized cytoplasmic flow 
directed at the paternal pronucleus/centrosome prior to apposition at the posterior cortex 
(Shelton et al., 1999).  Phospho-MLC, indicative of activated myosin light chain, 
colocalizes with the dynamic NMY-2 foci prior to fertilization (Jenkins et al., 2006).  In 
the absence of rho-1, phospho-MLC is not detected at the cell cortex, indicating that Rho-
1 promotes assembly or activity of the actomyosin contractile apparatus by inducing the 
phosphorylation of MLC-4.   
The RhoGEF ECT-2 (Pebble) localizes throughout the cell cortex prior the 
initation of polarity, and is required for A/P axis specification.  Loss of function 
phenotypes associated with ect-2 RNAi are similar to the loss of Rho-1, including the 
mislocalization of anterior PARs and a failure to form the dynamic contractile network 
(Motegi & Sugimoto, 2006; Jenkins et al., 2006). These data indicate that the activation 
of Rho-1 via ECT-2 (GEF) is required to set up the cortical contractile network required 
for anterior PAR localization.  ECT-2 and RHO-1 function to establish stable contractile 
meshwork such that tension is uniform throughout the cell cortex. 
Following establishment of the disparate A/P PAR domains, mutual inhibition 
between the anterior and posterior associated proteins stably maintains the cellular 
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asymmetry.  This ‘maintenance phase’ of polarity begins just after the meeting of the 
maternal and paternal pronuclei.   The anterior complex appears to antagonize the 
posterior domain, as loss of par-6, par-3, or pkc-3 leads to mislocalization of PAR-1 and 
PAR-2 throughout the cell cortex (Etemad-Moghadam et al., 1995; Watts et al., 1996; 
Tabuse et al., 1998; Hung & Kemphues, 1999; Cuenca et al., 2003).  Establishment of the 
anterior domain does not initially require PAR-2, as the anterior pullback of PAR-6::GFP 
occurs even when PAR-2 has been depleted by RNAi.  PAR-2 is required for domain 
maintenance however, as the anterior domain collapses back toward the posterior in the 
absence of PAR-2 (Cuenca et al., 2003).  PAR-2 localization at the cell cortex is inhibited 
by an aPKC kinase dependent mechanism (Boyd et al., 1996; Cuenca et al., 2003; 
Kemphues, 2000).    
PAR protein localization also feeds back to regulate actomyosin dymanics during 
the maintenance phase of polarization.  PARs -3, -6, and -5 are required for cortical flow, 
and also contribute to the localization of the anterior complex (Etemad-Moghadam et al., 
1995; Watts et al., 1996; Tabuse et al., 1998; Hung & Kemphues, 1999; Cuenca et al., 
2003).  PAR-2 inhibits the cortical localization of NMY-2 following the formation of the 
posterior domain (Tabuse et al., 1998; Hung and Kemphues; 1999; Etemad-Moghadam et 
al., 1995; Boyd et al., 1996; Cuenca et al., 2003).  These data suggest that maintenance of 
A/P domains involves mutual inhibition between the anterior and posterior PARs.   
 
The centrosome as a polarity cue 
Centrosomes are eukaryotic organelles that function as the major microtubule 
organizing center (MTOC) of the cell, responsible for the organization of bipolar spindles 
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during mitosis.  A centriole pair forms the core of the centrosome.  Centrioles are 
cylindrical, microtubule based structures with 9 fold radial symmetry (Palazzo, 2002).  A 
mature centrosome is comprised of a centriole pair, the matrix, in which the centriole pair 
is orthogonally embedded and flexibly held together, and the electron dense pericentriolar 
material (PCM), which surrounds the centriole pair.  The PCM is made up of numerous 
protein components, including γ-tubulin, which nucleates and anchors microtubules 
(Hamill et al., 2002; Palazzo, 2002). 
 In addition to the paternal complement of DNA, sperm donate a centriole pair to 
the oocyte, which lacks centrosomes.  Following fertilization, the sperm derived 
centrioles separate and each duplicates to form an adjacent daughter centriole (Kirkham 
et al., 2003).  Each new centriole pair recruits PCM components from the maternal 
cytoplasm, such that a mature centrosome exists at each spindle pole by the onset of first 
mitotic metaphase (Kirkham et al., 2003).   
The sperm donated centrosome is critical to the induction of the A/P axis 
(Goldstein & Hird, 1996; Sadler & Shakes, 2000). The centrosome, donated as a pair of 
centrioles, is required for the formation of both the anterior and posterior domains, while 
the Rho-GTPase activating protein (GAP) CYK-4, also donated by the sperm, is required 
for the formation of the anterior cortical domain (Cowan & Hyman, 2004; O’Connell, et 
al., 2000; Jenkins et al., 2006).  These cues likely act upstream of changes in actomyosin 
dynamics, as asymmetric actomyosin contraction is blocked in cyk-4 loss of function and 
ablation or blocking of centrosome maturation.  Specification of body axis in response to 
sperm donated cues is not unique to C. elegans.   Sperm also initiate polarization in 
Xenopus (Gerhart et al., 1981; Scharf & Gerhart, 1980) and mouse (Piotrowska & 
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Zernicka-Goetz, 2001), although the latter is more controversial. It is unknown whether 
sperm induced polarization in these species occurs by reorganization of actomyosin.   
Several centrosome proteins are essential for the assembly and function of a 
mature centrosome, including the coiledcoil proteins SAS-4, SAS-5, SAS-6, and the 
atypical kinase ZYG-1 (O’Connell et al., 2001; Kirkham et al., 2003; Delattre et al., 
2004; Leidel & Gonczy, 2003; Leidel et al., 2005).  SPD-2, localized to centrioles as well 
as the PCM, as well as the PCM components SPD-5, the Aurora kinase AIR-1, the 
microtubule nucleator γ-tubulin, and the ring structure complex ZYG-9/TAC-1 are also 
required (Pelletier et al., 2004; Bellanger et al., 2003; Hannak et al., 2002; O’Connell, 
2000; Hamill et al., 2002; Kemp et al., 2004; Matthews et al., 1998).   
While many of the essential centriole/centrosome components are paternal, many 
additional centrosome and PCM components are maternally acquired, and begin to be 
recruited to the centrosome prior to the completion of maternal meiosis (Dammerman et 
al., 2004; Pelletier et al., 2006).  Several maternal components are loaded prior to the 
onset of polarity (Hannak et al., 2002; Schumacher et al., 1998; Wallenfang & Seydoux, 
2000; Mango Lab) 
Several lines of evidence indicate that the sperm donated centrosome provides at 
least one polarizing cue.  First, the pole proximal to the site of sperm entry, occupied by 
the paternal pronuclear associated centrosomes, always becomes the posterior (Goldstein 
& Hird, 1996).  Second, anucleate sperm, which retain the centriole pair, are capable of 
polarizing the one cell zygote (Sadler & Shakes, 2000).  Third, asymmetries in both 
acytomyosin contractility and PAR protein localization are initiated when the 
centrosomes come into physical contact with the posterior cortex (O’Connell, et al., 
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2000; Cheeks et al., 2004; Cuenca et al., 2003; Munro et al., 2004; Cowan and Hyman, 
2004).   Polarity is abolished when physical contact is inhibited by defects in fatty acid 
synthesis or APC impairment (Rappleye et al., 2002; Rappleye et al., 2003).  Fourth, 
inhibition of centrosome maturation (ie, inhibition of centriole assembly or acquisition of 
essential PCM components) via RNAi-mediated knockdown of essential components 
leads to polarity defects with respect to both cortical PAR domain formation and 
actomyosin contractile asymmetry.  Similarly, loss of spd-2 or air-1 leads to 
mislocalization of PAR-3 throughout the cell cortex (O’Connell et al., 2000; Wallenfang 
& Seydoux, 2002).  The absence of spd-2 or spd-5 also causes defects in the posterior 
clearing of NMY-2 (Munro et al., 2004). Fifth, ablation of the centrosome prior to onset 
of posterior smoothing inhibits the formation of the PAR-2 domain, confirming that the 
centrosome or an associated component is required for the initiation of polarity.  Ablation 
of the centrosome during the formation of PAR-2 domain resulted in a reduced posterior 
domain, while ablation of the centrosome following establishment of the PAR-2 domain 
does not affect domain formation or maintenance (Cowan and Hyman, 2004), suggesting 
that the polarizing signal from the centrosome is transient, but essential for the initiation 
of A/P polarity. 
Given that the establishment of A/P polarity is an actomyosin dependent process, 
how does the centrosome exert its effects on actin to control cell polarity?  Although 
hotly debated, current evidence argues that the role of the centrosome in polarity is 
independent of its role in microtubule organization.  Nocodozol induced 
depolymerization of microtubules does not affect asymmetric A/P cortical domain 
establishment (Strome & Wood, 1983; Hyman & White, 1987; Strome & White, 1993; 
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Hird & White, 1993).  Pharmacological depolymerization data is confirmed by genetic 
knockdown of tubulin components.  RNAi targeting α-tub, β-tub, γ-tub, or γ-tub ring 
structure components abrogates the nucleation of microtubule asters normally observed in 
the one-cell zygote (Sonneville & Gonczy, 2004; Cowan & Hyman, 2004).   However, 
polarization of the A/P axis remains intact, with normal formation of the anterior (PAR-3, 
PAR-6) and posterior (PAR-1, PAR-2) domains (Sonneville & Gonczy, 2004; Cowan & 
Hyman, 2004).  In addition, the centrosome cue appears to function upstream of 
actomyosin relaxation in the posterior, as depletion of centrosome components cause 
defects in the relocalization of NMY-2::GFP (Munro et al., 2004).  
However, the idea that the centrosome cue is microtubule independent remains 
highly controversial, as other groups contend that microtubules are necessary and 
sufficient to initiate polarity.  This argument is based on the finding that inhibition of 
centrosome maturation using RNAi or mat mutants leads to a reversal of the A/P axis 
with respect to PAR domains and some cell fate determinants (PIE-1 but not p-granules) 
(Wallenfang and Seydoux, 2000; O’Connell et al., 2000).  The authors theorize that the 
accumulation of “posterior” factors near the arrested/degrading meiotic spindle indicate 
that the polarizing signal is provided by microtubule plus end contact with the cell cortex, 
a signal generally provided more robustly by the sperm associated centrosomes. This 
“reversed” polarity is sensitive to nocodozole, suggesting that this break in symmetry 
may also be microtubule dependent (Wallenfang & Seydoux, 2002; Tsai & Ahringer, 
2007).   More recent studies demonstrate in live embryos demonstrate a strong correlation 
between the presence of a parental nucleus associated microtubule aster and the onset of 
axis formation (Tsai & Ahringer, 2007).  In this study, knockdown of tubulin resulting in 
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delayed in aster formation also resulted in delayed polarity onset (Tsai & Ahringer, 2007).  
However, it has also been argued that complete abrogation of microtubules in the one cell 
embryo is technically challenging, and persistent astral microtubules may influence 
polarization.  The opposing view asserts that these attenuated microtubules would not be 
capable of transmitting polarization cues.   
The centrosome plays a clear role in the initiation of A/P polarity.  However, the 
specific centrosomal component(s) involved, as well as the mechanism of polarity 
initiation remains ambiguous Inhibiting centrosome maturation prevents not only 
nucleation and organization of astral microtubules, but also inhibits the acquisition of 
numerous PCM components.  Thus, the key questions remains; what component(s) of the 
centrosome are necessary to initiate polarity?     
One intriguing candidate is AIR-1.  Aurora-A kinase (AIR-1 in C. elegans), 
localizes to centrosomes and astral microtubules, and is essential for assembly of the 
bipolar mitotic spindle, as well as centrosome maturation and maintenance of separation 
(Hannak et al., 2001; Schumacher et al., 1998; Ferrari, 2006).  Genetic loss or mutation 
of AIR-1 leads to embryonic lethality due to severe aneuploidy (Schumacher et al., 1998).  
Aneuploid cells display disorganized mitotic spindles, abnormal centrosomes, and string-
like or hypercondensed chromatin (Schumacher et al., 1998).   AIR-1 is required for the 
recruitment of multiple PCM factors, including the kinase zyg-9, CeGrip, TACC, 
centrosomin (Cnn), and the microtubule nucleator y-tub, which is reduced ~60% in air-1 
(RNAi) embryos (Hannak et al., 2001; Giet et al., 2002; Terada et al., 2003).   
Recruitment of these molecules appears to be microtubule independent (Hannak et al., 
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2001).  Nuclear envelope breakdown (NEB) is delayed by one to two minutes (relative to 
other mitotic events) in air-1 RNAi embryos (Hannak et al., 2001). 
Aurora-A also functions in the generating cellular asymmetry.  C. elegans 
embryos depleted of air-1 have defects in the asymmetric distribution of germ line 
determinants, including PIE-1 and p-granules (Schumacher et al., 1998).  In addition, the 
anterior PAR-3 is mislocalized throughout the cell cortex (Wallenfang & Seydoux, 2003).  
Another example of Aurora based regulation of cell fate determinant asymmetry comes 
from experiments using Drosophila sensory organ precursor (SOP) cells.  In these cells, 
the cell fate determinant Numb is asymmetrically localized to the anterior cortex and 
segregated into the neuronal precursor cell.  Aurora-A is required for this asymmetric 
segregation, and appears to be independent of the role of Aurora in centrosome function 
(Berdnik & Knoblich, 2002).  Aurora-A members are emerging as key regulators of 
cellular asymmetry by controlling actomyosin dependent segregation of cell fate 
determinants (Hannak et al., 2001; Berdnik & Knoblich, 2002).  
 
CYK-4 as a sperm donated polarity cue 
In C. elegans zygote, the RhoGAP CYK-4 also acts as a sperm donated polarity 
cue, likely acting on RhoA and influencing the actomyosin network and anterior PAR 
domain formation (Jenkins et al., 2006). CYK-4 is dramatically enriched in sperm and is 
released into the presumptive posterior pole of the egg upon fertilization.  Paternally 
donated CYK-4 is positionally and temporally localized to the future posterior of the 
embryo, where it could function as a polarity cue.  In the posterior, this bolus of CYK-4 
forms punctuate structures that associate with sperm donated membranous organelles, the 
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paternal pronucleus, and the posterior cortex during maternal meiosis and through the 
onset of polarity (Jenkins et al., 2006).  The human ortholog of CYK-4 (male germ cell 
Rac GAP (mgcRac GAP)) is enriched in male germ cells, as is the Drosophila 
counterpart, Rotund Rac GAP, (RnRacGAP) (Toure et al., 1998; Agnel et al., 1992), 
suggesting that this polarizing cue may be evolutionarily conserved.   
RNAi mediated knockdown of paternal CYK-4 induces mislocalization of 
anterior PAR proteins, indicating that the CYK-4 cue controls formation of the anterior 
domain (Jenkins et al., 2006).  Scored at pronuclear meeting, PAR-6::GFP extends 
toward the anterior to occupy 87% egg length, as opposed to 47% egg length in wildtype 
embryos (Jenkins et al., 2006). In these embryos, endogenous PAR-3 is also mislocalized 
throughout the cortex (Jenkins et al., 2006).  PAR-2 localization is relatively wildtype, 
although a reduction in the size of the posterior domain is observed (~30% compared to 
405 in wildtype) (Mango lab, unpublished).  The maternal component of CYK-4, 
required for maternal meiosis as well as the first mitotic cytokinesis, is not required for 
the initiation of A/P polarity (Jenkins et al., 2006).  
The role of CYK-4 in the localization of PAR proteins likely occurs by regulation 
of the actomyosin contractile network.  In the absence of paternal CYK-4, the actomyosin 
network remains contractile over the entire cortical surface (Jenkins et al., 2006).  These 
data suggest that CYK-4 acts upstream of actomyosin relaxation and influences the 
formation of the anterior PAR domain.  Our data indicate that paternal CYK-4 controls 
the actomyosin network by negatively regulating the small GTPase Rho-1/RhoA.  The 
net effect of Rho-1 down regulation is local relaxation of the actomyosin network in the 
posterior (Jenkins et al., 2006).   
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Results and discussion 
We hypothesized that the sperm donated bolus of CYK-4 GAP poised in the 
posterior induces a local relaxation, resulting in a gradient of tension and the wave of 
actomyosin, leading to the relocalization of cortically associated PAR proteins to form 
the anterior domain.  We proposed a model of A/P axis specification in which the two 
sperm donated cues (the centrosome and CYK-4) act in a common pathway to control the 
formation of the anterior cortical protein domain.  In this model, a component of the 
centrosome, specifically the Aurora A kinase AIR-1, activates CYK-4 via 
phosphorylation, leading to an increase in GAP activity toward the small GTPase RHO-
1/RhoA, a key regulator of actin dynamics essential for A/P polarity induction in the one 
cell embryo.  
 This model was based on a paradigm from cytokinesis, in which CYK-4 was 
initially identified and studied (Jantsch-Plunger et al., 2000; Gonczy, 1999; Jantsch-
Plunger et al., 2000; Hirose et al., 2001; Ban et al., 2004).  Studies have demonstrated a 
phosphorylation based mechanism by which the CYK-4 ortholog mgcRacGAP to 
increases its latent GAP activity toward RhoA.   These studies have demonstrated that      
serine residues of mgcRacGAP are phosphorylated by Aurora B At the central midbody, 
a microtubule based structure derived from the central spindle (Minoshima et al., 2003).  
Aurora B is an Aurora family kinase functioning during mitosis, and localizes to mitotic 
chromosomes and the central midbody during late stages of mitosis and cytokinesis 
(Kitamura et al., 2001; Minoshima et al., 2003).  During telophase, direct interaction 
between Aurora B and mgcRacGAP results in mgcRacGAP becoming phosphorylated 
(Minoshima et al., 2003).  In vitro phosphorylation assays indicate that this 
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phosphorylation effects results in a dramatic increase in the ability of mgcRacGAP to 
hydrolyze GTP from RhoA, greater than 70% compared to unphosphorylated 
(Minoshima et al., 2003).  Phosphorylation by AuroraB does not affect the GAP activities 
toward Cdc-42 and Rac (Minoshima et al., 2003; Ban et al., 2002).   Serine 387, located 
in the highly conserved GAP domain, was identified as the critical residue for this 
phosphoswitch, although additional residues, including S387 and S410 are also 
phosphorylated by Aurora B (Minoshima et al., 2003; Ban et al., 2002).  These findings 
were confirmed in vivo using phosphospecific antibodies, kinase dead Aurora B, and 
phosphomimetic (S387D) and phosphodefective (S387A) versions of mgcRacGAP 
(Minoshima et al., 2003).  
 Based on these findings, we postulated that Aurora kinase AIR-1, localized at the 
centrosome, would be poised to phosphorylate the posterior localized bolus of CYK-4.  
This activation event would then trigger the locale decrease in actomyosin contractility 
by decreased activity of RhoA GTPase.  This model would account for the discrepancy 
between in vivo data, implicating RhoA as the likely target of CYK-4, and in vitro data, 
reporting the negligible GAP activity of CYK-4 toward Rho-1.  Both human and worm 
orthologs of CYK-4 show greater GAP activity toward cdc-42 and Rac than toward 
RhoA (Jantsch-Plunger et al., 2000; Toure et al., 1998).  Others have reported that CYK-
4/mgcRacGAP mediated GTP hydrolysis from RhoA is below the level of detection 
(Kawashima et al., 2000; Raymond et al., 2001).    This model would also account for the 
30 minute lag time observed between fertilization and the onset of A/P axis formation.  
 Aurora A (AIR-1) kinase is localized to centrosomes and is required for 
maintenance of centrosome separation and recruitment of y-tubulin (Hannak et al 2002).  
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To address whether AIR-1 is present and active at the onset of polarization, 
immunofluorescence assays were used to examine specific stages of A/P axis formation.  
Previous studies have demonstrated that loss of AIR-1 function results in polarity defects 
(Wallenfang and Seydoux, 2002; O’Connell et al., 2000), although whether this effect 
was due to failure of centrosome maturation and function was not addressed.   
To determine whether AIR-1 might function as a centrosomal effector of polarity 
and/or CYK-4 function, antibody stains were used to detect AIR-1 localization at the 
centrosome during the early stages of A/P polarization.  As we predicted that the role of 
AIR-1 would depend on kinase activity, we also tested the activation status of AIR-1 
using a phosphospecific antibody (Thr288-PO4, Cell Signaling, d13a11), and total AIR-1 
was assayed using a C.elegans specific AIR-1 antibody generated and generously 
provided by the Oegema lab (UCSD).  Antibody stains were performed using standard 
protocols, and were costained with polarity markers, including PAR-3, PAR-6::GFP and 
NMY-2::GFP.  The stages associated with polarity initiation were defined by pronuclear 
size and localization, DNA condensation of the paternal pronucleus, meiotic status of the 
maternal DNA, and the localization of anterior polarity markers.  The anterior pole was 
generally defined by maternal meiosis and/or the resulting polar body, and the paternal 
pronucleus was generally observed in the posterior.  As shown in Figure 24, AIR-1 total 
protein is initially high in the cytoplasm, and is recruited to the centriole pair during 
maturation and duplication of the centrosomes, which is associated with increased size of  
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the male pronucleus.  At this stage, the paternal pronucleus was often, but not always, 
associated with the posterior cortex.   Over time, levels of AIR-1 total protein in the 
cytoplasm decrease, concomitant with an increased size of centrosomes.  At the onset of 
polarity, fairly sizable but generally separated centrosomes were juxtaposed to the cortex, 
and if localized to one side of the pronucleus, this side of the embryo inevitably showed 
stronger clearing of anterior marks.  In contrast, Thr288-PO4 AIR-1 (activated) is 
extremely low in the cytoplasm, and localizes (or more likely is activated) at the 
centrosome just prior to, or coincident with the onset of polarity initiation.  As shown in 
Figure 25, >95% of embryos (N=43) have detectable activation of AIR-1 at the 
centrosome, while AIR-1 total is localized in earlier stages.  While some factor(s) 
responsible for activation of AIR-1 have been suggested in other species (i.e., TXP, Bora), 
the kinase has not been identified in C.elegans, and thus was not tested for a role in 
polarity (Karsenti, 2005; Ozlu et al., 2005). 
As shown in Figure 26, activated AIR-1 occupies a small domain in the interior of 
the centrosome, likely associated with the centriole pair.  These data demonstrate that 
AIR-1 is spatially and temporally highly regulated at the centrosome, and that activation 
strongly correlates with the onset of polarity.  Based on these findings, AIR-1 kinase is a 
strong candidate to activate CYK-4 GAP activity at the posterior cortex, inducing the 
local decrease in RhoA GTPase function and actomyosin contractility.   
We next wanted to examine the polarity defects associated with loss of AIR-1 
function, based on the hypothesis that if AIR-1 functions upstream of CYK-4, loss of 
these factors might have similar polarity phenotypes.  While we were unable to replicate 


















Figure 25.   Quantitation of AIR-1 localization during polarity onset.  In prepolarization I 
stage embryos, anterior polarity markers are localized throughout the cortex, the maternal 
pronucleus is in meiosis I, and the paternal pronucleus is highly condensed. 
Prepolarization II is characterized by maternal meiosis I/II, extrusion of the first polar 
body, and enlargement of the male pronucleus, but the absence of DNA condensation.  In 
prepolarization III, one or both polar bodies are extruded at the anterior and the male 
pronucleus is slightly larger but lacking DNA condensation.  Polarization is characterized 
by localization of the male pronucleus at the posterior cortex, roughly equivalent male 
and oocyte pronuclear size, condensation of the pronuclear DNA, extrusion of both polar 
bodies at the anterior, and the partial clearing of anterior markers from the posterior pole.  
Postpolarization stage embryos have more complete posterior clearing, obvious DNA 




RNAi resulted in variable polarity phenotypes.  As shown in Figure 27, antibody staining 
of fixed embryos demonstrates highly reproducible defects.  In control RNAi treated 
embryos, anterior markers (PAR-6::GFP, NMY-2::GFP, PAR-3) are relocalized to the 
anterior domain in the period following A/P polarity onset and pronuclear migration.  









Figure 26.   Activated AIR-1 is localized with a subset of AIR-1 total protein, while AIR-
1 total also localizes to astral microtubules.   
 
 
anterior markers (28%), reversed polarity, in which anterior markers are removed from 
the anterior cortex, perhaps in response to components associated with residual meiotic 
spindle (28%), bilateral clearing, in which small domains of anterior markers are cleared 
from both poles (27%), and anterior markers in the wildtype configuration but extended 
toward the midline and into the posterior domain.   
To address whether these variable phenotypes could be attributed to weak or 
partial RNAi knockdown, we examined the AIR-1 localization and activity by staining 
AIR-1-PO4 and microtubules.   As shown in Figure 28, >95% of air-1 RNAi treated 
embryos lack detectable AIR-1 activity and >90% fail to form microtubule asters during 
the early stages of polarization.  A proportion of late stage embryos, assayed at 
pronuclear meeting, form microtubules asters that fail to separate and appear wiggly, 
disorganized, and off axis.  The associated polarity phenotypes do not seem to correlate 
in any specific pattern with these changes.  We did not address however, possible delays  
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Figure 28.  Variable air-1 phenotypes are not likely related to partially effective RNAi.  
A.  air-1 RNAi induces loss of AIR-1 PO4 staining (active) in NMY-2::GFP, which in 
this embryo is completely mislocalized.  Similar effects were observed in the PAR-
6::GFP strain.  The quantification of loss of AIR-1 staining following air-1 RNAi is 
shown at the right.  B.  air-1 RNAi also leads to loss of microtubule asters.   In early 
embryos, when asters are normally separated and localized to each side of the paternal 
pronucleus, air-1 RNAi treated embryo lack asters, and instead, show short microtubules 
localized throughout the embryo.  This effect is quantified in the graph at the left.  In late 
stage air-1 treated embryos (pronuclear meeting), microtubule asters are observed, 
although these are highly disorganized.  Centrosomes also fail to separate, leading to 
mitotic defects.   
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in cell cycle, pronuclear migration, and chromosome condensation that may result from 
air-1 RNAi (Portier et al., 2007; Hachet et al., 2007).   
We were intrigued to note the consistent variability associated with air-1 RNAi, 
and we hypothesized that this might be suggestive of an additional, partially redundant 
polarizing pathway.  An attractive candidate to function such a pathway is the posterior 
localized RING-finger protein PAR-2.  First, we characterized the par-2 RNAi phenotype 
during the early stages of embryogenesis.  Previous studies (Cuenca et al., 2003; 
Kemphues and Strome labs) found that PAR-2 functions in the maintenance phase of 
polarity, rather than the initiation phase.  By performing RNAi using highly stringent 
conditions (injection at >2 mg/ml RNAi, and 25oC incubation of P0 until ~20 % sterility 
prior to dissection of embryos), we found that loss of PAR-2 function induced ~20% 
overextension of PAR-6::GFP, and ~50% overextension of NMY-2::GFP.  These effects 
are shown in Figure 29.  A previous study (Tsai & Ahringer, 2007) found that the relative 
levels of anterior and posterior PAR proteins can affect the polarity phenotypes, and this 
may contribute to these affects.  However, we also observed a proportion of embryos 
with defects in microtubule aster formation, including weak nucleation of microtubules, 
misaligned or delayed localization of the paternal pronucleus at the posterior cortex 
relative to chromosome condensation and pronuclear size.  A previous study also showed 
that PAR-2 localizes transiently to the anterior cortex during meiosis (Boyd et al., 1996); 
this may contribute to the reversed or bilateral phenotypes.   
We hypothesized that AIR-1/centrosomal initiation of polarity functions in a 
common pathway with Rho-1/RhoA GTPase, CYK-4 (GAP), and actomyosin dynamics.  
To test the hypothesis that PAR-2 functions in polarity initiation, we performed double  
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Figure 29.  PAR-2 plays a subtle role during polarity initiation.  A.  par-2 RNAi induces 
extension of the PAR-6::GFP anterior domain, as well as reduced astral microtubules and 
delay in pronuclear migration.  B.  Quantitation of par-2 RNAi polarity defects in lines 
expressing GFP marked anterior factors.   
 
 
RNAi epistasis experiments by injecting par-2 and air-1 or rho-1 dsRNA in equal 
concentrations.  Control experiments were performed by injecting each RNAi in 
combination with an off target RNAi (pha-4), to ensure equivalent targeting and 
interaction with RNAi machinery.  Embryos were dissected from NMY-2::GFP or PAR-
6::GFP P0 worms injected with 1 mg/ml each RNAi, and fixed, stained, and imaged.  In 
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addition to scoring polarity phenotypes, comarkers (i.e., microtubules, PAR-2) and 
Dapi/DNA were used to verify effective depletion of targeted genes.  For air-1 RNAi, 
only embryos lacking microtubule asters were scored.  PAR-2 staining was used to 
confirm the absence of protein in embryos scored in par-2 RNAi treatment.  Following 
treatment with rho-1 RNAi, actomyosin foci are lost (in NMY-2::GFP), and partial 
failure in meiosis II leads to increased DNA in the oocyte pronucleus (anterior).  This 
phenotype, and the quantitation of the additive/synergistic effects are shown in Figure 30.   
Embryos treated with air-1 and rho-1 single RNAi show similar percentages of complete 
mislocalization of anterior polarity markers, suggesting these factors may function in a 
common pathway.  air-1+rho-1 double RNAi treated embryos are similar to the single-
RNAi treated samples (20-30% complete mislocalization).   Embryos treated with par-2 
RNAi show a percentage of partial mislocalization, but no complete mislocalization.  
However, combining par-2 RNAi with either air-1 or rho-1 induces a dramatic increase 
in the percentage of complete mislocalization of anterior markers.  This synergistic effect 
demonstrates that par-2 functions in a pathway parallel to the air-1/rho-1 pathway of 
polarity specification.  Our double RNAi studies in NMY-2::GFP also demonstrate that 
air-1 is epistatic to rho-1 RNAi with respect to contractile foci formation (data not 
shown), lending additional support for function in a common pathway.  We also observed 
while rho-1 RNAi resulted in the absence of NMY-2::GFP contractile foci as previously 
reported, the addition of par-2 RNAi led to the surprising phenotype of increased 
concentration of NMY-2 at the cortex.  This finding suggests that PAR-2 may feed in to 
the polarity pathway at the level of actomyosin.  A proposed model for these interactions 







Figure 30.   Effects of rho-1 and rho-1+par-2 RNAi in NMY-2::GFP embryos.  Top: 
Additive effects of rho-1+par-2 suggests these factors function in separate pathways.  
Bottom:  Quantitation of air-1, rho-1, par-2 and combinatorial RNAi demonstrates 














Figure 31.   A model of A/P polarity initiation.  AIR-1 acts as a centrosomal effector of 
polarity, acting upstream of CYK-4(GAP), RHO-1/RhoA GTPase and actomyosin 




Our findings are consistent with a recently published study demonstrating 
embryos lacking actomyosin activity (by depletion of the regulatory myosin light chain 
mlc-4 or the Rho-GEF ect-2) are polarized by PAR-2 (Zonies et al., 2010).  This study 
also addressed the antagonism of NMY-2 at the cortex by PAR-2, and showed that PAR-
2 indirectly inhibits NMY-2 cortical localization by antagonism of PAR-3 (Zonies et al., 
2010).   A subsequent study went on to demonstrate an interaction between PAR-2 and 
the centrosome/astral microtubules (Motegi et al., 2011), including localization of PAR-2 
at the MTOC core, and loss of PAR-2 at the cortex when microtubules are absent.  PAR-
2 was shown to bind microtubules in vitro (Motegi et al., 2011); this activity may account 
for the destabilization of microtubules and/or failure to properly nucleate astral 
microtubules.  Motegi and colleagues went on to show that microtubule binding protects 
PAR-2 from aPKC phosphorylation, and that this activity is essential to PAR-2 
localization to the cortex and polarity initiation. 
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 We next wanted to address the interaction of AIR-1 and CYK-4, as our hypothesis 
suggests that AIR-1 kinase activates the GAP activity of CYK-4 toward RHO-1 GTPase.  
As shown in Figure 32, CYK-4 contains multiple domains that are conserved with 
mgcRacGAP (the human ortholog of CYK-4).  In addition, both proteins contain a 
number of potential AuroraA/AIR-1 phosphorylation sites, including a cluster of sites in 
the N-terminal region.  The alignment of this region is shown in (B), and the underlined 
amino acids were found to be required for mcgRacGAP activation by Aurora B kinase  
 
Figure 32.  CYK-4 orthologs in humans and other species.  Top panel (A) schematizes 
conservation of domains in human and C.elegans.  GAP (GTPase activating) and DAG 
(diacylglycerol interacting) and AuroraA consensus sites ([KR]XX[ST][ILVGA]) are 
shown.  The boxed regions are shown in B.  Lower panel (B), shows alignments of 
several Caenorhabditis species, as well as human and mouse.  The AuroraA sequence 
required for activation during cytokinesis is underlined in red.  Additional conserved sites 
are highlighted in yellow, and the likely equivalents of these in mammalian species are 
boxed.  The S224/226 couplet does not fit the canonical Aurora site defined in 
mammalian cells, and were not analyzed in our study.   
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during cytokinesis (Ban et al., 2004).  We postulated that these residues (S209/211), and 
the upstream residues S197/198, which represent conserved Aurora phosphorylation sites, 
might be targeted by AIR-1 activity and function in A/P polarity initiation.  The 
downstream serine residues (S224/226) are less strong Aurora sites, and were not 
addressed in our study.   
Our collaborators in the Ferrari lab at the University of Zurich (SW) performed in 
vitro kinase assays using recombinant human Aurora A and GST tagged C.elegans CYK-
4.  These assays demonstrated that Aurora A is capable of phosphorylating CYK-4 
(Figure 33).  Moreover, deletion of the control region (CR) containing S197, S198, S209 
and S211 led to reduced phosphorylation in these assays, supporting our hypothesis.  













Figure 33.    Kinase assay with recombinant proteins suggests that human AurA/AIR-1 
phosphorylates CYK-4 at conserved phosphorylation sites (CR, 197/198, 209/211) in 
vitro.  (Courtesy of the Ferrari lab). 
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additional sites may also be phosphorylated in vitro, but whether the CR sites or others 
are phosphorylated in vivo could not be addressed, as attempts to generate and purify a 
phosphospecific CYK-4 antibody were unsuccessful.   
We next addressed whether these conserved Aurora phosphorylation sites 
(S197/198, S209/211) are essential for CYK-4 function by a transgenic method.  Using 
the C.briggsae transgenic system, CYK-4 constructs introduced in single copy by the 
mosSCI system (as described in Appendix I).  We also generated lines containing point 
mutations to generate phosphomimetic (S E and S  D) and phosphodefective (S  
A) CYK-4 mutant lines.  The serines 197/198 and serines 209/211were mutated in pairs, 
as in addition, all 4 sites were mutated to alanine (phosphodefective).  The different 
mutant strains are summarized in Table 6.  As shown, most strains, including both the 
wildtype and mutated CYK-4 lines express in both the germ line and embryos (data not 
shown).  We then assessed whether these different mutant constructs were able to rescue 
the cyk-4 (ok1034) background.   
As expected (and discussed in Appendix A), the wildtype C.briggsae CYK-4 
transgenic was able to fully rescue a cyk-4 null background.  We also predicted that the 
CYK-4 GAP defective mutations would be unable to rescue the cyk-4 null, as the GAP 
activity is thought to be required for both the polarity and cytokinesis functions of CYK-4.  
Both GAP domain point mutations (R459A and R459K) result in constructs that express 
and localize similar to wildtype when the C.elegans cyk-4 is present (data not shown).  
However, these constructs do not rescue when crossed into the cyk-4 (ok1034) null strain, 
resulting in sterile adults the homozygous F2 generation, and develop to adulthood based 
on the maternal contribution from the heterozygous F1.  In contrast, strains containing  
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single copies of C.briggsae cyk-4 which have been mutated to convert S197/198 and/or 
S209/211 to alanine (phosphodefective) or glutamic/aspartic acid (E/D, phosphomimetic) 
were able to fully rescue, resulting in Mendelian inheritance patterns by genotyping PCR.  
These homozygous mutant populations appear fully viable and fertile.  However, we did 
not test GAP activity or of these mutants in vitro, nor did we test individual recombinant 
mutant proteins in Aurora kinase assays.  As CYK-4 phosphospecific antibodies could 
not be generated, we were also unable to test whether these point mutations changed the 
phosphorylation status.  As we were unable to confirm the affects of point mutations with 
respect to AuroraA/AIR-1, and all mutants (with the exception of GAP defective mutants, 
which serve as proof of principle) were fully viable, we did not further examine polarity 
defects in these mutants.  However, based on our findings and those of the Seydoux lab, 
the ability of PAR-2 to act in a separate polarizing pathway may account for the observed 
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nonlethal phenotypes of these mutants.  The requirement for CYK-4 GAP activity during 
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